MYC transcriptional functions controlling epidermal stem cell self-renewal and differentiation by Nascimento, Elisabete
MYC transcriptional functions
controlling epidermal stem cell
self-renewal and differentiation
Elisabete Nascimento
Darwin College
University of Cambridge
A dissertation submitted for the degree of
Doctor of Philosophy
September 2011
This dissertation is dedicated to my mum, dad and brother.
Declaration
This dissertation is the result of my own work and includes nothing which is the
outcome of work done in collaboration except where specifically indicated in the
text.
The work described was carried out at the Wellcome Trust Centre for Stem Cell
Research, University of Cambridge, and the Cancer Research UK Cambridge Re-
search Institute under supervision of Dr. Michaela Frye and Dr. Duncan Odom.
The length of this thesis does not exceed 60,000 words, not including figures, pho-
tographs, tables, appendices and bibliography, as specified by the Biology Degree
Committee.
This dissertation is not substantially the same as any that I submitted for a de-
gree or diploma or other qualification at any other University.
Furthermore, I state that no part of this dissertation has been, or is concurrently
being, submitted for any degree, diploma, or other qualification.
Elisabete Nascimento
September 2011
ii
Abstract
The oncoprotein MYC has long been recognized as an important stem cell regula-
tor, yet its direct biological contributions have been difficult to determine. MYC
activation can induce pleiotropic phenotypes and mediates cellular functions as
opposing as cell growth and proliferation, metabolism, differentiation and apopto-
sis. In addition, functional redundancy with MYCL and MYCN proteins as well
as dose dependency, complicates the identification of the most relevant biological
functions. Studies in tissues with high proliferative capacity and rapid turnover
have shown that MYC is a key regulator of homeostasis by balancing stem cell
self-renewal, proliferation and differentiation processes. In skin, MYC induces the
exit of epidermal stem cells from their niche, increases proliferation of progenitor
cells and subsequently stimulates lineage specific differentiation into interfollicu-
lar epidermis and sebaceous glands; yet the direct transcriptional roles of MYC
in these processes remained elusive. To gain insight into the transcriptional roles
of MYC in epidermal stem cell homeostasis, I performed chromatin immunopre-
cipitation on microarrays (ChIP-on-Chip) using mouse proximal promoter arrays
combined with mRNA expression data that was generated using epidermal cells
from wild-type and transgenic K14MycER mice, treated in a time-course from
zero to six days with tamoxifen, to induce the Myc transgene expression in the
basal undifferentiated layers of the epidermis. Data analysis revealed that 2187
genes, which corresponds to 15% of the promoter regions covered, were directly
regulated by MYC. To identify genes uniquely regulated by MYC in skin, I per-
formed gene expression studies on mouse skin in which MYC was conditionally
deleted in the basal layer of the epidermis. Remarkably, I found that 45% of all
repressed genes were related to epidermal maintenance and differentiation. To
better understand the mechanism of how MYC induces keratinocytes to differen-
tiate specifically into lineages of sebaceous glands and interfollicular epidermis,
I analyzed whether MYC might have directly regulated genes involved in skin
differentiation. Here, I focused my studies on a single 2.2 Mb locus located on
mouse chromosome 3 designated as the epidermal differentiation complex (EDC).
To assess how activation of MYC could influence the expression of genes local-
ized to the EDC, I performed ChIP-on-Chip for MYC, H3K4me3, H3K27me3,
iii
as well as transcription factors, which have been described to regulate terminal
differentiation in skin, such as CEBPα, OVOL-1, KLF4, TCFAP2-γ and SIN3A,
among others. I demonstrated that MYC recruits a specific set of tissue-specific
transcription factors to the EDC, (e.g. KLF4 and OVOL-1) and thereby prevents
binding of a different and distinct set of genomic regulators, (e.g. CEBPα, MXI1
and SIN3A). Using a combination of mouse models and systems biology tools, I
then identified SIN3A as a key regulator in this MYC-dependent transcriptional
network. I found that MYC and SIN3A form a negative feedback loop, which
is required to balance proliferation and differentiation in epidermis, and both
factors are essential to maintain skin homeostasis.
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Chapter 1
Introduction
1.1 Anatomy of the skin
The skin serves as a protective barrier against environmental insults potentially
harmful to the organism. It prevents the body from dehydration, microbial in-
fection and UV radiation; while also providing temperature regulation and tac-
tile sensitivity. This protective function is supported by the acquisition of ap-
pendages, such as hair follicles (HFs), sebaceous glands (SGs), sweat glands and
nails that are formed through a sequence of complex epithelial-mesenchymal inter-
actions during development [Fuchs, 2007]. Mammalian adult skin can be divided
into two main layers: the epidermis (ectoderm origin) and the dermis (mesoderm
and neural crest origins) (Figure 1.1). The epidermis, also designated as interfol-
licular epidermis (IFE), is the outermost layer of the skin, covers the whole surface
of the body and is separated from the dermis by a basement membrane. Lying on
top of this membrane sits a basal layer of mitotically active epidermal cells, also
known as keratinocytes. These cells express keratins, produce and secrete extra-
cellular matrix (ECM) proteins and growth factors. Basal keratinocytes provide
support to the suprabasal cells, which have already initiated terminal differen-
tiation and therefore detached from the basement membrane, withdraw the cell
cycle and moved upwards to the skin surface [Pincelli and Marconi, 2010]. This se-
quence of events generates spinous and granular layers, culminating in a cornified
envelope that contains transcriptionally inactive, flattened, dead keratinocytes
1
that will eventually be shed from the skin surface by inner cells moving upwards
[Candi et al., 2005]. It is the balance between keratinocyte’s proliferation and
differentiation that maintains skin homeostasis. This equilibrium must depend
on a source of long-lived, high proliferative cells with regenerative potential, in
other words putative stem cells [Fuchs, 2009a].
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Figure 1.1: Schematic illustration of the murine skin. The skin is subdivided
into two layers: epidermis and dermis. The interfollicular epidermis (IFE) is interdis-
persed with appendages such as hair follicles (HF) and sebaceous glands (SG). These
structures are maintained throughout the life of the organism and are constinuously
self-renewed due to the presence of stem cells (depicted in blue). These cells are lo-
cated in niches in the basal layer of the epidermis and sebaceous glands and in the
bulge region of the hair follicle. In addition, other structures of the hair follicle are
shown such as: ORS - outer root sheath, IRS - inner root sheath, DP - dermal papilla,
HG - hair germ, HS - hair shaft and the matrix. This figure was adapted and modified
from Khavari [2004].
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1.2 Stem cells, transit amplifying cells and com-
mitted progenitors
Stem cells are currently defined through functional criteria by the ability to con-
tinuously self-renew and generate daughter cells, or committed progenitors, with
potential to undergo terminal differentiation [Lajtha, 1979; Schofield, 1983]. Dur-
ing mammalian development, embryonic stem cells are able to divide and give
rise to all differentiated cell types in the embryo. In contrast, highly dynamic
tissues such as the skin, hematopoietic system or intestinal gut, require adult
stem cells to maintain tissue integrity after cell death or injury; these however
are restricted to generate progenitors and differentiated cells within that lineage
[Hall and Watt, 1989]. The skin constitutes an attractive model to study stem
cell biology, not only because of its dynamic nature and self-regenerative capac-
ity, but also due to its high cell turnover and accessibility. Epidermal stem cells
are believed to divide rarely in order to preserve their proliferative potential (i.e.
clonogenicity) and genomic DNA integrity. They can divide and generate transit
amplifying (TA) or committed progenitor cells with a more restricted prolifera-
tive potential. TA cells will inevitably initiate a terminal differentiation program
and exhaust their proliferative capacity in order to maintain normal homeostasis.
The slow-cycling nature of keratinocyte stem cells is shown by their ability
to retain modified DNA precursors [e.g. tritiated thymidine (3H-T) or bromod-
eoxyuridine (BrdUrd)] or chromatin labels (e.g. H2B-GFP) in label-retaining
assays [Bickenbach, 1981; Bickenbach and Chism, 1998; Tumbar et al., 2004]. In
these experiments, TA or progenitor cells with a high division rate, will dilute the
dye, whereas stem cells will preserve it. These studies, combined with the fact
that label retaining cells (LRCs) exhibit high clonogenicity in vitro, recognized
LRCs as epidermal stem cells, located in three distinct locations or niches: HF
bulge, SGs and basal layer of the IFE. In normal physiological conditions it is
believed that each stem cell niche gives rise to its own progeny and, only under
the appropriate stimuli (e.g. wounding), an epidermal stem cell will generate
progeny in the three different lineages [Ghazizadeh and Taichman, 2001].
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1.3 Epidermal stem cell niches
1.3.1 Hair follicle
The hair follicle is a skin appendage that undergoes continuous cycles of growth
(anagen), regression (catagen) and rest (telogen) [Hardy, 1992] (Figure 1.2). Dur-
ing anagen, slow-cycling LRCs residing in the murine and human bulge region
and produce rapid, but transiently, proliferating matrix keratinocytes [Akiyama
et al., 2000; Cotsarelis et al., 1990; Lyle et al., 1998; Tumbar et al., 2004]. In
mice, matrix cells divide in the hair bulb after receiving signals from the dermal
papilla (DP); a region in the HF that aggregates dermal cells and capillaries.
Their progeny moves upwards and differentiates into the seven different lineages
that will constitute the hair shaft (HS) and inner root sheet (IRS). As soon as
catagen begins, the DP regresses through apoptosis and starts moving upwards.
Consequently, matrix cells stop receiving signals from the mesenchymal cells of
the DP, cease to proliferate and the HF enters a dormant phase known as telogen
(reviewed in [Blanpain and Fuchs, 2009; Braun and Prowse, 2006; Fuchs, 2009b]).
Dermal papilla (DP)
Mature Anagen Catagen Telogen Early Anagen
Figure 1.2: Hair follicle cycles. Scheme of the different cycles of hair follicle regen-
eration. Anagen, the growth phase of the hair cycle (mature and early), the regression
phase where the dermal papilla (DP) is pushed upwards closer to the interfollicular epi-
dermis (catagen) and the resting phase (telogen). This figure was adapted and modified
from http://hairline.ge/photos/uploads/sub-about-hs-eng-01.jpg.
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The mechanisms regulating HF regeneration remain poorly understood, however
there is evidence for crosstalk between epidermal and dermal cells [Fuchs and
Horsley, 2008].
Currently, the HF bulge constitutes the best defined epidermal stem cell niche.
Located at the site of attachment of the musculus arrector pili, this region con-
centrates the higher number of LRCs within the appendage. Nevertheless, bulge
LRCs can be stimulated to proliferate under stress conditions, for example, upon
treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) or as a consequence
of physical injury [Cotsarelis et al., 1990; Jaks et al., 2010; Morris and Potten,
1999]. In mice, the majority of LRCs overlaps, both locally and in terms of gene
expression, with bulge cells expressing the cell surface marker CD34 [Trempus
et al., 2003] (Figure 1.3). CD34 expressing keratinocytes display high prolifera-
tion potential in vitro and are able to fully reconstitute HF and IFE in vivo -
functional characteristics of epidermal stem cells [Blanpain et al., 2004; Trempus
et al., 2003; Tumbar et al., 2004]. This population of stem cells overlaps with
other stem cell marker which has been identified in the region covering the bulge
and upper region of the hair germ (HG), keratin 15 (KRT15). Keratinocytes
expressing KRT15 have a gene expression profile identical to the one presented
for CD34+ bulge cells [Morris et al., 2004; Trempus et al., 2007] (Figure 1.3).
Interestingly, CD34+ and KRT15+ keratinocytes express high levels of leucine-rich
repeat-containing heterotrimeric guanine nucleotide-binding protein (G protein)-
coupled receptor 5, LGR5 (Figure 1.3). In contrast to the markers previously
described, LGR5 marks actively cycling keratinocytes in the HG at the onset
of anagen, as well as a rare number of bulge LRCs [Jaks et al., 2008] (Figure
1.3). Despite the fact that the LGR5+ cell population does not comply with the
historic definition of a stem cell population, LGR5+ keratinocytes can originate
functional HFs in and ex vivo; supporting a model in which the HF is main-
tained by quiescent as well as actively cycling stem cells [Li and Clevers, 2010].
The regions located above the bulge region (namely, infundibulum and isthmus)
also arbour highly clonogenic keratinocytes, fully able to reconstitute the HF. In
the upper isthmus, keratinocytes expressing the thymus stem cell marker PLET1,
which is recognized by the monoclonal antibody MTS24, are able to fully differ-
entiate in HF and IFE lineages, as multipotent of stem cells would [Jensen et al.,
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Figure 1.3: Stem cell markers in murine skin. Stem cell populations have been
identified in the hair follicle (HF), sebaceous glands (SG) and interfollicular epider-
mis (IFE) and are represented according to their gene/protein expression or promoter
activity: LGR5 (dark blue, hair germ and bulge), CD34 (light green, bulge), KRT15
(light blue, bulge), LGR6 (magenta, lower isthmus), BLIMP1 (white, sebaceous gland
opening), LRIG1 (dark green, isthmus), PLET1 or MTS24 (pink, isthmus), KRT5/14
(orange, basal layer of epidermis) and MYC (yellow, basal layer of epidermis and se-
baceous gland). Slow diving label retaining cells, LRCs (grey, bulge). This figure was
adapted from Jaks et al. [2010] and Khavari [2004].
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2008]. These cells do not express CD34, but do express low levels of integrin alpha
6, ITGα6 and the infundibulum marker, stem cell antigen 1, LY6A. Moreover,
another population of quiescent HF cells has been identified in the upper region
of the isthmus and lower infundibulum; this population expresses the leucine-
rich immunoglobin-like protein, LRIG1 marker [Jensen et al., 2009] (Figure 1.3).
Finally, in the region between CD34+ bulge cells and MTS24/LRIG1 expressing
cells, another subpopulation of highly clonogenic keratinocytes was also identified,
marked by LGR6. Similarly to the LGR5 population, LGR6+ keratinocytes do
not retain labels; nevertheless, these cells fulfil all functional criteria that define
an epidermal stem cell, being able to supply the IFE and SG lineages [Snippert
et al., 2010]. Interestingly, LGR5, LGR6 and LRIG1 are co-expressed during de-
velopment at embryonic day 18.5 (E18.5) with SOX9, a marker expressed during
hair morphogenesis, suggesting the existence of a common precursor for HF stem
cells in the adult [Jaks et al., 2008, 2010; Jensen et al., 2009; Nowak et al., 2008;
Snippert et al., 2010; Vidal et al., 2005]. Early murine bulge LRCs also express
other transcription factors associated with stemness, such as: TCF3, LHX2 and
NFATC1 [Nowak et al., 2008].
The majority of previous studies identified stem cell populations in the murine
HF. The main reason for this is that in humans, the bulge region is difficult to
identify morphologically; and only, few stem cell markers have been identified,
due to the understandable inability to conduct lineage tracing experiments in
humans. Still, it has been possible to demonstrate that human HF bulge ker-
atinocytes are quiescent and express high levels of KRT15, similarly to mouse
bulge keratinocytes. However, the expression pattern does not overlap with CD34
because in humans KRT15 is expressed in the lower ORS of the HF [Cotsarelis,
2006; Lyle et al., 1998; Ohyama et al., 2006]. Gene expression profiling of human
HF bulge cells revealed CD200 as a new marker for quiescent HF cells; but it also
confirmed the existence of different stem cell populations between mouse and hu-
man [Ohyama et al., 2006]. Although murine and human bulge stem cells express
different markers, the signalling pathways that govern HF stem cell maintenance,
induction, cell fate and differentiation processes appear to be conserved, and
therefore mouse models are a useful model to study skin stem cells, as reviewed
in Pincelli and Marconi [2010].
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The bulge region of the HF constitutes a protective microenvironment that
maintains stem cells quiescent and sheltered from external stimuli. The factors
that regulate quiescence are poorly understood, but one of the pathways that is
known to affect the cell cycle of bulge stem cells is WNT/β-catenin. Indeed, when
β-catenin is conditional deleted in adult skin, hair follicle loss is observed. On the
other hand, when β-catenin is activated it results in de novo hair morphogenesis
[Braun and Prowse, 2006; Gat et al., 1998; Huelsken et al., 2001; Merrill et al.,
2001], whereas transient expression of β-catenin prompts HFs to enter anagen
earlier, and induces formation of ectopic HFs [LoCelso et al., 2004; Silva-Vargas
et al., 2005; VanMater et al., 2003].
BMP signalling is also important in bulge stem cell activation. When this
pathway is impaired, either by deletion of its receptor Bmp1r, or by overexpres-
sion of Nog (encodes a protein that inactivates BMP) [Kulessa et al., 2000], it
causes formation of cysts within the HF structure [Andl et al., 2004] or impaired
differentiation in the matrix [Kobielak et al., 2003], respectively.
In summary, bulge cell fate decisions can be manipulated in response to en-
vironmental signals, suggesting that quiescence is not an intrinsic property of
the stem cells, but a response that is mediated by intrinsic factors and external
stimuli. This allows the co-existence of epidermal and non-epidermal stem cells
in the same tissue, such as: melanocyte [Nishimura et al., 2002], neural crest
[Sieber-Blum et al., 2004] and nestin-positive, keratin-negative stem cells [Amoh
et al., 2005].
1.3.2 Sebaceous gland
The sebaceous gland’s main function is to provide hair lubrication and prevent
microbial infection through secretion of lipids and sebum which are produced by
sebocytes [Stewart and Downing, 1991]. For this reason, SGs are frequently seen
as HF appendages, in the sense that in some instances it is possible to lose their
structure concomitantly to HF loss [Selleri et al., 2006]; yet there is evidence that
a single population of SG stem cells is able to maintain homeostasis of this skin
appendage. Studies where epidermal cells were retrovirally labelled have shown
that SGs can arise and be maintained by a single population of cells unrelated
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to the HF [Ghazizadeh and Taichman, 2001; LoCelso et al., 2008]. Furthermore,
transgenic mice lacking HFs, still present SGs, and these persist in skin lacking
HFs (e.g. footpad epidermis) [Allen et al., 2003; Nakamura et al., 2001]. Seba-
ceous gland stem cells are thought to be located in the basement membrane of
the gland (Figure 1.3). The cells in this region present a high proliferative ca-
pacity as well as high levels of Myc expression. In fact, overexpression of Myc or
deletion of Rac1 in different mouse models, causes hyperplasia, suggesting a role
in sebocyte differentiation [Arnold and Watt, 2001; Benitah et al., 2005; Braun
et al., 2003; Bull et al., 2005; Frye et al., 2003; Waikel et al., 2001]. BLIMP1
(also known as PDRM1), a known Myc repressor, has been described as a marker
of sebaceous gland progenitors (Figure 1.3). Lineage tracing experiments have
shown that BLIMP1 positive cells can generate sebaceous glands and that when
Blimp1 is mutated, sebaceous gland homeostasis is affected [Horsley et al., 2006].
LRIG1 also has been shown to contribute, during homeostasis, to the population
of SG BLIMP1+ cells located in the junctional zone between the infundibulum
and SG [Jensen et al., 2009]. These cells are thought to maintain their quiescence
state due to BLIMP1 and LRIG1 negative regulation over Myc expression [Hors-
ley et al., 2006; Jensen et al., 2009]. LGR6+ HF stem cells also contribute to the
sebaceous gland lineage under homeostatic conditions [Snippert et al., 2010] and
Sonic hedgehog (SHH) signalling was also shown to have an effect in sebocyte
proliferation. Activation of SHH through expression of a mutant smoothen recep-
tor induces ectopic sebocyte development [Allen et al., 2003]. In vitro treatment
of sebocytes with Indian hedgehog (IHH) increases sebocyte differentiation [Nie-
mann et al., 2003]. Conversely, inhibition of this pathway through a dominant-
negative mutant of GLI2, suppresses sebocyte development [Allen et al., 2003;
Fuchs and Horsley, 2008]. Inhibition of WNT signalling through expression of
a dominant negative form of LEF1, ∆NLEF1, results in sebocyte differentiation
at the expense of HF formation [Gat et al., 1998; LoCelso et al., 2004; Van-
Mater et al., 2003]. Confirming these results, degradation of β-catenin through
increased expression of Smad7 also results in SG hyperproliferation [Han et al.,
2006]. Nevertheless, the fact that overexpression of Tcf3 results in suppression
of sebocyte formation [Nguyen et al., 2006], seems to point to the fact that a
proper balance between WNT and SHH signalling needs to be established during
9
SG development [Fuchs and Horsley, 2008]. Sebocyte differentiation is also reg-
ulated by the adipogenic transcription factor peroxisome proliferator-activated
receptor-γ, PPARγ. This was shown in studies using embryonic stem cells null
for Pparγ which contributed poorly to sebaceous glands formation in chimaeric
mice [Horsley et al., 2006; Rosen et al., 1999]. Additional supporting evidence
for these observations comes from studies where skin was treated with PPARγ
ligands. These treatments increase sebocyte differentiation in vitro and sebum
production in humans [Trivedi et al., 2006].
1.3.3 Interfollicular epidermis
The interfollicular epidermis is a stratified squamous epithelium, structurally or-
ganized with a basal layer of mitotically active keratinocytes, and suprabasal
layers with progressively decreased self-renewal potential. The basal layer se-
cretes ECM proteins such as laminin 5, and uses α3β1-integrin as part of the
ECM [Blanpain and Fuchs, 2006]. As cells migrate from basal to suprabasal lay-
ers, a series of events starts to take place, such as withdrawal of the cell cycle,
decreased integrin and laminin expression and initiation of a terminal differen-
tiation program. The epidermis also contains a high content of keratins; these
are obligate heterodimers which form 10 nm intermediate filaments that interact
with desmosomes containing α6β4 integrin [Blanpain and Fuchs, 2006]. These
interactions form a stable network that is attached to the ECM through desmo-
somal cadherins. Typically, the basal layer of the adult IFE expresses keratins 5
and 14 (KRT5 and KRT14) (Figure 1.3), the spinous layer expresses keratins 1
and 10 (KRT1 and KRT10) and the granular layer produces filaggrin and loricrin
structural proteins. In the IFE, terminal differentiation is controlled by spe-
cific transcription factors, such as: JUN, TCFAP2, CEBPs, KLFs, PPARs and
NOTCH [Dai and Segre, 2004]. The molecular mechanisms governing epidermal
differentiation will be discussed later in Section 1.7.
The IFE stratification process is thought to be initiated when basal epidermal
cells detach from the basement membrane and neighbouring keratinocytes are
pushed upwards into the spinous layer, through delamination [Vaezi et al., 2002].
There is some evidence that stratification might depend on the orientation of
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the mitotic spindle orientation of basal cells regarding the basement membrane
where these are attached. In other words, if the mitotic spindle is perpendicular
to the basement membrane, it will immediately place one of the daughter cells in
the suprabasal layer. Studies in embryonic murine epidermis seem to favour this
hypothesis [Lechler and Fuchs, 2005]. Namely, because asymmetric segregation of
cell fate determinants might play an important role in differentiation, as seen in
stem cells in other organisms such as Drosophila melanogaster or Caenorhabditis
elegans [Cowan and Hyman, 2004; Wodarz, 2005].
Evidence for the existence of stem cells in the IFE is illustrated by the ability
to culture human epidermal keratinocytes in vitro [Rheinwald and Green, 1975]
and subsequently perform transplantation in patients with severe skin burns [Gal-
lico et al., 1984]. These autografts show regenerative capacity after many genera-
tions in culture and are able to completely restore the burned skin [Rochat et al.,
1994]. The grafts can also persist on the patients for several years, even when
hairless skin biopsies are used [Pellegrini et al., 1999]. This healing process relies
on epidermal stem cells as these cell populations alone are sufficient to maintain
the IFE. In fact, when epidermal stem cells are grown in culture at clonal density,
large actively growing colonies (holoclones) are formed whereas, when more com-
mitted progenitors or differentiated cells are grown in culture, these tend to form
irregular, slow-dividing abortive colonies (meroclones and paraclones), which will
eventually undergo terminal differentiation after few rounds of division [Barran-
don and Green, 1987].
In humans, the epidermis is thicker and forms ridges. Human epidermal stem
cells are thought to lie on top of these ridges and to divide less frequently, when
compared to what is observed in mouse skin [Lavker and Sun, 1982]. When
cultured in vitro, human epidermal stem cells express high levels of β1 integrin
and show high clonogenicity [Jones and Watt, 1993]. These observations led
to another hypothesis in which these cells might be located at the tips of the
dermal papilla and TA cells would migrate to the ridges. Attempts to try to
establish a specific genetic signature for human IFE stem cells have shown that,
IFE putative stem cells express high levels of integrin α6, melanoma chondroitin
sulphate (MCSP), KRT15, and low levels of the transferrin receptor, CD71 [Jones
and Watt, 1993; Legg et al., 2003; Li et al., 1998; Tani et al., 2000; Webb et al.,
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2004]. However, none of these markers has been proven to be specific only for IFE
stem cells in vivo, due to the inevitable heterogeneity observed in the fluorescence-
activated cell sorted populations used in the experiments. In addition, deletion
of integrin molecules in the IFE does not lead to a stem cell depletion phenotype
[Lo´pez-Rovira et al., 2005] consequently, the search for stem cell markers in the
IFE still continues. Single cell profiling however, is a useful experimental tool
that might be able to address the heterogeneity problem and therefore provide
increased sensitivity. LRIG1, a key marker of stem cell quiescence, was identified
using this method [Jensen and Watt, 2006].
1.4 Epidermal stem cell plasticity
The stem cell populations of the HF, IFE and SG are interconvertible. This
means that even though cell autonomous regulators (such as: transcription fac-
tors, asymmetric division determinants, clock genes [Lin et al., 2009]) restrict
stem cells to a specific lineage, these signals can be modulated by extrinsic signals
such as cytokines, growth factors or morphogens, direct contact with neighbour-
ing cells, availability to oxygen and nutrients and even stretch forces [Connelly
et al., 2010; Spradling et al., 2001; Watt and Hogan, 2000]. The combination
of these forces on an epidermal stem cell will dictate the specific differentiation
pathway. For example, dermal papilla cells, when in contact with the basal
layer of adult epidermis can induce HF formation, suggesting that communica-
tion between IFE keratinocytes with dermal papilla cells reprograms the previous
lineage commitment to HF morphogenesis [Reynolds and Jahoda, 1992]. Also,
overexpression of the gene encoding the transcription factor, ZIPRO1, deletion of
Rxrα or the vitamin D receptor in adult mouse epidermis originates cysts with
absent or abnormal HFs. Presumably, these results reflect the induction of an
IFE differentiation phenotype [Li et al., 2000b, 1997; Niemann and Watt, 2002].
Moreover, activation of β-catenin in the basal layer of the epidermis, under con-
trol of the Krt4 promoter, induces ectopic formation of hair follicles in the IFE
[Gat et al., 1998; LoCelso et al., 2004; VanMater et al., 2003]; whereas, inhibi-
tion of this gene or overexpression of a N-terminally truncated form of LEF1,
∆NLEF1, which lacks the β-catenin binding site, induces hair loss and formation
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of dermal cysts [Niemann and Watt, 2002]. These studies confirm the importance
of environmental cues dictating epidermal stem cell fate, and denote a role for
β-catenin in activating HF differentiation.
Similarly, manipulation of the microenvironment through activation of MYC
in basal undifferentiated layers of the epidermis, stimulates differentiation of epi-
dermal stem cells into the IFE and sebaceous glands, at the expense of HFs (Fig-
ure 1.7) [Frye et al., 2003; Gebhardt et al., 2006; Waikel et al., 2001]. Increased
differentiation is measured, for example, by an increase in epidermal suprabasal
layers expressing KRT10 and involucrin (IVL). Furthermore, when cells from the
IFE are subjected to mesenchymal stimuli, these can differentiate into the HF
and SG lineages [Ferraris et al., 1997; Reynolds and Jahoda, 1992].
Epidermal stem cell plasticity can also be observed during wound healing
response, when multipotent bulge stem cells are able to regenerate the IFE [Ito
et al., 2005; Levy et al., 2005; Taylor et al., 2000; Tumbar et al., 2004]. These
studies demonstrate that epidermal stem cells from the IFE, HF and SG are all
multipotent and able to regenerate the tissue where they reside.
1.5 Models of skin homeostasis and repair
Skin homeostasis requires a perfect balance between cell proliferation and differ-
entiation. For several years, a hierarchical model has been used to describe this
process in which a single quiescent stem cell would be activated to asymmetri-
cally divide and give rise to a new stem and TA cell that after a few rounds of
division would differentiate. This model was designated as the epidermal pro-
liferative unit (EPU) model, where the epidermis was thought to be maintained
by EPU units, each containing one stem cell that would divide asymmetrically,
giving rise to mitotically active progenitors or TA cells and later to differentiated
cells overlaying it [Lechler and Fuchs, 2005; Mackenzie, 1970; Potten and Booth,
2002] (Figure 1.4).
Stem cell symmetric division was tought to only occur during tissue expansion
or damage. In recent years this model has been challenged by lineage tracing
experiments in vivo in murine epidermis where stem cells and TA cells are tracked
during clonal expansion of individual cells [Clayton et al., 2007; Snippert et al.,
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Figure 1.4: Epidermal proliferative unit (EPU) model. Model for skin renewal
in the mouse based on Potten’s model of epidermal proliferative units. This model
considers that one in ten basal cells are stem cells (S). The neighboring basal cells and
all cells in the suprabasal layers would have derived from the single stem cell in a typical
stem cell-transit amplifying cell model. The surface view shows that each unit derived
from a single stem cell forms a hexagonal shape that encompasses about ten basal cells
–the epidermal unit –. Each black cell denotes the single stem cell in each unit. Taken
from Potten and Booth [2002].
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2010]. Data analysis using the EPU model would predict that, if a TA cell was
labelled (using the LACZ or GFP), the label would be lost due to differentiation;
whereas in the case of a stem cell, this would result in increased expansion of a
labelled clone, because stem cells rarely divide in the classical definition; and when
division would take place it would be asymmetric. Consequently the resultant
expansion of the clonal area would originate an epidermal unit [Mackenzie, 1970].
Unexpectadly, what has been observed is that labelled clones are continuously
lost and replaced by neighbouring clones, with the overall number of labelled cells
being kept constant over time [Clayton et al., 2007]. This observation suggests
a stochastic model where stem cell division can lead to one of three different
outcomes: it can originate two stem cells, two TA cells or one stem cell and one TA
cell [Clayton et al., 2007; Jones et al., 2007; Klein et al., 2007]. Stochasticity also
assumes that, at the single cell level, the stem cell fate cannot be predicted but, at
the population level, the average fate can be set to be one stem cell originating one
TA cell [Simons and Clevers, 2011]. These results have led to the conclusion that
the murine epidermis is maintained by a unipotent population of progenitor cells
in homeostatic conditions. Nevertheless, the stochastic model does not exclude
the possibility of a second, more dormant, stem cell population, which would
only be activated upon injury. In fact, there is evidence for such population in
the upper region of the murine HF [Jensen et al., 2009; Snippert et al., 2010].
Furthermore, when this model is used to predict the fate of human epidermal
stem cells in vitro, it seems to favour the existence of cell division heterogeneity
as well as the notion that maintenance of homeostasis within the human epidermis
might require different stem cell populations, expressing different levels of stem
cell markers (e.g. β1 integrin, LRIG1). This suggests that LRCs are far more
common than what was initially predicted, and that stem cell quiescence is not a
necessary requisite for stemness. In fact, comparison of stem cell’s proliferation
rates in tissues with high cell turnover such as, the intestine, HF bulge and
mammary gland, all point to the fact that label retention is a property of some
stem cells, but not all. It seems that stem cells might adjust their cell cycle
properties in response to the microenvironment around them. A good example
for this idea, comes from studies where slow-cycling bulge stem cells are depleted
from the HF and the more active-cycling cells of the HG repopulate and regenerate
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the bulge niche [Fuchs, 2009a; Ito et al., 2004].
Considerable progress has been made to try to understand the key regulators
of epidermal stem cell maintenance, activation and lineage determination. In the
following sections I will summarize some of the key aspects of epidermal strat-
ification and the transcriptional regulators of stem cell activation and terminal
differentiation in normal IFE, as well as in disease.
1.6 Morphological aspects of epidermal differ-
entiation
As previously mentioned, the differentiation of the IFE is a multistep process
where, basal proliferative keratinocytes detach from the basement membrane and
commit to differentiation by migrating upwards through the suprabasal layers.
This sequence of events is known as cornification and implies changes in keratin
intermediate filaments (IFs), appearance of keratohyalin granules and formation
of a cornified envelope (CE). The morphological changes accompanying this pro-
cess have been well documented. Briefly, as basal keratinocytes migrate to the
spinous layer, they exit from the cell cycle and start synthesizing structural pro-
teins essential for keratinization, such as KRT1 and KRT10, replacing the initial
keratins, KRT5 and KRT14. Subsequently, keratinocytes start to accumulate
granules containing profilaggrin (a precursor of filaggrin, FLG) and other struc-
tural proteins are also synthesized (e.g involucrin, loricrin, trichohyalin, S100 cal-
cium binding proteins, late cornified envelope proteins-LCEs, small proline rich
proteins-SPRRs) [Candi et al., 2005] (Figure 1.5). These proteins are cross-linked
by transglutaminases (TGMs) forming the CE structure. Lipids (e.g. ceramides)
covalently bond to the newly formed isopeptides, form lamellar granules that are
extruded into the extracellular space, conferring impermeability to the epidermal
barrier [Candi et al., 2005]. Cornification is a highly regulated process where the
majority of the genes encoding for structural proteins important for establish-
ment of the CE are clustered in a region of the mammalian genome designated
as the epidermal differentiation complex (EDC).
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Figure 1.5: Cornification process in the epidermis. As basal epidermal cells
[marked by KRT5 and KRT14 (KRT5/14) ] divide, detachment from the basement
membrane (BM) triggers them to move upwards to the suprabrasal layers of the epi-
dermis, namely the spinous, granular and cornified layers. Throughout this process epi-
dermal cells initiate the expression of genes encoding for KRT1 and KRT10 (KRT1/10),
as well as other structural proteins, such as S100A calcium binding proteins, involucrin
(IVL), loricrin (LOR), small proline rich proteins (SPRRs), filaggrin (FLG) and tri-
chohyalin (TCHH). As soon as a cell reaches the epidermal surface, it has already
lost its nucleus and its structure changed from round to flat, due to cytoskeleton
rearrangements. At this point this cell constitutes a dead keratinized squame that
will eventually be shed from the surface and replaced by inner cells, in a continu-
ous process throughout the lifetime of the organism. This image was adapted from
http://www.ncbi.nlm.nih.gov/books/NBK26865/bin/ch22f2.jpg. Information for the
mRNA expression pattern of the differentiation related genes in the epidermis was
taken from Williams et al. [2002].
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1.6.1 The epidermal differentiation complex (EDC)
The epidermal differentiation complex (EDC; 1q21 in human, 3q2.1 in mouse
and 2q34 in rat) clusters around 61 genes which encode the main substrates of
TGMs important for the keratinocyte differentiation pathway [Brown et al., 2007;
Williams et al., 2002]. EDC genes are organized into four different families: corni-
fied envelope precursor proteins (involucrin, loricrin and SPRRs), filaggrin-like
proteins (FLG and TCHH), calcium binding proteins (S100A) and late cornified
envelope proteins (LCE) [Marshall et al., 2001; Mischke et al., 1996]. The ex-
pression pattern of EDC genes during keratinocyte differentiation is represented
in (Figure 1.5). Spatial constrain of these genes, over billions of years and across
species, suggests that EDC genes possibly share regulatory elements, to tightly
and temporally control transcription during epidermal differentiation [Mischke
et al., 1996; Williams et al., 2002; Zhao and Elder, 1997]. One possible model
for coordinate expression would involve cis-regulatory elements. Indeed, 48 con-
served non-coding elements (CNEs) have been identified in silico and two have
been experimentally confirmed to possess in vivo enhancer activity and capable
of dynamically regulating the expression of LCE3C and LCE3B genes during
differentiation and proliferation [DeGuzmanStrong et al., 2010]
The coordinate arrangement and transcription of the EDC genes, creates a
region extremely attractive for lineage commitment studies, particularly in the
IFE. It would be interesting to understand which signalling pathways control
keratinocyte differentiation, as well as what are the genetic alterations that might
predispose to skin diseases such as psoriasis or cancer. Below, I will describe some
of the key features and roles of selected epidermal structural proteins encoded at
the EDC.
1.6.2 Involucrin - IVL
Involucrin, IVL, is a soluble precursor of the epidermal CE. It presents several
glutamine reactive sites that are used to establish isopeptide covalent bonds with
other structural proteins present in the envelope [Eckert et al., 2004]. This struc-
tural protein acts as an amine receptor in transglutaminase enzymatic reactions
[Watt, 1983] and this allows it to be used as a scaffold for other precursors of the
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CE. Involucrin expression usually starts in the early formed spinous layer and it is
maintained through the granular layer, however the protein itself, is only incorpo-
rated in the transition zone between the two layers. In addition, Ivl expression,
and consequently keratinocyte differentiation, is regulated by extrinsic factors
such as: calcium [Bikle et al., 2001; Deucher et al., 2002], vitamin A [Poumay
et al., 1999] protein kinase C (PRKC) [Welter, 1995] retinoids [Monzon et al.,
1996] and antioxidants [Balasubramanian et al., 2002]. This protein is not exclu-
sively expressed in the stratified squamous epithelium of the skin, but it is also
present in other epithelia: esophageal, lingual, conjunctival and corneal [Banks-
Schlegel and Green, 1981; Eckert et al., 1993]. Surprisingly, overexpression of Ivl
or deletion in transgenic mice does not induce major defects in epidermis [Candi
et al., 2005; Crish et al., 1993; Djian et al., 2000].
1.6.3 Loricrin - LOR
Loricrin, LOR, is the most abundant protein of the CE, covering 75% of its pro-
tein content. Its structure is predicted to be disorganized and enriched in glycine,
serine and cysteine residues and the lack of ordered structure is thought to con-
tribute to the elastic properties of the CE. In general, the majority of isopeptide
bonds established are LOR-LOR interactions, although binding to SPRRs and
profilaggrin is also observed [Candi et al., 2005]. In humans, there is evidence
that LOR is firstly deposited with profillagrin in the granular layer, where kerato-
hyalin granules are released [Yoneda and Steinert, 1993] to an already established
scaffold containing IVL, desmosomal proteins and S100 calcium binding proteins.
Loricrin is also a substrate for transglutaminases, TGM1, TGM2, TGM3 and
TGM5 [Candi et al., 1995]. Surprisingly, overexpression of the human LOR gene
or deletion in mice yields a normal phenotype; suggesting that this is not an es-
sential gene and it can be substitute by other structural proteins, such as SPRRs
[Jarnik et al., 2002; O’Driscoll et al., 2002]. Overexpression in transgenic mice
also does not interfere with normal assembly of the CE; confirming that LOR
is deposited later into the pre-existing scaffold [Yoneda and Steinert, 1993]. In
vitro studies show that LOR expression is increased by calcium and phorbol ester
and decreased by retinoic acid [Dlugosz and Yuspa, 1993; Hohl et al.]. Defects in
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the LOR gene have been linked to two skin diseases: Vohwinkel syndrome and
progressive symmetric erythrokeratodermia (PSEK). The first is characterized by
hyperkeratosis of the palms and soles, which in some instances can lead to ampu-
tation; while the second is characterized by erythematous plaques over the entire
body and palmoplantar hyperkeratosis [Armstrong et al., 1998; Ishida-Yamamoto
et al., 1997; Korge et al., 1997].
1.6.4 Filaggrin - FLG
Filaggrin, FLG, is a dephosphorylated form of profilaggin (a filaggrin precursor).
In its phosphorylated form, this protein accumulates in keratohyalin granules
along with LOR, throughout the granular layers of the epidermis. In vitro, FLG
is able to form aggregates with keratin intermediate filaments, establishing or-
dered arrays. These interactions are thought to cause some of the drastic mor-
phological changes observed when keratinocytes move from a round to a more
flattened shape, possibly due to their effect in the cytoskeleton [Candi et al.,
2005]. Mutations in the FLG gene are linked to the disease Ichthyosis vulgaris
(IV). Patients carrying this mutation, show low levels of FLG, mild hyperker-
atosis and a diminished granular layer [Segre, 2006]. In mice, a mutated form
of FLG induces a phenotype designated as flaky tail, also establishing a link
with IV. These mice express an abnormal form of profilaggrin and present similar
phenotype to what have been observed in humans patients with IV [Hoffjan and
Stemmler, 2007; Presland et al., 2000]. In addition, mutations in FLG seem to
constitute a predisposed factor for atopic dermatitis [Palmer et al., 2006; Smith
et al., 2006].
1.6.5 Trichohyalin - TCHH
Trichohyalin, TCHH, is a keratin-intermediate filament associated protein that
is also expressed in the granular cells of the epidermis. Its biochemical structure
is very similar to FLG; both proteins present calcium binding domains at the N-
terminus, similar to the ones observed in S100 calcium binding proteins (discussed
below) [Ishida-Yamamoto et al., 1997]. TCHH structure suggests that TCHH
gene expression might be dependent on calcium concentration. This protein is
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present in small amounts in keratohyalin granules in the epidermis, and it is
expressed at much higher extent in the HF, when compared to the IFE [Lee
et al., 1993; Rothnagel and Rogers, 1986; Tarcsa et al., 1997].
1.6.6 Small-proline rich proteins - SPRRs
The family of Sprr genes was first identified in response to UV radiation [Fischer
et al., 1996]. However, these genes are normally expressed during normal epider-
mal differentiation. Sprr genes encode small (6-18kDa) proline-rich proteins, in
which the structure consists of variable, subclass specific, internal repeats, flanked
by conserved amino carboxy terminus [Candi et al., 1995]. These repeats con-
tain domains rich in glutamine and lysine and the amino- and carboxy- terminals
share many features with the domains observed in Ivl and Lor, suggesting that all
must have diverged from the same ancestral gene [Gibbs et al., 1993]. However,
contrarily to its neighbour genes, Sprrs function appears to have evolved to con-
stitute a mechanism that allows modification of the physical properties of the CE.
For example, the ratio of SPRR to LOR varies from 1:100 to 1:3 if one compares
the structure of the CE in the IFEs of lip and sole epidermis to stomach; each
subtype of skin epithelium presents different flexibility requirements [Candi et al.,
1995]. In addition to being expressed differentially in different stratified epithelia,
SPRR proteins are also induced in response to different environmental cues, such
as: epidermal injury [Gibbs et al., 1993; Kartasova et al., 1988], inflammation
[Yaar et al., 1995], hyperproliferation [Hohl et al., 1995], keratinization disorders,
tumourigenesis [Lohman et al., 1997] and also during normal aging skin [Garmyn
et al., 1992].
1.6.7 S100A calcium binding proteins - S100A
The S100A genes encode for a family of proteins that act as messengers of cal-
cium response in a variety of tissues, including the brain [Donato, 1999; Heizmann
et al., 2002]. In human epidermis, as well as, in vitro cultivated keratinocytes, at
least eleven out of the more than twenty known S100A proteins are expressed in
the cytoplasm of basal and spinous layers of the IFE, but transported laterally
into the cell during differentiation. These genes are also expressed in the HF,
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where they seem to play a role in regeneration [Ito and Kizawa, 2001; Les´niak
et al., 2007]. Structurally, S100 proteins present two EF hands (helix-loop-helix
calcium binding proteins), separated by an hinge region and flanked by amino-
and carboxy- terminals [Eckert et al., 2004]. In the cell they exist as anti-parallel
homo- or heterodimers with monomers linked together by non-covalent interac-
tions which are used as a substrate for TGMs [Zimmer and Dubuisson, 1993].
The S100A structure suggests a role in reorganization of the CE, probably linked
to transmembrane influx of calcium. Furthermore, some proteins such as S100A7,
have been shown to interact with E-FABP, an epidermal fatty acid binding pro-
tein, also suggesting a role for lipid metabolism during epidermal differentiation
[Hagens et al., 1999]. These proteins function has also been linked to the in-
flammatory response [Jinquan et al., 1996]. For example, human heterodimer
S100A8/S100A9 acts as a chemostatic molecule in inflammation [Newton and
Hogg, 1998], S100A4 presents angiogenic potential [Ambartsumian et al., 2001]
and S100A12 is involved in the host-parasite response [Marenholz et al., 2004].
Alteration of S100A protein levels has been described in a variety of illnesses,
such as: heart disease, diseases from the central nervous system, inflammatory
diseases such as psoriasis and cancer [Alowami et al., 2003; Broome et al., 2003;
Marenholz et al., 2004; Shrestha et al., 1998].
1.6.8 Late cornified envelope proteins - LCE
The LCE proteins contain an N-terminal region similar to the one observed for
SPRR proteins, also harbouring glycine-serine-cysteine rich motifs comparable to
the ones observed in LOR. In fact, in Lor -null mice, the expression of Lce genes
increases, suggesting functionally redundancy [Koch et al., 2000a,b]. Genome-
wide association studies have shown that mutations in certain LCE genes, such
as the ones encoding for LCE3C/LCE3B are associated to psoriatic skin [Zhang
et al., 2009].
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1.7 Transcriptional control of epidermal differ-
entiation
The morphological changes occurring during epidermal maturation are known
and have been well described in the literature, however, information regarding
the signalling pathways that govern stem cell activation and differentiation in the
IFE is lacking. Recently, mouse genetics has shed light to some of the mechanisms,
highlighting the role of transcription factors JUN,TCFAP2, CEBPs, KLFs, MYC,
TRP63, OVOL1, amongst others, in these processes. In this section I am going
to summarize the main findings regarding the role of these trascription factors in
either stem cell activation or lineage determination (terminal differentiation) in
the epidermis.
1.7.1 Epidermal stem cell activation
The transcription factor (TF) TRP63 is expressed in the basal layer of the IFE
and has been involved in the switch from basal to spinous layer. In vivo, mice
lacking Trp63 do not progress to skin morphogenesis beyond embryonic devel-
opment; the epidermis fails to stratify, leaving embryos with few and poorly
differentiated layers [Blanpain and Fuchs, 2009; Laurikkala et al., 2006]. Several
studies have shown that TRP63 is not only required for initiating the stratifica-
tion programme but also for maintenance of the self-renewal capacity of the stem
cells. There have been identified two splicing variants of Trp63 which appear
to have opposing effects. Overexpression of ∆TRP63 in cultured keratinocytes
blocks calcium induced differentiation [King et al., 2003], suggesting a role in
proliferation, whereas ectopic expression of another splicing variant, Tap63, con-
verts a normal epithelium positive for KRT18 into a KRT14 and KRT5 expressing
squamous epithelium [Koster et al., 2004], indicating a role in lineage specifica-
tion. Overall, studies suggest that TAP63 has a role in epidermal stratification
and ∆TRP63 is important for progenitors proliferation. The proper balance of
both splicing forms needs to be established for normal homeostasis [Koster and
Roop, 2008].
Another TF with important functions in epidermal stem cell regulation is
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MYC. Also, expressed in the basal layer of the epidermis, its expression has been
shown to induce keratinocyte differentiation [Gandarillas and Watt, 1997]. MYC
expression drives stem cells to enter the TA compartment where keratinocytes
proliferate for a short period before engaging into a terminal differentiation pro-
gram. A mouse model where MYC is overexpressed in the basal layers of the
epidermis, under the control of the Krt14 promoter, induces extensive hyperpro-
liferation, hair loss, impaired wound healing and significant expansion of the TA
compartment at the expense of SC loss [Arnold and Watt, 2001; Waikel et al.,
2001]. The mechanism suggested for the physiological role of MYC in epidermis,
postulates that this TF affects the stem cell-niche interactions because increased
expression of Myc causes a decrease in the levels of integrin proteins and other
ECM components. In addition, ectopic expression of Myc stimulates IFE and
SG lineage differentiation at the expense of the HFs, raising the possibility that
MYC might have a role in epidermal lineage determination [Frye et al., 2003].
In the IFE it has been suggested that MYC regulates the switch from basal to
suprabasal not only by repressing ECM components but also by inducing global
histone modifications associated with an active chromatin state [Frye et al., 2007].
Histone modifications have been shown to impact IFE differentiation; for exam-
ple, when EZH2 a component of the PRC2 complex [Cao et al., 2002] is targeted
for deletion in the epidermis causing removal of trimethylated lysine 27 of his-
tone H3, H3K27me3 (histone mark associated with gene repression), premature
activation of epidermal differentiation specific genes is observed [Ezhkova et al.,
2009].
1.7.2 Epidermal lineage commitment
Among the factors which have been shown to be important for epidermal lineage
commitment is retinoblastoma protein 1, RB1. Targeted deletion of Rb1 in the
epidermis results in increased proliferation of basal and suprabasal keratinocytes,
which ultimately leads to loss of the stem cell pool. In culture, depletion of
Rb1 triggers keratinocytes to re-enter the cell cycle even when the differentiation
program has been initiated [Ruiz et al., 2003].
Other important regulator of epidermal differentiation is the OVOL1 zinc
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finger protein. This protein is expressed in differentiated keratinocytes and is
activated in response to β-catenin/LEF1 signalling. Epidermis lacking Ovol1
shows increased proliferation and upregulation of TFs MYC and ID2, as well as
defects in terminal differentiation. There is also evidence that OVOL1 acts as a
repressor of Myc, Id2 and Lor by direct binding to the promoter region of these
genes [Nair et al., 2006, 2007]. In addition, ID2 may also regulate epidermal stem
cell maintenance since it has been observed that a quarter of the mice lacking Id2
present defects in the epidermal barrier [Yokota et al., 1999].
OCT1, OCT6 and OCT11 proteins belong to the POU family of TFs and
are all expressed in the epidermis. Skin specific overexpression of Oct11 in vivo
prompts keratinocytes to differentiate, whereas deletion of both Oct6 and Oct11
induces expression of the basal stem cell marker KRT14 in the suprabasal layers
of the epidermis [Andersen et al., 1997]. It appears that these TFs might be im-
portant for repression of genes in basal undifferentiated cells, as well as important
activators of epidermal specific differentiation genes [Dai and Segre, 2004].
JUN and TCFAP2 TFs have long been considered key players in IFE matura-
tion. In silico analysis has revealed binding sites for both proteins in promoters
of genes encoding epidermal structural proteins [Eckert et al., 2004; Jang and
Steinert, 2002; Sark et al., 1998]. In vivo studies show that inactivation of JUN
in the suprabasal layers of murine epidermis causes hyperproliferation and hy-
perkeratinosis [Rorke et al., 2010]. In addition, targeted deletion of Tcfap2α
and Tcfap2γ in the basal layer of murine epidermis leads to defects in epidermal
stratification. Namely, at embryonic day 17.5, E17.5, the epidermis of the double-
knockout (DKO) mice does not present granular layer or stratum corneum, failing
to terminally differentiate, and to increase terminal differentiation markers ex-
pression such as Krt1, Krt10, Ivl and Lor. Interestingly, the basal layer of these
mice remains unaffected, with normal expression of Krt5 /Krt14 basal markers,
suggesting that loss of both TCFAP2 proteins only affects commitment of IFE
keratinocytes from basal to suprabasal [Wang et al., 2008]. Furthermore, ex-
pression of CEBPα/CEBPβ TFs, which is important for gene regulation in the
suprabasal layers, is also affected.
CEBPα/CEBPβ are expressed in the basal layer of the epidermis and are
upregulated during keratinocyte commitment to differentiate. These TFs are
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required for Krt1 and Krt10 expression, as well as for downregulation of ∆Trp63.
Mice lacking Cebpα/Cebpβ, fail to exit the cell cycle and accumulate stem cell
gene expression signatures such as, persistent expression of Krt14 in the upper
layers of the IFE [Lopez et al., 2009].
Kruppel-like factor 4, KLF4, is a TF expressed in the suprabasal layers of the
IFE and required for maintenance of the epidermal barrier. Loss of Klf4 in the
epidermis results in misexpression of EDC genes required for formation of the
CE, namely Sprr genes, such as Sprr2a [Segre et al., 1999].
Another TF that appears to regulate IFE differentiation is Distal less-3,
DLX3. This protein is expressed in the suprabasal layers of the epidermis and
ectopic expression in mouse basal keratinocytes causes precocious activation of
IFE related differentiation genes, such as loricrin and profilaggrin in the basal
keratinocytes [Morasso, 1996].
Finally, FOXN1 is also another regulator of IFE differentiation. Overexpres-
sion of Foxn1 in differentiated keratinocytes induces gene activation of early dif-
ferentiated markers (Krt1 ) and suppresses the expression of later genes (Flg, Lor
and Ivl). FOXN1 seems to be necessary for the temporal control of epidermal
lineage commitment [Baxter and Brissette, 2002].
A full understanding of the transcriptional control occurring during epider-
mal differentiation is still lacking. In particular, it is not known how the different
signalling pathways activated through the described TFs integrate in order to pro-
mote epidermal homeostasis. Genetic approaches using transgenic mouse models
to assess the effects of gain- and loss- off function of specific epidermal transcrip-
tion regulators, for example, targeted to specific layers of the epidermis and the
combination of double and even triple mutants to understand if such regulators
act individually or in cooperation, the use of genomic approaches to map TF
binding sites, such as chromatin immunoprecipitation [Odom et al., 2004] and
crosstalk with genetic profiling, seem invaluable strategies necessary to under-
stand the signalling networks underlying stem cell activation and commitment at
the IFE, as discussed in Dai and Segre [2004].
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1.8 Myc: oncogene and stem cell regulator
In my project I focused on the question of whether the oncogene Myc had a direct
role in epidermal stem cell activation and lineage determination. For more than
30 years now, MYC has been extensively studied in normal tissues as well as
cancer, with no consensus being made on the primary functions of this TF in a
normal physiological context [Eilers and Eisenman, 2008]. The underlying reasons
for this seem to rely lie in the fact that MYC assumes pleiotropic functions, some-
times as antagonistic as metabolism, growth and proliferation, differentiation and
apoptosis. In addition, it has been difficult to fully dissect MYC primarily func-
tions due to redundancy with other members of the MYC family, mainly MYCL
and MYCN [Watt et al., 2008]. Nevertheless, knockout studies in tissues with
rapid cell turnover such as, skin, intestine, blood and testis, as well as genome
wide studies using expression arrays, SAGE (serial analysis of gene expression),
chromatin IP, promoter scanning and whole cell proteomic approaches, to identify
MYC target genes, are starting to unravel other functions of MYC in addition
to proliferation [Sodir and Evan, 2009]. In fact, due to its role as a weak tran-
scriptional factor, it is astonishing how MYC is able to regulate as much as 15%
of the genes in mammalian genomes, converting MYC primarily to a modulator
of context-specific biological functions. In this section, I am going to describe
MYC’s role as an activator as well as repressor, its expression and function in
different tissues, as well as, the general mechanisms that control MYC activity in
the specific contexts of epidermal homeostasis and cancer.
1.8.1 MYC structure and gene targets
MYC belongs to a family of basic helix-loop-helix leucine zipper (bHLH) proteins
that also comprises MYCL and MYCN. During embryonic development, Myc is
highly expressed in the extraembryonic tissues, while Mycn is more abundant in
the primitive streak and other regions of the embryonic mesoderm [Downs et al.,
1989] and Mycl is expressed in the developing kidney, lung, brain and neural
tube [Hatton et al., 1996]. At later developmental stages and through adulthood,
MYC proteins are expressed in highly proliferative cell populations, in general
decreasing the levels throughout differentiation. Collectively, deregulation of the
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proteins encoded by these genes has been associated with specific types of tumours
in humans, such as Burkitt lymphoma (MYC ), small-cell lung carcinoma (MYCL)
and neuroblastoma (MYCN ) [Atchley and Fitch, 1995; Watt et al., 2008].
MYC proteins are thought to require obligate heterodimerization with the
binding partner MAX in order to activate the majority of its target genes. Trans-
activation occurs through binding to promoters of genes containing the E-box
canonical DNA motif CACA/GTG; whereas repression involves interaction with
other TFs, such as MIZ-1 or recruitment of dimethyltransferase DNMT3A [Ad-
hikary and Eilers, 2005; Eilers and Eisenman, 2008] (Figure 1.6).
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Figure 1.6: Myc protein domains and interactions. (A) Structure of the MYC
protein. Illustrated is the carboxy-terminal domain (CTD), the central region of the
protein and the amino terminal domain (NTD) which contains conserved MYC Boxes
I and II (MBI and MBII) that are essential for the transactivation of MYC target
genes. (B) Proteins shown to interact with MYC include: co-activator TRAAP (trans-
formation/transcription domain associated protein), part of a complex that contains
histone acetyltransferase (HAT) activity. TRAAP interacts with MBII region mediat-
ing chromatin remodeling on histones; TIP48 and TIP49 interact with NTD and are
also implicated in chromatin remodeling. MIZ-1 interacts with CTD and affects MYC
transcriptional activity being responsible for MYC mediated repression; SP1 interacts
with the central region of MYC. Modified from Pelengaris et al. [2002b].
Gene expression profiling in settings where Myc is overexpressed led to the
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unified conclusion that MYC modulates the expression of thousands of genes in
the genome, predominantly upregulating genes involved in cell growth, ribosome
biogenesis, metabolism, protein translation and mitochondrial function, as it has
been discussed in several reviews [Dang et al., 2006; Eilers and Eisenman, 2008;
Zeller et al., 2003]. However, as previously mentioned, MYC also acts as a re-
pressor, downregulating genes involved in cell adhesion, cell-cell communication,
cytoskeleton [Frye et al., 2003; Gebhardt et al., 2006; Wilson et al., 2004] and
cell cycle arrest [Knoepfler et al., 2002; Staller et al., 2001]. In recent years, TF
binding location in the genome using promoter or genome-wide arrays (ChIP-
on-Chip) or high-throughput sequencing (ChIP-Seq) have been used to try to
identify direct gene targets of MYC. In summary, the majority of these studies
confirmed that MYC functions are broad and cover almost all biological processes
found in genome wide expression studies. Furthermore, the majority of the genes
bound by MYC were also transcriptional modulated by the protein. Overall,
these studies confirmed that MYC-MAX heterodimers bind to E-box elements
[Berberich and Cole, 1992; Blackwell et al., 1993; Blackwood et al., 1992; Little-
wood et al., 1992] to promote gene activation [Amati et al., 1992; Amin et al.,
1993; Kretzner et al., 1992] and that MYC binding covers 10-15% of the whole
genome in mammalian cells [Fernandez et al., 2003; Rahl et al., 2010]. ChIP-Seq
techniques uncovered that Myc binding sites are not exclusively associated with
coding regions, but are also associated with enhancer regions for cooperative regu-
lation in cell specific developmental contexts (e.g. epidermal differentiation [Watt
et al., 2008] or β - cell differentiation [Lawlor et al., 2006]). Moreover, these sites
could also represent non-coding RNAs that regulate transcription, such as miR-
NAs [Chang et al., 2008; O’Donnell et al., 2005] or RNA polymerase III products
(tRNAs or 5S rRNA) [Gomez-roman et al., 2003], which seem to correspond to
MAX-independent MYC functions. An elegant study in Drosophila melanogaster
where dMyc and dMax null-alleles, transgenic RNAi and overexpression where
employed, provided strong evidence for MYC activity independent of MAX bind-
ing being linked to activation of RNA polymerase III transcripts and synthesis of
small non-coding RNAs [Gallant and Steiger, 2009; Steiger et al., 2008]. In addi-
tion, other MYC binding sites might correlate with recruitment to core-promoter
regions by interaction, for example, with MIZ-1. Remarkably, because some of
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these core-promoters do not present MIZ-1 binding, they uncover the exciting
possibility of MYC mediated repression via interaction with other proteins such
as: SP1, nuclear-factor Y (NFY), transcription factor II-I (GTF2I), SMAD2/3
and yingyang-1 (YY1) [Adhikary and Eilers, 2005; Feng et al., 2002]. A great ef-
fort has been made to try to dissect both activator and repressor MYC functions.
Identifying mutants that either disrupt the MYC-MAX or the MYC-MIZ-1 in-
teraction has been a challenge. However, one of the first mutants to be identified
was MycV394D, which has been shown unable of MYC-MIZ1 binding as well as
MYC’s ability to repress genes [Herold et al., 2002]. Other MYC mutants that
lack the transactivation domain have been generated, but these affected MYC
transcriptional activity.
1.8.2 Regulators of MYC transcriptional activity
The observed widespread binding of MYC in the genome, favours the idea that
binding of this oncogene must somehow be directed and regulated across the
genome. Indeed, genome-wide studies using mouse embryonic stem cells (ES)
seem to embrace this idea, suggesting that chromatin marks, such as histone
methylation are key determinants of MYC binding [Kim et al., 2010]. MYC
appears to select regions in the genome with high levels of histone H3 lysine 4
(H3-K4) and lysine 79 (H3-K79) methylation, normally associated with active
transcription, when compared to lysine 27 (H3-K27) (repressive mark) [Guccione
et al., 2006]. In general, these studies have shown that MYC preferentially binds
to regions that are or have already been actively transcribed, also modulating
the transcriptional process itself. In fact, it is known that MYC interacts with
proteins of the RNA transcriptional machinery, such as transcription elongation
factor, P-TEFb. This interaction mediates phosphorylation of the C-terminal
domain of RNA polymerase II, contributing to its pause-release and therefore to
elongation [Cowling and Cole, 2007; Eberhardy and Farnham, 2002; Rahl et al.,
2010]. Lastly, MYC also contributes to mRNA cap methylation [Cowling and
Cole, 2007].
On the other hand, MYC binding to the genome can be restricted by com-
petition with members of the MNT/MAD family of transcriptional repressors,
30
namely MXD1 (MAD1), MXI1 (MAD2), MXD3 (MAD3), MXD4 (MAD4), MNT
and MGA [Ayer et al., 1993; Hurlin et al., 1995, 1997; Meroni et al., 1997; Zer-
vos et al., 1993]. These proteins contain a basic helix-loop-helix leucine zipper
(bHLHz) domain, identical to the one present in MYC proteins, and therefore
compete for their common heterodimer protein, Max, as well as for available
binding sites [Grinberg et al., 2004]. Repression by MAD-MAX heterodimers is
mediated through interaction with the co-repressor proteins SIN3A and SIN3B,
which are multiprotein complexes that recruit histone deacetylases (HDACs),
among other proteins [Ayer et al., 1995; Hurlin et al., 1995, 1997; Schreiber-
Agus et al., 1995]. HDACs are ultimately involved in chromatin remodelling
and induction of heterochromatin states, usually associated with transcriptional
silencing [Alland et al., 1997; Hassig et al., 1997; Laherty et al., 1997]. Con-
sequently, MXD functions are antagonistic of MYC, which is known to recruit
acetyltransferases GCN5 and TIP60 via TRAAP and CBP/EP300 activator pro-
teins in order to promote a more permissive/transcriptional active euchromatic
state [Frank et al., 2003; McMahon et al., 1998, 2000; Vervoorts et al., 2003].
Several lines of evidence suggest that MXD and MNT function as antagonists
of MYC activity. Studies in Drosophila melanogaster comparing binding sites of
DMYC, DMNT and DMAX, have shown that these proteins share binding sites
which tend to vary in number with protein concentration [Orian et al., 2003]. In
addition, MYC and MNT have opposite roles in cell growth [Loo et al., 2005].
Also, mouse embryonic fibroblasts (MEFs) null for Mnt, phenotypically resemble
Myc overexpressing cells [Hurlin et al., 2003; Nilsson et al., 2004; Walker et al.,
2005]. Deletion of Mxd1 delays terminal differentiation of granulocytes, as well as,
deletion of Mxi1 ; both favouring proliferation [Foley et al., 1998; Schreiber-Agus
et al., 1998]. Mxd genes are also preferentially expressed in differentiated cell pop-
ulations [Ayer et al., 1993; Hurlin et al., 1995; Que´va et al., 1998; Va¨strik et al.,
1995] as well as quiescent cells [Marcotte et al., 2003], contrarily to Myc which is
downregulated during differentiation and absent in the G0 phase of the cell cycle,
only to be expressed upon mitogenic stimulation (e.g. WNT/β-catenin, NOTCH,
RTK/RAS signalling) or ectopic expression [Eilers et al., 1991; Kelly et al., 1983;
Rabbitts et al., 1985]. The MYC protein has an extremely rapid turnover, with
a half-life of 20 minutes, that correlates with an increase during the G1 phase of
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the cell cycle and rapid decline in the S phase, upon mitogens withdrawal [Kelly
et al., 1983; Rabbitts et al., 1985]. These observations therefore comply with a
model where Mxd proteins, being more expressed in differentiated cells, are up-
regulated when levels of Myc are downregulated during differentiation or exit of
the cell cycle [Hooker and Hurlin, 2006]. However, it is not entirely clear what is
the limiting step controlling the balance between MXD/MNT-MAX and MYC-
MAX heterodimers, and what ultimately controls the balance between activation
and repression of MYC target genes. Since the half-life for MXD, MNTt and
MYC is much lower than MAX (t1/2 = 24 hours) [Blackwood et al., 1992], MAX
does not seem to be the limitating factor. Nevertheless, it has been observed that
the proportion of MNT-MAX heterodimers decreases upon Myc induction, even
though Mnt levels remain constant [Walker et al., 2005]. This observation can
either explain that more molecules of MYC are present to compete with MXD
or MNT for MAX or that during MYC activation, MXD or MNT proteins are
transiently post-translationally modified in a way that interferes with their bind-
ing to MAX. The later hypothesis is more attractive as MNT proteins have been
shown to interact with SIN3A upon phosphorylation [Popov et al., 2005], so in
theory, similar protein modifications are possible and might prevent binding of
these proteins to MAX.
1.8.3 Life cycle of MYC
Deregulation of the MYC protein can arise through direct alterations in the MYC
gene, such as: chromosomal translocations (Burkitt lymphoma), gene amplifica-
tions (colon cancer), viral integrations (human papilloma virus cervical cancer)
and mutations in cis-regulatory regions or, as a consequence of an increase in
mRNA or protein stability. In addition, failure to induce MYC’s auto-repressive
mechanism can also have a deleterious impact in cells [Levens, 2010; Murphy
et al., 2008; Nesbit et al., 1999]. Hence, it appears reasonable to assume that
mutations or misregulation of the pathways involved in regulation of MYC activ-
ity, can potentially promote tumorigenesis. MYC is induced by multiple signal
transduction pathways, such as: WNT, RAS/RAF/MAPK, JAK/STAT, TGFβ
and NF-kB. Several of these pathways are also deregulated in cancer cells, of-
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ten contributing to enhanced MYC expression [Vervoorts et al., 2006]. Thus,
MYC is subjected to several and interdependent post-transcriptional and post-
translational modifications (e.g phosphorylation, acetylation, ubiquitination) that
allow tight control of its activity.
The protein itself presents several phosphorylation sites; two of them, in the
acidic domain, are substrates for the protein casein kinase 2, CSNK2 [Lu¨scher
et al., 1989]. Two additional sites locate in the N-terminal region of the protein,
within the transactivation domain (TAD) and are targets for glycogen synthase
kinase (GSK3β) and proline directed kinases [Sears, 2004]. The consequences of
CSKN2 phosphorylation remain unknown, although some studies suggest a role in
increasing MYC stability [Channavajhala and Seldin, 2002], others suggest a role
modulating MYC/MAX and MAX/MAX complexes and regulation of the activ-
ity of caspases during apoptosis [Berberich and Cole, 1992; Krippner-Heidenreich
et al., 2001]. Additional MYC phosphorylation sites are found in the Mycbox I
region, specifically in threonine 58 and serine 62 (Thr58 and Ser62). However,
phosphorylation at Ser62 is necessary for subsequent phosphorylation at Thr58.
Serine 62 can be phosphorylated by several kinases, such as c-JUN N-terminal
kinase (JNK), cyclin dependent 1 kinase (CDK1) and mitogen-activated kinase
(MAPK); this modification seems to stabilize MYC activity [Vervoorts et al.,
2006]. The Ras signalling pathway is known to be involved in the process, through
activation of MAP kinases that phosphorylate Ser62. At this point, Thr58 is a
substrate for GSK3β phosphorylation, triggering a cascade of reactions with the
ultimate goal of MYC degradation [Sears, 2004; Vervoorts et al., 2006]. In addi-
tion, RAS inhibits GSK3β through the PI3K pathway, stabilizing MYC. The im-
portance of the phosphorylation of both Thr58 and Ser32 in MYC’s degradation
is shown by the recognition of PIN1 prolyl isomerase, that subsequently facili-
tates the access of protein phosphatase 2A (PP2A) to dephosphorylates Ser62.
Threonine 58 phosphorylation, desestabilizes MYC and once it is recognized by
F-box protein 7 (FBW7), a subunit of the SKP1-Cul1-F-box protein (SCF) ubiq-
uitin ligase that stimulates ubiquitination, the protein is targeted to proteasomal
degradation [Adhikary and Eilers, 2005]. These post-translation modifications
are essential for normal homeostasis as, mutations in Thr58 and amino acids in
its vicinity are frequently associated with Burkitt lymphoma. When MYC is mu-
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tated at Thr58, it fails to activate the expression of BH3-only protein BCL2L11,
a pro-apoptotic gene like Bcl2, reducing apoptosis and enhancing self-renewal
of the transformed cells. This response seems independent of the pro-apoptotic
effects of MYC through CDKN2A, an inhibitor of MDM2 E3 ligase that leads
to TP53 stabilization [Hemann et al., 2005; Vervoorts et al., 2006; Zindy et al.,
1998]. In addition to SCF-FBW7, other proteins have been shown to be involved
in MYC’s degradation, such as SCF-SKP2 and HUWE1. The first, is required
for MYC transactivation; but, MYC is also used as a substrate of SCP-SKP2,
indicating that ubiquitination of MYC is probably required for MYC activation
[Lehr et al., 2003]. Furthermore, HUWE1 seems to be important for MYC recruit-
ment of other acetyltransferases such as CBP/EP300 to the far N-terminal part
of the protein. Ubiquitinases also seem to enhance the recruitment of Mediator
complexes [Eberhardy and Farnham, 2002] as well as elongator factor, P-TEFb
[Kanazawa et al., 2003]. In addition, MYC also recruits several cofactors contain-
ing histone acetyltransferase activity (HATs), such as CBP/EP300, GCN5 and
TIP60 [Bouchard et al., 2001; Dang et al., 2006; Frank et al., 2003]. These HATs
are used to trigger acetylation at the promoters of MYC target genes; yet the
MYC protein itself can also be modified by these enzymes at several potential
lysine sites. Interestingly, acetylation at particular sites confers increased stabil-
ity of the protein in vitro [Patel et al., 2004]. Although some sites appear to
overlap with ubiquitination potential sites, it will be interesting to understand
how strongly connected these two modifications are and what is the impact in
MYC function, particularly in its degradation but also in the recruitment of other
cofactors.
1.8.4 Physiological functions of MYC in normal tissues
The physiological functions of MYC have been difficult to dissect. MYC acts as
a weak transcription factor and modulates a plethora of biological processes. In
fact, one could say that MYC primarily acts as a coordinator, fine-tuning the
action of additional TFs with enhanced transcriptional activity. Nevertheless, in
vivo and in vitro gain and loss-of-function studies, in different model organisms,
have contributed extensively to a better understanding of the role of MYC in
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normal tissues. It also helped shaping the current view that MYC biological
functions are broad but context-specific. Conditional excision of genes (e.g. Cre
recombinase system), as well as use of inducible systems using the oestrogen
receptor (ER) that responds oestrogens related molecules such as tamoxifen (4-
OHT), is a valuable tool that has been used to address the biological roles of
MYC in vivo as well as in vitro.
In vitro experiments using Rat1 fibroblast cells, with undetectable levels of
MYCL and MYCN, have shown that these cells can remain viable after targeted
deletion of Myc through recombination. However, these studies revealed extensive
doubling times due to defects in the cell cycle as well as a delay in the activity
of cyclin CDK complexes. This data directly attributed to MYC the role of cell
cycle regulator [Mateyak et al., 1997].
Experiments using conditional excision enable the generation of Myc null mice,
but excision of the gene causes death at E9.5 with embryos presenting hematopoi-
etic, vascular and placental defects. These experiments indicated that Myc is
crucial for development beyond this developmental stage [Baudino et al., 2002].
Mycn deficient mice are also embryonic lethal, but at E10.5 [Davis et al., 1993],
whereas Mycl mice are able to survive [Hatton et al., 1996], indicating that Myc
and Mycn are essential genes during embryonic morphogenesis. In these studies,
the Myc genes where excised using the Cre-LoxP system. This system uses Cre
(Cyclization Recombination), a sequence specific DNA recombinase that recog-
nizes specific stretches of DNA, Lox-P (Locus of X-over P1) sites, and excises
these when flanking a particular DNA region of interest. As deletion of Myc is
embryonic lethal, subsequent studies aimed to target the excision of this gene
in adult tissues using tissue specific promoters. In the gastrointestinal gut, Myc
was deleted using a Cre-oestrogen receptor (ER) fusion transgene driven by a
intestine-specific villi promoter, Cyp1a. The deletion resulted in growth inhibi-
tion of the intestinal crypts [Muncan et al., 2006].
In the mammary gland, Cre was induced with the promoter Wap (Wap Whey
acidic protein) to target deletion of Myc in the luminal alveolar cells of the mam-
mary gland during mid-pregnancy and through lactation. When WapCre trans-
genic mice are crossed with Mycfl/fl mice, pregnant mothers exhibit lower milk
production, mainly because the terminal end buds required for the alveoli fail to
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develop. Subsequent pregnancies increase the phenotype and demonstrate that
mRNA translation, proliferation and maturation of the alveolar cells is compro-
mised upon Myc deletion [Sodir and Evan, 2009; Stoelzle et al., 2009].
In hematopoietic stem cells (HSCs), deletion of Myc results in accumulation
of these cells in the niche, increased anaemia and failure to differentiate. Absence
of Myc in this context does not interfere with the proliferation of progenitor cells,
as in the intestine or mammary gland, but rather interferes with the interactions
of the HSCs and their niche [Malynn et al., 2000]. Also, when an additional
deletion of Mycn is added to the system, the combinatorial effects result in HSCs
lethality, suggesting that both proteins are absolutely required for HSC prolif-
eration, differentiation and survival [Laurenti et al., 2008; Wilson et al., 2004].
Similar results were observed in neural stem and precursor cells [Hatton et al.,
2006; Knoepfler et al., 2002].
Knockout of Myc in the epidermis leads to an exhaustion of the epidermal
stem cell compartment, leading to a dramatic reduction in keratinocyte’s cell
size, growth and endoreplication. As a consequence, the epidermis shows lack of
elasticity, tears off in areas of mechanical friction and displays impaired wound
healing [Zanet et al., 2005].
In the pancreas, conditional inactivation of Myc impairs development of the
exocrine pancreas [Nakhai et al., 2008] and in the bone marrow, results in accu-
mulation of megakaryocyte and erythroid progenitors [Guo et al., 2009]. MYC has
also been described as a modulator of the renal stem cell progenitor population,
as deletion of Myc impacts late renal differentiation/maturation and homeosta-
sis [Couillard and Trudel, 2009]. The combination of these studies suggests a
role for MYC in lineage determination, in addition to proliferation and cell cycle
regulation.
Finally, overexpression of a dominant negative form of MYC that efficiently
blocks the transactivation activity of MYC, MYCL and MYCN (OMOMYC) also
affects adult tissues the skin, bone marrow and testis, by reducing the proliferation
rate of these tissues. However, no cell death is observed. In less-proliferative
tissues such as pancreas, liver, lungs and kidney these effects where not observed
[Soucek et al., 2004].
Tamoxifen inducible systems have also been generated to study MYC biology.
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This approach relies on the fusion of the MYC protein to the hormone-binding
domain of estrogen receptor (ER). The fused protein forces MYC functions to de-
pend on the ER ligand β-estradiol. This ligand displaces ER from its inactive form
when associated with the heat shock protein 90 (HSP90), and promotes transloca-
tion of the recombinant protein to the nucleus. Mutant ERs have been generated
which do not respond to physiological estrogens but only to the synthetic ligand,
4-hydroxy-tamoxifen (4-OHT), MYCER [Indra et al., 1999; Littlewood et al.,
1995]. The advantages of using such system are that 4-OHT inducible proteins
are activated within minutes and their activation is reversible upon withdrawal of
the synthetic compound. In addition, expression of the recombinant protein can
be induced in any tissue by use of a specific promoter and the levels of protein,
rather than its transcription, are controlled and relatively easy to predict.
Induction of the MYCER construct in the suprabasal layer of the epidermis, by
the Ivl promoter, triggers post mitotic differentiated cells to enter the cell cycle
and induces the formation of papillomas. Nonetheless, this phenotype is com-
pletely reversible upon removal of 4-OHT [Pelengaris et al., 1999]. Conversely,
when MycER is targeted to the basal layer of the epidermis, using the Krt14
promoter, the epidermal stem cells exit the niche and amplify as TA cells, differ-
entiating into IFE and SG lineages (Figure 1.7). In this system, the phenotype
cannot be restored upon MYCER deactivation [Arnold and Watt, 2001].
In pancreatic β cells, MYCER activation, driven by an insulin (Ins2 ) pro-
moter, drives entry into the cell cycle, but ultimately causes cell death by apop-
tosis [Pelengaris et al., 2002a]. Interestingly, time-course expression profiling of
β pancreatic cells following MYCER activation and deactivation confirms that
MYC regulates genes involved in cell-cycle, cell growth and metabolism, but also
genes which are cell-type specific. Several genes specific for pancreatic β cells
were repressed upon MYC activation [Lawlor et al., 2006].
These studies, highlight the fact that the consequences of MYC activation are
cell-type specific and also dependent on the threshold of MYC in vivo [Murphy
et al., 2008].
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Figure 1.7: Epidermal morphological changes upon MYC activation. (A)
MYC activation in epidermal stem cells is thought to promote stem cell’s exit from
the niche, proliferation of the progenitor’s pool and differentiation into interfollicular
epidermis and sebaceous gland lineages. (B) Proliferation is observed by an increase
in KI67 positive keratinocytes in K14MycER mice (MYC was induced in the basal
layer of the epidermis) and (C.D) differentiation is shown by the increased number of
suprabasal layers positive for keratin 10, KRT10 (C, red) and involucrin, IVL (D, red)
in K14MycER mice compared to wild-type. Expression of the extracellular component
integrin α6, ITGα6, is shown in green. Scale bar: 50 µm.
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1.9 In vivo studies of MYC in skin
In the epidermis, seven mouse models have been generated to understand the
function of the stem cell regulator MYC in the epidermis [Watt et al., 2008].
Ectopic expression of the Myc gene in LOR positive cells, targeting the basal and
suprabasal layers of the epidermis, induces hyperproliferation, hyperkeratinosis
and sensitivity to UVB-induced apoptosis [Waikel et al., 1999]. Inducible expres-
sion of Myc in the suprabasal layers of the epidermis, under the Ivl promoter,
induces reversible tumour formation [Pelengaris et al., 1999]; whereas expression
in basal undifferentiated Krt15+ keratinocytes triggers hyperproliferation and ir-
reversible keratinocyte tumour transformation [Rounbehler et al., 2001]. Ectopic
expression of Myc in the basal Krt14+ keratinocytes, as previously discussed,
has shown to exhaust the stem cell pool [Waikel et al., 2001], while inducible
Myc expression directs differentiation into the IFE and SG lineages [Arnold and
Watt, 2001]. Furthermore, deletion of Myc in the basal layer from the epidermis,
depending on the mouse model used, either affects the epidermis by impairing
wound healing and the epidermal barrier [Zanet et al., 2005], or does not seem
to have a substantial effect in epidermal homeostasis [Oskarsson et al., 2006]. In
these studies, the use of mouse models has revealed that the effects of MYC in
differentiated cells are reversible, but not in basal undifferentiated keratinocytes.
This suggests that deregulation of MYC in the stem cell compartment might
potentially cause for skin cancer [Watt et al., 2008].
1.10 MYC in normal and tumorigenic skin
As an organ subjected to continuous regeneration, the epidermis maintains a tight
control of keratinocytes proliferation and differentiation. This implies a continu-
ous balance between division of epidermal stem cells and subsequent commitment
of the daughter cells. Disruption of any of these processes, as a consequence
of deregulation of the underlying signalling pathways, can disrupt normal epi-
dermal homeostasis and lead to disease. Because the suprabasal, differentiated
keratinocytes are continuously shed from the surface of the skin and replaced
by the inner cells, it has been hypothesized that epidermal stem cells are the
39
cells more likely to accumulate genetic mutations and more prone to tumorige-
nesis, due to their continuous self-renewal and long tissue residence [Honeycutt
et al., 2004; Owens and Watt, 2003; Perez-Losada and Balmain, 2003; Youssef
et al., 2010]. MYC has been shown to be involved in both proliferation and dif-
ferentiation processes within the epidermis, and deregulation of its expression is
known to contribute to skin cancer (e.g. non-melanoma skin cancer, basal and
squamous cell carcinoma). For example, 50% of the squamous cell carcinomas
(SCCs) express high levels MYC across the entire tumour mass and this is caused
by amplification of the MYC gene [Watt et al., 2008]. Deregulation of MYC is
found in many other tumours types including breast [Nass and Dickson, 1997],
colon [Kopnin, 1993] and lung [Gazdar]. The key role of MYC in tumorigenesis
relates with its ability to induce cell proliferation, specifically in the G1 to S
transition of the cell cycle. MYC has been shown to control the expression of cell
cycle regulators: CCNB2, CDK4, MCM7 and CDKN2B [Bouchard et al., 1999;
Fernandez et al., 2003; Hermeking et al., 2000; Honeycutt et al., 2004; Staller
et al., 2001]. However, deregulation of MYC alone does not seem sufficient to in-
duce cancer. Ectopic expression of Myc in fibroblasts, in the absence of survival
factors, induces apoptosis indicating that for a putative tumour cell to emerge
it must evade apoptosis [Evan et al., 1992; Pelengaris et al., 2002a]. Therefore,
in light of these studies, in order for MYC to induce tumorigenesis, its deregula-
tion has to cooperate with either overexpression of anti-apoptotic proteins (e.g.
BCL2, BCL2L1) or loss of tumour suppressors (e.g CDKN2A, TP53). Studies of
lymphomagenesis in transgenic mice corroborate both ideas [Adams and Cory,
1985; Blyth et al., 1995; Elson et al., 1995; Pelengaris et al., 2002a; Strasser et al.,
1990]. In epidermis, MYC induced differentiation is thought to act as a fail-safe
mechanism, similar to apoptosis, to prevent tumorigenesis [Jensen and Watt,
2006]. Undeniably, both processes share many features such as, expression of
TGMs, loss of ECM interactions as well as cell nucleus [Gandarillas et al., 1999].
However, since keratinocytes are known to be resistant to apoptosis [Pincelli and
Marconi, 2010], MYC expressing cells need to acquire additional oncogenic mu-
tations in order to induce tumours such as SCCs. Deregulation of MYC and
overexpression of the anti-apoptotic gene Bcl2l1, suppressed MYC ability to in-
duce apoptosis, allowing tumour formation [Pelengaris et al., 2002a]. Similarly,
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analysis of mammary gland tumours suggest cooperative transformation between
BCL2L1 and MYC [Nass et al., 1996] and in fact, human SCCs have been shown
to express high levels of BCL2L1 [Delehedde et al., 1999]. It is interesting to
note that human SCCs express many markers characteristic of normal, actively
cycling stem cells, such as melanoma associated CSPG4, while downregulating
markers required for stem cell dormancy, such as LRIG1 and MAP4 [Jensen
et al., 2008]. These observations are in agreement with the fact that activation of
MYC in actively-cycling stem cells induces a transcriptional program that shares
many similarities with the one observed for cancer cells [Kim et al., 2010; Wong
et al., 2008]. Finally, mutations in TP53 and deregulation of RAS have also
been related to SCCs development [Brash and Ponte´n, 1998; Dajee et al., 2003].
Mammary tumours where Myc is transiently deleted, rapidly relapse after Myc
re-expression, presenting mutations in the encoded RAS protein, ERAS [D’Cruz
et al., 2001]. Other studies also suggest that epidermis lacking Myc is less sus-
ceptible to RAS induced tumorigenesis [Oskarsson et al., 2006], indicating that
MYC induces genomic instability and potentiates the emergence of mutations in
the cells. In skin, even though Myc overexpression by itself does not seem to
induce epidermal SCCs, MYC might facilitate the emergence and survival of cells
that have sustained additional oncogenic mutations [Adhikary and Eilers, 2005].
1.11 Genome-wide approaches for the study of
epidermal cell fate commitment
Epidermal differentiation is thought to be coordinated by a group of highly regu-
lated TFs that, responding to environmental cues, regulate gene expression forc-
ing cells to maintain or alter a specific state. A number of TFs (e.g. TRP63,
MYC, OVOL1, KLF4, TCFAP2), as well as miRNAs (e.g. miR-203), has emerged
as strong determinants of epidermal stem cell lineage commitment [Blanpain and
Fuchs, 2009; Dai and Segre, 2004]. Most of these studies have used genetically
modified mice where the TF of interest was either overexpressed or depleted.
Alterations in these transgenic mice were then analysed at the gene level, using
microarray gene expression arrays, quantitative real-time PCR or immunohisto-
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chemistry/immunofluorescence. Although these approaches are useful to infer
TF functions in the epidermis, the differential gene expression that results from
the gain or loss a TF, does not necessarily correlate with the direct regulation
of a gene. For example, MYC is known as a potent regulator of epidermal stem
cell decisions, and overexpression of Myc in the epidermal stem cells produces
hyperplasia, hair loss and enlargement of the sebaceous glands [Frye et al., 2003].
The use of microarrays for cells isolated with one and four days of MYC acti-
vation using the K14MYCER mouse model [Arnold and Watt, 2001] involved
MYC in a variety of processes that had already been previously described such
as, cell growth, proliferation and differentiation [Eisenman, 2001; Frye et al.,
2003]. However, some of these gene expression changes might have occurred as a
cause of secondary effects, due to direct interaction of MYC with the promoter of
intermediate genes. In addition, information of whether MYC was directly regu-
lating IFE and SG lineage specific genes was lacking, as well as the knowledge of
whether MYC transcriptional function was isolated or in cooperation with other
TFs already known to have important roles in epidermis maturation. It seems
therefore crucial to combine mouse genetics models with gene expression arrays,
as well as techniques that are able to map TF binding to the study of epidermal
stem and progenitor cell commitment. Chromatin immunoprecipitation (ChIP)
is a useful tool that allows identification of the physical interactions between
proteins (e.g TFs) and DNA in the context of chromatin. It involves chemical
cross-linking of DNA-protein interactions in living cells to capture TFs at their
binding sites on the genome. The cross-linked chromatin is then fragmented ei-
ther enzymatically, using DNA nucleases, or mechanically, using sonicators and
the protein-DNA complexes are enriched by immunopurification with antibodies
specific for the protein of interest. DNA-protein cross-links are then reversed
and the enriched DNA is purified and subjected to one of the three different
approaches. Firstly, the DNA fragments can be amplified and subsequently hy-
bridized to whole-genome promoters or customized DNA microarrays, in a tech-
nique designated as ChIP-on-Chip [Buck and Lieb, 2004; Iyer et al., 2001; Ren
et al., 2000]. Here, the analysis takes into consideration a ratio of the fluorescent
signal intensity of ChIP-DNA over control DNA, and this reflects the relative en-
richment of the TF at the genomic binding sites. Secondly, ChIP-DNA fragments
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can be cloned in a plasmid library and then be sequenced. This method is desig-
nated as ChIP-PET (paired ends di-tags) and it overcomes the problems found
in hybridization, such as probe performance or genome coverage, as the binding
site where the TF is located can be sequenced [Wei et al., 2006]. Lastly, ChIP-
seq (sequencing), which is a technique that brought several advantages over the
previous two mentioned. Here, ChIP-DNA is size-selected, amplified and deep
sequenced. ChIP-Seq is far more advantageous than the previous two approaches
as it requires small amounts of ChIP-DNA; it has deeper coverage and is more
efficient [Robertson et al., 2007; Valouev et al., 2008]. Initially costly and less
available than ChIP-on-Chip or ChIP-PET, nowadays ChIP-Seq is increasingly
becoming the method of choice for TF binding location analysis, especially for
example, for rare populations of somatic cells, such as epidermal stem or progeni-
tor cells. These TF location methods are also useful for identification of putative
interactors, including epigenetic regulators (e.g repressors) or components of the
chromatin (e.g modified histones). In the epidermis for example, the use of ChIP
has helped in the identification of a member of the polycomb repressor complex,
EZH2, which is expressed in basal epidermal progenitors during development
and is essential to prevent precocious differentiation and recruitment of other
epidermal differentiation regulators such as JUN [Ezhkova et al., 2009]. In an-
other study, ChIP-Seq was used to profile the epigenetic landscape of HF stem
cell populations [Lien et al., 2011]. The global transcription landscape required
for maintenance or cell fate commitment of epidermal stem cells is poorly un-
derstood. One explanation might be due to the difficulty in obtaining a large
number of homogeneous bona fide somatic stem cells and progenitors in vitro for
analyses. Unipotent and multipotent stem or progenitor cells of several tissues
can be isolated and cultured in vitro, however their proliferative potential in cul-
ture is limited to a few rounds of divisions (e.g. human primary keratinocyte
cultures) due to limited knowledge of the optimal medium conditions. The role
of TFs either as regulators of epidermal stem cell maintenance or differentiation
is of immense interest, because it will contribute to our understanding of normal
epidermal homeostasis as well as skin disease. Therefore, mapping the epider-
mal stem cell transcription network will provide valuable clues. Nevertheless,
a drawback of genome-wide ChIP studies is the fact that not every single TF
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target gene can analysed functionally for its biological relevance, as this would
be technically extremely challenging. In an attempt to overcome this limitation,
global TF mapping has been correlated with microarray gene expression. This
approach has revealed that not all genes are directly regulated by one single TF,
and that association with additional TFs, binding to enhancers, or recruitment of
cofactors, is also important to induce a transcriptional response. This is also true
for the epigenetic state of the chromatin, as it can also determine binding location
of TFs. For example, MYC is thought to potentially modify the chromatin archi-
tecture in order to be more permissive for the binding of OCT4 and SOX2 during
reprogramming, via recruitment of HATs and therefore affecting global histone
acetylation (histone modification associated with active transcription) [Takahashi
and Yamanaka, 2006]. In summary, few studies have been performed to dissect
transcriptional networks that control epidermal stem cell maintenance and differ-
entiation. A combination of mouse models, where specific TFs are overexpressed
or deleted, following by mapping of putative regulators of the process and gene
expression analysis (preferably including coding and non-coding regions), might
provide invaluable information regarding these processes.
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1.12 Research aims
Activation of MYC in the epidermis appears to induce a global chromatin struc-
ture permissive for TF binding, where the occurrence TF binding in the genome
is cell-context specific. To test this hypothesis I set myself to answer the following
questions in the specific context of an epidermal stem/progenitor cell:
1. Is MYC directly regulating the genes involved in cell adhesion and prolifer-
ation responsible for triggering epidermal cell fate commitment in skin?
2. Does MYC directly regulate the expression of skin-specific differentiation
genes?
3. How does MYC binding affect tissue-specific transcriptional networks to
trigger lineage differentiation specifically into the IFE and SG lineages?
To answer to these questions I induced MYC-specific differentiation in the epi-
dermis by expressing an inducible construct of Myc in the basal undifferentiated
layers of the epidermis, using the previously described transgenic mouse model
K14MycER [Arnold and Watt, 2001]. Following activation of MYC, murine epi-
dermal cells were isolated and subjected to genome-wide assays such as genome-
wide gene expression and ChIP assays, following functional validation.
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Chapter 2
Material and Methods
2.1 Mouse lines
During the course of this work all mouse breeding and experimental protocols used
were subjected to ethical approval and performed under the terms of a United
Kingdom Government Home Office Project and Personal Licenses. All mouse
lines were bred to a mixed genetic background of CBA x C57BL/6J. K14MycER
line was kindly provided by Professor Fiona Watt [Arnold and Watt, 2001]. The
Krt14-cre/Esr1 (The Jackson laboratory) line was crossed with mice carrying
floxed alleles for Sin3a (K14Sin3af/f) and Myc (K14Mycf/f). Mice were genotyped
according to published protocols: K14MycER [Arnold and Watt, 2001], Sin3af/f
[Dannenberg et al., 2005] and Mycf/f [Alboran et al., 2001].
2.1.1 Treatment with 4-hydroxy-tamoxifen (4-OHT)
Mice were treated with 1 mg of 4-OHT (Sigma-Aldrich) diluted in acetone. Ta-
moxifen was topically applied to a shaved area of the dorsal mouse skin and, if
not stated otherwise, the treatment was followed for a period of four days, in
K14MycER mice, for expression of the Myc transgene in KRT14 positive basal
cells of the epidermis. Mouse lines K14Sin3af/f and K14Mycf/fK14Sin3af/f (gener-
ated and kindly provided by Claire Cox) were treated for 14 days and K14Mycf/f
mice for 21 days, in order to induce excision of the floxed alleles by Cre recom-
binase. Following 4-OHT treatment, the mice were sacrified for removal of the
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dorsal skin. All mouse lines were either compared to 4-OHT treated wild-type or
vehicle (acetone) transgenic littermates.
2.1.2 Isolation of epidermal cells from mouse skin
Primary mouse keratinocytes were isolated from 4-OHT or acetone treated dorsal
skin of transgenic and non-transgenic mice. The shaved dorsal skin was cut and
washed in 10% (v/v) betadine solution (20 ml in 180 ml sterile water), following
one wash in 70% (v/v) ethanol and two washes in phosphate buffer saline (PBS)
(PAA Laboratories). The dermal side of the skin was thoroughly scraped with
a scalpel to remove excess fat. The tissue was trypsinized for 2 hours at 37 ◦C
or overnight at 4 ◦C floating (epidermal side up) in 0.25% (v/v) trypsin with no
EDTA (Invitrogen), to separate the dermis from the epidermis. The epidermis
was subsequently scraped from the dermis, cut in small pieces and re-suspended
in 30 ml of FAD(-Ca) medium [1 part Ham’s F12 medium, 3 parts Dulbecco’s
modified Eagle’s medium (DMEM), 1.8x10−4 M adenine] (custom made by PAA
Laboratories) supplemented with 10% fetal calf serum (FCS) (Sigma-Aldrich) and
a cocktail of 0.5 µg/ml hydrocortisone (Fisher Scientific), 5 µg/ml insulin (Sigma
Aldrich), 10−10 M cholera toxin (Enzo Life Sciences) and 10 ng/ml epidermal
growth factor, EGF (Peprotech), as previously described [Jensen et al., 2010].
The cell suspensions were filtered through a 70 µm cell strainer (BD Biosciences)
and centrifuged for 7 minutes at 1500 rpm (Eppendorf, 5702). Cell pellets were
resuspended in 3 ml of complete FAD(-Ca) media and kept on ice until further
processing.
2.2 ChIP-on-Chip Protocol
2.2.1 Formaldehyde crosslinking of keratinocytes
Epidermal cells grown in culture or isolated from mouse skin were washed in
PBS (PAA Laboratories) and cross-linked by addition of 1% (v/v) formaldehyde
(Sigma Aldrich) solution in PBS for 10 minutes. Cross-linking was terminated by
addition of 2.5 M of glycine in water and incubation for 5 minutes. Cell pellets
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were recovered by centrifugation at 1350 x g for 5 minutes at 4 ◦C or flash-frozen
in dry ice and stored at -80 ◦C until further processing.
2.2.2 Pre-blocking and binding of antibodies to magnetic
beads
A volume of 100 µl of protein G magnetic beads (Dynabeads, Invitrogen), was
used for each ChIP. Protein G beads were dissolved in 1 ml of blocking solu-
tion [0.5 % (w/v) of bovine serum albumin, BSA (Sigma Aldrich) in PBS (PAA
Laboratories)] and subsequently collected using a magnetic stand (Invitrogen),
for removal of the supernatant. After two additional washes, the beads were
resuspended in 250 µl of blocking solution and 10-15 µg of antibody specific to
transcriptional regulator in study were added. Beads were incubated with the
antibody overnight at 4 ◦C in a rotating platform specific for microcentrifuge
tubes. All antibodies used for ChIP-on-chip/Seq are listed in Table 2.1.
48
Antibody Catalogue # Clone Host Source
c-MYC sc-764 N-262 Rabbit pc Santa Cruz
H3K4me3 ab71998 na Mouse mc Abcam
H3K27me3 07-449 na Rabbit pc Millipore
CEBPα sc-9314 C-18 Goat pc Santa Cruz
CEBPβ sc-150 C-19 Rabbit pc Santa Cruz
SIN3A sc-994 K-20 Rabbit pc Santa Cruz
KLF4 sc-20691 H118 Rabbit pc Santa Cruz
OVOL1 na na Rabbit pc gift from X.
Dai [Nair et al.,
2006]
OVOL2 na na Rabbit pc gift from X. Dai
[Wells et al.,
2009]
TCFAP2γ 05-909 6E4/4 Mouse mc Millipore
MXI1 sc-1042 G-16 Rabbit pc Santa Cruz
RBP2 na 1416 Rabbit pc gift from E.V.
Benevolenskaya
[Lopez-Bigas
et al., 2008]
Table 2.1: Antibodies used for chromatin immunoprecipitation experiments: pc, poly-
clonal; mc, monoclonal; na, information not available.
2.2.3 Cell sonication
Formaldehyde fixed cell pellets were resuspended in 10 ml of cold Lysis Buffer 1 [50
mM Hepes-KOH, pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol, 0.5%
(v/v) NP-40 and 0.25% (v/v) Triton X-100 in distilled water]. The resuspended
cell pellet was incubated during 10 minutes at 4 ◦C in a rotating platform, followed
by centrifugation for 5 minutes at 4 ◦C and 1350 x g. The newly recovered cell
pellet was resuspended in 10 ml of Lysis Buffer 2 [200 mM NaCl, 1 mM EDTA,
0.5 mM EGTA and 10 mM Tris pH 7.5 in distilled water] and incubated at 4 ◦C
in a rotating platform for 5 minutes. Cells were again collected by centrifugation
at 4 ◦C and 1350 x g and resuspended in 3 ml of Lysis Buffer 3 [1 mM EDTA,
0.5 mM EGTA, 10 mM Tris-HCl pH 7.5, 0.1% (w/v) Na-deoxycholate and 0.5%
(w/v) N-lauroyl sarcosine in distilled water]. Lysis buffers 1, 2 and 3 all contained
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protease inhibitor cocktail tablets (Complete mini EDTA free, Roche). Cells were
sonicated using an automatic sonicator (Misonix 3000), cycles of 30 seconds were
applied with an output of 27-30 W and 1 minute intervals, with a total processed
time of 12 minutes. The cell lysate was kept in an ice water bath during sonicaton.
Cell extracts were transferred to 1.5 ml microcentrifuge tubes where 1/10 volume
of 10%(v/v) Triton X-100 solution in water was added. Cell debris was removed
by centrifugation at 2500 x g for 10 minutes at 4 ◦C in a table top centrifuge.
After clearing, 50 µl of each sonicated fraction, corresponding to the whole cell
extract (wce) supernatant (background reference/ input control) were transferred
to 1.5 ml microcentrifuge tubes, and diluted in 150 µl of Elution buffer [50 mM
Tris pH 8.0, 1 mM EDTA, 1% (w/v) SDS in distilled water] and stored at -20
◦C. The remaining samples were used for chromatin immunoprecipitation.
2.2.4 Chromatin immunoprecipitation
Pre-cleared sonicated fractions were incubated with 100 µl of antibody prebound
protein G magnetic beads at 4 ◦C, overnight on a rotating platform. The beads
had been previously washed three times with 1 ml of the BSA blocking solution,
in order to remove the excess of unbound antibody.
2.2.5 Wash, elution, and cross-link reversal
Following ChIP, the beads were washed four times with cold RIPA buffer [50
mM Hepes pH 7.6, 1 mM EDTA, 0.7% (w/v) Na-deoxycholate, 1% (v/v) NP-40
and 0.5 M LiCl in distilled water], and once with cold TE buffer [50 mM Tris
pH 8.0, 1 mM EDTA and 1% (w/v) SDS in distilled water]. All washing steps
were performed in a cold room at 4 ◦C, using a magnetic stand (Invitrogen)
to recover the beads. The DNA-protein complexes were then eluted in 200 µl
of Elution buffer [50 mM Tris-HCl pH 8.0, 10 mM EDTA and 1% (w/v) SDS in
distilled water] after incubation at 65 ◦C for 10 to 15 minutes with brief vortexing
every 2 minutes. At this step, the immunoprecipitate (IP) as well as wce samples
(previously kept at -20 ◦C), were reverse cross-linked overnight at 65 ◦C.
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2.2.6 Digestion of cellular protein and RNA
Following reverse-crosslinking, the 200 µl of IP and wce samples were centrifuged
at 20000 x g and the supernatant was recovered and diluted in 200 µ of TE buffer.
Samples were incubated for 30 minutes with 8 µl of 1 mg/ml of RNase A (Ambion)
at 37 ◦C, in order to digest RNA molecules. Subsequently, 4 µl of 20 mg/ml
of proteinase K (Invitrogen) were added to each sample in order to digest all
proteins. Samples were incubated for 1 hour at 55 ◦C, and DNA was isolated using
one volume of phenol: chlorophorm: isoamyl alcohol (Sigma-Aldrich) following
centrifugation at 20000 x g for 5 minutes. The aqueous layer from each sample
was collected and transferred to a new 1.5 µl microcentrifuge tube in which 16 µl
of 5 M NaCl (Sigmal-Aldrich) and 1 µl of glycoblue (Ambion) were added. DNA
was precipitated with 800 µl of 100% (v/v) ethanol by centrifugation at 20000 x
g at 4 ◦C for 15 minutes. The DNA pellets were washed with 500 µl 80% (v/v)
of ethanol and centrifugated at 20000 x g at 4 ◦C during 10 minutes, air-dried
(following supernatant removal) and resuspended in 60 µl of 10 mM Tris-HCl pH
8.0. The DNA concentration of the wce sample was normalised to 100 ng/µl using
a Nanodrop spectrophotometer (ND-1000, Nanodrop Technologies). In addition,
2 µl of each IP and wce samples were kept and analyzed in a 2% (w/v) agarose
gel for fragment size verification (see preparation of agarose gel below).
2.2.7 End Repair to add ’A’ bases to 3’ Ends of DNA
To perform 3’ end repair of the DNA fragments, the following reagents were mixed
directly into PCR tubes kept on ice:
30 µl IP or 50 ng of wce DNA sample
5.0 µl of 10x NEB2 buffer (New England Biolabs)
1.0 µl of dNTP mix (10 mM) (New England Biolabs)
2.5 µl of T4 DNA polymerase, 3 U/ µl (New England Biolabs or Enzymatics)
1.0 µl of Klenow fragment (New England Biolabs or Enzymatics)
1.0 µl of polynucleotide kinase (PNK) (New England Biolabs or Enzymatics)
33 µl of ultrapure water (Ambion)
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The IP and wce reaction mixtures were incubated for 30 minutes at 12 ◦C and the
DNA samples were purified using DNA Clean Concentrator-5 columns (Zymo
Research, USA). DNA was eluted with 32 µl of ultrapure water at 50 ◦C and the
following mixture was prepared to add ’A’ bases:
32 µl IP or wce DNA sample
5.0 µl of NEB2 buffer (New England Biolabs)
10 µl of dATP (1 mM) (New England Biolabs)
2.0 µl of exo-Klenow (Invitrogen or Enzymatics)
following incubation for 30 minutes at 37 ◦C and purification with DNA Clean
Concentrator-5 columns (Zymo Research). DNA was eluted with 8 µl of ultra-
pure water and blunt-ended ligation was perform by addition of:
12.5 µl of ligase buffer (Invitrogen or New England Biolabs)
3.0 µl of annealed linkers 102+/103 1
1.0 µl of T4 ligase (Invitrogen or New England Biolabs)
The mixture was incubated overnight at 16 ◦C in a thermoblock (BioRad) and
samples were purified with DNA Clean Concentrator-5 columns (Zymo Research,
USA) and eluted in 25 µl ultrapure water at 50 ◦C. A reaction mixture was pre-
pared with the following reagents:
25 µl of the blunt-ended IP or wce DNA sample
5.0 µl of 10x Thermopol buffer (New England Biosciences)
5.0 µl of dNTPs (2.5 mM dNTPs) (New England Biolabs)
2.0 µl oligo102+ primer (40 µM)
12 µl of ultrapure water (Ambion)
1.0 µl of AmpliTaq (Applied Biosystems, Roche)
1 375 µl of oligo 102+ G*CGGTGACCCGGGAGATCTGAATTCT (40 µM) were annealed
to 375 µl of oligo103 G*AATTCAGATC (40 µM) in 250 µl of Tris-Hcl (1M), pH 9.0 after
heating the oligos for 95◦C during 5 minutes, following 70◦C and subsequent cooling; * denotes
phosphorothioate modification.
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to perform the first DNA amplification (LM-PCR15) of the ligated IP and wce
DNA fragments. The PCR program used was the following: 1 cycle (2’ at 95
◦C), 14 cycles (30” at 95 ◦C, 30” at 60 ◦C and 1’ at 72 ◦C) and 1 cycle (1’ at 72
◦C). Ten microliters of the LM-PCR15 amplified products were added to a new
reaction mixture containing:
5.0 µl of 10x Thermopol buffer (New England Biolabs)
5.0 µl of dNTPs (2.5 mM dNTPs) (New England Biolabs)
2.0 µl oligo102+ primer (40 µM)
27 µl of ultrapure water (Ambion)
1.0 µl of AmpliTaq (Applied Biosystems, Roche)
A second amplification step was performed, LM-PCR25 with the following pro-
gram: 1 cycle (2’ at 95 ◦C), 24 cycles (30” at 95 ◦C, 30” at 60 ◦C and 1’ at 72
◦C) and 1 cycle (5’ at 72 ◦C). Finally, the DNA was purified using a QiAquick
PCR purification kit (Qiagen), following the manufacturer’s protocol. DNA was
resuspended in 50 µl of Qiagen elution buffer and the concentration was nor-
malised to 100 ng/µl using a Nanodrop spectrophotometer (ND-1000, Nanodrop
Technologies).
2.2.8 Cy3/Cy5 labelling of IP and wce DNA amplified
fragments
One microgram of IP or wce sample was diluted in 24 µl of ultrapure water
(Ambion) and 26 µl of 2.5X random primer solution (Invitrogen Bioprime labeling
kit). Samples were boiled for 5 minutes in a heatblock, following incubation in
an ice water bath for 5 minutes. Eight microliters of 10x low T dNTP mix (1.2
mM dATP, dCTP, dGTP each and 0.6 mM dTTP), 1 µl of high concentration
exo-Klenow (40 U/ml, Invitrogen Bioprime labeling kit) and 1 µl of cy5-dUTP
(Enzo Life Sciences) or 0.5 µl of cy3-dUTP (Enzo Life Sciences) and 0.5 µl of
sterile water, were added to the IP and wce fractions, respectively. Samples
were incubated overnight in the dark at 21-25 ◦C. Subsequently, labelled IP and
wce samples were purified with a QiAquick PCR purification kit, precipitated
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with 25 µl of ammonium acetate and 300 µl of 100% (v/v) cold ethanol. The
DNA pellets were air-dried and resuspended in 50 µl of Tris (Sigma-Aldrich) pH
8.0 solution. Cyanine 3 and cy5 incorporation was analyzed using a Nanodrop
spectrophotometer (ND-1000, Nanodrop Technologies).
Note: The protocol just described has been published by Ren et al. [2000].
2.2.9 Hybridization on Microarrays
Equal amounts of wce-cy3 and IP-cy5 labeled DNA were combined (6-10 µg of
total DNA) and hybridized overnight at 65◦C to mouse proximal promoter mi-
croarrays (Agilent, G4490A) or mouse whole genome chromosome 3 (Amadid
15317), using the oligo CGH/ChIP-on-Chip hybridization kit (Agilent) and fol-
lowing the manufacturer’s suggested protocol.
Arrays were scanned using a microarrays scanner (Agilent G2565CA) and data
was extracted using the Feature Extraction software (Agilent, v10.5). A mini-
mum of two biological independent replicates was used for each experiment. One
biological replicate consisted of biological material containing, either, isolated
mouse keratinocytes pooled from seven mice, or human primary keratinocytes
with a total number of 5 x 107 - 1 x 108 cells.
2.2.10 Microarray scanning and data analysis
ChIP-on-chip data analysis of mouse whole genome proximal promoter arrays
was performed in collaboration with Matthew Trotter 1. ChIP-on-chip analy-
sis of mouse whole genome chromosome 3 was performed in collaboration with
Stewart MacArthur 2. Both analyses were carried out using R and Bioconductor,
namely the Ringo [Toedling et al., 2007], RColorBrewer, WGCNA, limma and
xtable packages. To generate scatterplots for the ChIP-on-chip raw data, known
mouse binding events for MYC were used as targets to center each window. A
half size window corresponding to 3000 bp was defined and a minimum number
1Laboratory of Regenerative Medicine, LRM - University of Cambridge
2Bioinformatics core, Cancer Research UK - Cambridge Research Institute. Currently at
Illumina Cambridge Limited
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of 3 probes was set to consider a binding event. Targets were predicted using a
0.90 or 0.99 quantile and genomic regions between 1.0 Kb upstream and 0.3 Kb
downstream of the TSS of annotated genes (Genome built used: NCBI37/mm9)
.
ChIP-on-chip data access:
Data from ChIP-on-Chip mouse proximal promoter arrays for MYC and H3K4me3
were submitted to the ArrayExpress Database (http://www.ebi.ac.uk/arrayexpress/)
under the accession number E-MTAB-555.
Data from ChIP-on-Chip in mouse whole genome chromosome 3 arrays for all TFs
used were submitted to the ArrayExpress Database under the accession number
E-MTAB-556.
2.3 Modification of the ChIP-on-chip protocol
to enable sequencing (ChIP-Seq)
All previous steps of the ChIP-on-chip protocol described, until DNA ligation,
were the same as for ChIP-Seq. If sequencing of the IP or wce fragments was
desired then ligation overnight was performed with Illumina oligo adapters rather
than linkers 102+/103.
2.3.1 Ligation of Illumina sequencing adapters to DNA
fragments
Following digestion of the cellular protein and RNA from IP and wce samples the
following reagents were mixed in 1.5 ml microcentrifuge tubes:
8.0 µl IP or 50 ng of wce DNA sample
12.5 µl DNA ligase buffer (New England Biolabs)
2.0 µl Adapter Oligo mix (Illumina)
2.5 µl DNA ligase (New England Biolabs)
Samples were incubated overnight at 16 ◦C in a thermocycler PCR machine or
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water bath. Subsequently, the ligated DNA fragments were purified using DNA
Clean Concentrator-5 columns (Zymo Research). DNA samples were eluted with
23 µl of pre-heated at 50 ◦C Qiagen elution buffer (QIAquick PCR purification
kit) and samples were kept on ice until furhter processing.
2.3.2 Enrichment of adapter modified DNA by PCR
After the ligation step, the following reagents were added to pre-cooled PCR
tubes:
23 µl of IP or wce DNA sample
25 µl Phusion DNA Polymerase 2x mastermix (Illumina)
1.0 µl PCR primer 1.1 (Illumina)
1.0 µl PCR primer 1.2 (Illumina)
in order to perform amplification of the adapter modified IP or wce DNA. The
PCR program used was the following: 1 cycle (30” at 98 ◦C), 17 cycles (10” at
98 ◦C, 30” at 65 ◦C and 30” at 72 ◦C) and 1 cycle (5’ at 72 ◦C). Amplified DNA
fragments were purified with the QIAquick PCR purification kit (Qiagen) and
eluted with 33.5 µl of pre-heated (50 ◦C) Qiagen elution buffer. One microliter of
eluted IP or wce DNA was mixed with 9 µl of elution buffer and stored at -20 ◦C
(Solexa 18 sample). The remainder sample of 32.5 µl was stored as SolexaPreGel
sample. Note: Solexa18 was an aliquot that could be used for reamplification
and microarray or real-time PCR analysis. SolexaPreGel was the sample which
was ready for sequencing after Gel purification.
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2.3.3 Reamplification of Solexa 18 for ChIP-on-chip or
ChIP-qPCR
Two microliters of Solexa 18 IP or wce samples were mixed in PCR with:
5.0 µl 10x Thermopol buffer (New England Biolabs)
0.5 µl dNTP mix (25 mM each) (New England Biolabs)
2.5 µl Primer 1.2 for reamplification (10 µM) (Illumina)
2.5 µl Primer 2.2 for reamplification (10 µM) (Illumina)
1.0 µl AmpliTaq (Applied Biosystems, Roche)
Primer sequences used were the following:
Primer 1.2 for reamplification (5’AATGATACGGCGACCACCGAGATCTA
CACTCTTTCCCTACACGACGCTCTTCCGATCT3’) (Illumina)
Primer 2.2 for reamplification (5’ CAAGCAGAAGACGGCATACGAGCTCTTC-
CGATCT3’) (Illumina)
Primers 1.1 and 1.2 are from the Genomic DNA sequencing kit (Illumina).
The PCR program for reamplification used was the following: 1 cycle (2’ at 95
◦C), 24 cycles (30” at 95 ◦C, 30” at 65 ◦C and 1’ at 72 ◦C) and 1 cycle (5’ at
72 ◦C). Amplified DNA fragments were purified with QIAquick PCR purifica-
tion kit (Qiagen) and eluted with 25 µl pre-heated (50 ◦C) Qiagen elution buffer.
The IP and wce amplified DNA samples were measured with NanoDrop (Nan-
oDrop Technologies). At this point the samples were ready for further microarray
processing, such as Cy3 and Cy5 labelling or RT-qPCR.
2.3.4 Gel purification of SolexaPreGel for ChIP-Seq
A 50 ml 2% (w/v) agarose (BioRad) TAE gel with 1x SYBR Safe (Invitrogen) was
cast onto a BioRad gel electrophoresis tank. Meanwhile, a DNA ladder (NEB,
cat. # N3233) was prepared by adding 3 µl of 50% (v/v) glycerol solution to
8 µl of the DNA ladder. In addition, 10 µl of 50% (v/v) glycerol solution were
also added to the SolexaPreGel samples (only one sample was run per agarose
gel). Both ladder and DNA sample were loaded into the wells of the agarose
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gel. The gel was run at 120 V for 45 minutes and DNA fragments of 200-300 bp
were excised on a Dark Reader and purified with the MinElute Gel Extraction
kit (Qiagen) following the manufacturer’s instructions. Purified DNA was eluted
with 15 µl of pre-heated (50 ◦C) Qiagen elution buffer. DNA libraries were run
on a Bioanalyzer (Agilent) for estimation of the concentration the IP and wce
samples, which were submited for sequencing at the Cancer Research Institute
(CRI) - Cambridge Research Institute Genomics Facility.
2.3.5 ChIP-Seq analysis
The analysis of the ChIP-Seq data was performed in collaboration with Sabine
Dietmann1. Sequence tags of 36 nucleotides were aligned to the human refer-
ence genome (UCSCGRCh37/hg19) using the BOWTIE software (hht://bowtie-
bio.source.net). After quality inspection the first 5’ base were trimmed from the
sequence tags. Mapping of the sequences, at not more than three genomic loca-
tions, and with more than two mismatches in a seed of lenght equal to 28, was
used for data analysis. ChIP-Seq enriched regions were determined using MACS
[Zhang et al., 2008] and CCAT [Xu et al., 2010] software packages for peak call-
ing. A false discovery rate (FDR) of 0.1 and 0.05 was used to determine enriched
peaks with a maximum of 10 reads aligning at the same position.
2.4 Confirmation of IP enrichment by nucleolin-
specific PCR
2.4.1 Preparation of PCR amplification reaction
To confirm the protein of interest was bound to the Ncl promoter I performed
PCR using the following reagents:
2.0 µl of IP and wce (in a dilution series, e.g 20 ng, 60 ng) DNA sample
2.0 µl of 5 µM Forward Ncl primer: 5’-GGCTGGAAGCGAGAGAAAG-3’
1Bioinformatics facility, Wellcome Trust Centre for Stem Cell Research - University of
Cambridge
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2.0 µl of 5 µM Reverse Ncl primer: 5’-TCACCTCTTAAAGCAGCCCA-3’
13.6 µl of ultrapure water (Ambion)
0.2 µl of dNTPs (New England Biolabs)
2.0 µl of 10x Thermopol buffer (New England Biolabs)
0.2 µl of AmpliTaq (Applied Biosystems, Roche)
The PCR program used for amplification of the Ncl promoter was: 1 cycle (2’ at
94 ◦C), 28 cycles (45” at 94 ◦C, 1’ at 56 ◦C and 1’ at 72 ◦C) and 1 cycle (10’ at
72 ◦C).
2.4.2 Loading of PCR amplified DNA samples in an agarose
gel
A 50 ml of a 2% (w/v) agarose (Invitrogen) gel in 1 x TAE buffer (Invitrogen)
with 3 µl of ethidium bromide (Solarbio), were poured in a gel electrophoresis
tank (Mupid-One Gel Electrophoresis Unit from Anachem). A set of 13 combs
was added to allow the formation of wells where the PCR samples could be
loaded following gel polymerization. Six microliters of 6x DNA loading dye (0.25%
(w/v) Orange G (Sigma-Aldrich) and 15% (v/v) (Ficoll-400 (Sigma-Aldrich))
were added to 20 µl of each PCR reaction and samples were loaded into each of
the wells formed in the gel. In one of the wells a mixture of 3 µl of 1 Kb DNA
ladder (Invitrogen, cat # 15615-016) and 6 µl of DNA loading dye were loaded.
The gel was run for 150 V for 45 minutes and visualized under UVP Imaging
system.
2.4.3 ChIP-qPCR
Semi-quantitative qPCR was used on to confirm enrichment in IP samples (ChIP-
qPCR). Two microliters of IP or wce DNA (previously normalised to 100 ng/µl)
were diluted in a 20 µl qPCR reaction mixture containing 12.5 µl of Fast SYBR
Green (2x) (Applied Biosystems), 0.6 µl of forward and reverse primers (600
nM each) and 12 µl of ultrapure water. The qPCR reaction and preliminary
analysis was performed using a 7900HT Fast Real-Time PCR System (Applied
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Biosystems). Quantification of IP enrichment was performed using Ct values of
IP relative to wce. The primers used for ChIP-qPCR were designed to target
the promoter of genes bound by MYC and the corresponding sequences are listed
below in Table 2.2
Primer Sequence
Ncl forward GGCTGGAAGCGAGAGAAAG
Ncl reverse TCACCTCTTAAAGCAGCCCA
Suz12 forward AATAGGTCGCTCCCTTTCGT
Suz12 reverse GATCCCGAGACTGTGTGGTC
Ezh2 forward ACCTACCCCTGGAGATTTGG
Ezh2 reverse TGGTGACAGGTGCTAACGAA
Id2 forward GGCAGAGTCCGGTGATGTAG
Id2 reverse TGCAGGGCAGAGTCCTTCT
Hdac2 forward ACCCCTTCGGTCCTCAGAT
Hdac2 reverse CGTGCCATGTCCATCTCCT
Sprr1a forward AGGGCTCGGGTGCCTTGGG
Sprr1a reverse CAGCAGCAGGTGAAGCAGCCTTG
S100a1 forward AGCGTTGGTTCGGTAGCTCCAGT
S100a1 reverse CCCACTCTCGCCCAGCCCTT
Table 2.2: SYBR-green PCR primer sequences for ChIP-qPCR.
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2.5 Gene expression microarrays
2.5.1 Biological material
A minimum of three biological samples were used for the mouse K14MycER line
for each time point of 4-OHT treatment (0, 1, 2, 4 and 6 days), with corresponding
wild-type controls. For mouse lines K14Sin3a∆/∆, K14Myc∆/∆K14Sin3a∆/∆ and
K14Myc∆/∆ a minimum of four biological replicates were used treated with 4-
OHT or acetone for 14 or 21 days, as previously described.
2.5.2 Extraction of total RNA
Samples from dorsal skin of transgenic and non-transgenic mice treated with
4-OHT or acetone were cut and flash-frozen in liquid nitrogen until further pro-
cessing. Frozen tissues were added to nalgene centrifuge 50 ml tubes, previously
rinsed with RNAaseZap solution (Ambion) and containing 3 ml of Trizol reagent
(Invitrogen). Tissues were macerated using a homogeneizer (this step, and all
involving Trizol usage were performed under a chemical hood). Tissue suspen-
sions were incubated for 5 minutes at 21-25 ◦C and 0.6 ml of choroform were
added. Samples were run in a vortex for 15 seconds and incubated for 15 min-
utes at 21-25 ◦C following centrifugation at 12000 x g for 30 minutes at 4 ◦C.
The aqueous supernatant was removed and RNA was kept for 30 minutes on ice
while precipitating in 1.5 ml of 2-propanol. RNA pellets were collected by cen-
trifugation at 12000 x g for 30 minutes at 4 ◦C and were washed with 500 µl of
70% (v/v) ethanol by centrifugation at 12000 x g for 5 minutes. RNA samples
were air-dried and diluted in 500 µl of ultrapure water and the concentration
content was assessed using a Nanodrop spectrophotometer (ND-1000, Nanodrop
Technologies). Concentrations were normalised to 25 ng/µl and sent to CRI Ge-
nomics Core facility for assessment of RNA integrity (RIN) using a Bioanalyzer
(Agilent). From this step onwards only samples with a RIN = 9 were further
processed.
61
2.5.3 Microarray sample preparation and hybridization
Microarray sample preparation and hybridization was performed in collaboration
with Michelle Osborne 1. A sample of 250 ng of total RNA was converted to
complementary RNA (cRNA) target using a Illumina TotalPrep-96 Kit (Ambion
4397949). Briefly, total RNA was reverse transcribed and converted to double-
stranded cDNA using a T7 promoter-Oligo(dT) primer and purified with mag-
netic oligo(dT) beads. This reaction formed the template for an in vitro transcrip-
tion (IVT) reaction which included a biotinylated nucleotide/ribonucleotide mix
for both cRNA amplification and biotin labeling. Quality control using a Bioana-
lyzer (Agilent) and normalisation was performed and the cRNA was hybridized to
arrays (3 Sentrix BeadChip Array MouseWG-6 v2 Part #11278593). Hybridiza-
tion, washing, staining and scanning were performed according to standard Illlu-
mina protocols (Illumina WGGX DirectHyb Assay Guide 11286331 RevA).
2.5.4 Microarray data analysis
Microarray data analysis was performed in collaboration with Stewart MacArthur.
Analysis involved the use of scripts written in R (R Development Core Team
2008; www.r-project.org) and Bioconductor (www.bioconductor.org) [Gentleman
et al., 2004]. Differential gene expression analysis was performed using limma
Smyth [2005] and time course analysis using the timecourse package [Tai and
Speed, 2009]. The microarray data was clustered using Euclidian distance and
the complete agglomeration method. Clusters were visualized in R software, using
the gplots package (http://CRAN.R-project.org/package=gplots) [Warnes et al.].
Visualization of the time course of expression for individual genes was also per-
formed in R. A more detailed description of the analysis follows below.
The raw beadlevel data was imported and processed using the beadarray package
and differential expression was carried by applying linear models using the limma
package. Following import of the data, a range of quality control (QC) steps were
performed in order to see if there were any spatial effects during hybridization
that might confound the data analysis. The BASH package was used to help
1Genomics core, Cancer Research UK - Cambridge Research Institute, CRI
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remove spatial aberrations on the arrays. Positve and negative control spots on
the arrays behaved normally during QC analysis.
Data was quantile normalised and log2 transform to remove small differences be-
tween arrays (Figure 2.1).
Figure 2.1: Density plot of log expression values. Data was quantile normalised
to remove small differences between arrays. Numbers 4544478119A-E represent exam-
ples of samples hybridized.
Clustering was performed in order to try to see if there was a problem with sample
mis-labelling or other confounding problems. Clustering of the arrays was based
either on all probes or on the most variable probes (above the third quantile of
variance) and the euclidian distance and complete method were used. Clustering
should not be seen by other groups (e.g gender, age) other than genotype and
treatment. In the rare cases that the arrays did not follow this presumption,
samples history was tracked by histological analysis.
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Annotation information for the Mousev2 beadarrays platform was obtained from
the Cambridge Computational Biology Group’s Illumina BeadChip Probe Re-
annotation data. Identification of genes statistically differentially expressed was
performed using linear models from the limma package. In some arrays where
poor correlation between replicates was observed, these were weighted by how
well replicates matched a fitted linear model.
Base packages used in this analysis:
Base
datasets
grDevices
graphics
methods
stats
tools
utils
Other packages used:
AnnotationDni 1.4.2
Biobase 2.2.1
RColorBrewer 1.0-2
WGCA 0.79-1
annotate 1.201
beadarray 1.11.3
dynamicTreeCut 1.20
fields 5.02
flashClust 0.10
gdata 2.4.2
geneplotter 1.20.0
gplots 2.6.0
gtools 2.5.0
hwriter 0.93
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1.14.0
lattice 0.17.17
limma 2.16.3
sma 0.5.15
spam 0.15-3
x-table 1.5-4.
Loaded via a namespace: DBI 0.2-4, KernSmooth 2.22-22, RSQLite 0.7-1, grid
2.8.1.
R version used: R version 2.8.1/ 2008-12-22
Microarray mRNA expression data access:
Data from mRNA gene expression microarrays for wild-type and K14MycER
time-course treated from 0 to 6 days with 4-OHT were submitted to the Ar-
rayExpress Database under the accession number E-MTAB-553 (released date
2012-02-25).
Data from mRNA gene expression microarrays for K14Sin3a∆/∆, K14Myc∆/∆
and K14Myc∆/∆K14Sin3a∆/∆ treated for 14 and 21 days with 4-OHT were sub-
mitted to the ArrayExpress Database under the accession number E-MTAB-554
(released date 2012-02-25).
2.6 RT-qPCR for mRNA expression analysis
Total RNA samples were extracted as previously described. Double stranded
cDNA was generated from 1 µl of RNA using Superscript III reverse transcriptase
(Invitrogen) enzyme following manufacturer’s instructions. Reverse transcription
quantitative PCR (RT-qPCR) and analysis was conducted using the 7900HT
Real-Time PCR System (Applied Biosystems). The standard amplification pro-
tocol was used with pre-designed probe sets and TaqMan Fast Universal PCR
Master Mix (2) (Applied Biosystems). A list of the pre-designed probes used is
shown in Table 2.3. A Gapdh probe (4352932E) was used to normalize samples
using the ∆Ct method.
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Gene Taqman Probe ID
Itgα6 Mm01333831 m1
Ivl Mm00515219 s1
Myc Mm00487803 m1
Sin3a Mm00488255 m1
Ncl Mm01290591 m1
Suz12 Mm013041352 m1
Hdac2 Mm00515108 m1
Sprr1a Mm01962902 s1
Id2 Mm00711781 m1
S100a1 Mm00845129 g1
S100a11 Mm00845129 g1
Lce1e Mm00783163 s1
S100a16 Mm00509522 m1
Lce1g Mm00787694 s1
Lce3f Mm02605425 s1
Ovol1 Mm00498263 m1
Klf4 Mm00516104 m1
Cebpα Mm01265914 s1
S100a10 Mm00501457 m1
Lce1a2 Mm00783433 s1
MYC Hs00153408 m1
Table 2.3: List of probes used for reverse transcription quantitative PCR (RT-pPCR).
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2.7 Flow cytometry
Following the mouse epidermal keratinocytes isolation protocol, above described,
cells were resuspended in PE-conjugated ITGα6 antibody (Clone GoH3, eBio-
sciences). After incubation for 45 minutes at 4 ◦C, cells were washed twice in
PBS (PAA Laboratories). Cells were gated using forward versus side scatter to
eliminate debris. Cell doublet discrimination was carried out using pulse width.
The non viable cells, stained with DAPI (4’,6-diamidino-2-phenylindole, dihy-
drochloride) DNA staining reagent (Sigma-aldrich) were then gated for their ex-
clusion using a 450/65 nm filter. ITGα6 PE stained cells were detected using a
580/30 nm filter. Cells were then sorted based on ITGα6 expression (fluorescence
detected using a 580/30 nm filter), after gating out dead cells (based on DAPI
staining) with a MoFlo high-speed sorter (Beckman Coulter). This work was
performed in collaboration with Nigel Miller 1.
2.8 Immunohistochemistry
Skin tissue samples were fixed in 4% (w/v) formaldehyde and paraffin embedded
and sectioned at 5 to 10 µm for H&E staining at the Histology facility with the
help of Margaret Mcleish2. Immunohistochemistry was performed using Ventana
Discovery (Ventana Medical Systems, Inc) on paraffin embedded tissues, follow-
ing manufacturer’s guidelines. Antigen retrieval was performed using Ventana
Cell Conditioning 1 solution (Roche) for 40 minutes at 99 ◦C. Primary antibody
incubation was performed for 54 minutes at 37 ◦C. Secondary antibody incuba-
tion (Donkey anti-rabbit or anti-goat Ig biotinylated, Jackson) was performed
for 30 minutes at 37 ◦C. Antibody detection was performed using the DAB Map
detection kit (Ventana) and sections were counterstained using hematoxylin and
bluing reagent (Roche). Primary antibodies used are listed in Table 2.4. All
antibodies were used at a 1:100 dilution.
1Department of Pathology, University of Cambridge
2Histology Facility, Wellcome Trust Centre for Stem Cell Research - University of Cambridge
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Antibody Catalogue # Clone Host Source
c-MYC sc-764 N-262 Rabbit pc Santa Cruz
CEBPα sc-9314 C-18 Goat pc Santa Cruz
SIN3A sc-767 AK-11 Rabbit pc Santa Cruz
KLF4 sc-20691 H118 Rabbit pc Santa Cruz
KI67 VP-RM04 SP6 Rabbit mc Vector Labs
Table 2.4: Primary antibodies used for immunohistochemistry: pc, polyclonal; mc,
monoclonal
2.9 Immunofluorescence
Skin tissue cryosections of 5 to 10 µm, previously embedded in Optimal Cut-
ting Temperature (OCT) solution (Raymond A Lamb) and fixed with 4% (w/v)
paraformaldehyde were incubated for 5 minutes with a 0.2% (v/v) solution of
Triton X-100 and subsequently blocked with blocking solution [10% (v/v) fetal
calf serum (FCS), 0.05% (w/v) Na-azide in PBS]. Tissue sections were incu-
bated with primary antibodies overnight at 4 ◦C (antibodies diluted in blocking
solution). Subsequently, sections were washed three times with PBS (PAA Lab-
oratories) for 10 minutes and incubated with secondary antibodies (antibodies
diluted in blocking solution) in addition to DAPI (4’,6-diamidino-2-phenylindole,
dihydrochloride) DNA staining reagent (Sigma-aldrich) (1:1000 dilution) at 21-
25 ◦C for 1 hour. Sections were washed three times with PBS for 5 minutes and
mounted with Mowiol mounting media. The primary and secondary antibodies
used are listed in Table 2.5:
Antibody Dilution Clone Host Source
KRT10 1:500 PRB-159 Rabbit pc Covance
ITGα6 1:250 SP6 Rat pc Serotec
IVL 1:500 ERLI-3 Rabbit pc gift from Li ([Li
et al., 2000a])
Rabbit IgG whole
molecule Alexa 594
1:1000 na Goat pc Molecular
Probes
Rat IgG whole
molecule Alexa 488
1:1000 na Goat pc Molecular
Probes
Table 2.5: Primary and secondary antibodies used for immunofluorescence: pc, poly-
clonal; na, information not available
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2.9.1 Preparation of Mowiol Mounting media
Mowiol was prepared by using 24 g analytical grade glycerol (Sigma-aldrich), 9.6
g Mowiol 4-88 (Sigma-Aldrich), 24 ml distilled water and 48 ml 0.2 M Tris buffer,
pH 8.5 were combined and homogeneized with a stir bar on a hot plate on 60 ◦C
for at least 4-5 hours until dilution of the Mowiol powder in the solution. The
solution was centrifuged at 5000 x g for 15 minutes and the supernatant was
stored in aliquots at -20 ◦C for a maximum of 12 months. Mowiol was used at
21-25 ◦C.
2.9.2 Image acquisition
Microscopic white field images were acquired using an Olympus IX80 microscope
and a DP50 camera. All the images were processed with Photoshop CS4 (Adobe)
software.
2.10 Cell culture
All mammalian cell culture was performed using aseptic technique under a lami-
nar flow hood. Cells were maintained at 37 ◦C in a humidified incubator with a
5% CO2 atmosphere. Cells were grown on plastic dishes or flasks of tissue cul-
ture grade (Falcon). Medium renewal was performed every two to three days and,
when necessary cells were frozen in 1 ml aliquots containing 106 cells per mililiter
in freezing medium (FCS and 10% (v/v) DMSO). Cell were first subjected to
freezing in a Mr. Frosty freezing container (Nalgene) and kept one day at -80 ◦C
following transfer to a liquid nitrogen container used as a cell bank.
2.10.1 Cell lines
HEK-293 cells were obtained from ATCC and maintained in DMEM (Invitro-
gen) supplemented with 10% (v/v) FCS serum (Sigma-Aldrich), 100 U/ml peni-
cillium (PAA laboratories), 100 µg /ml streptomycin (PAA laboratories) and
splitted 1:8 once a week according to ATCC guidelines.
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COS-7 cells were obtained from ATCC and maintained in DMEM (Invitrogen)
supplemented with 10% FCS serum (Sigma-Aldrich), 100 U/ml penicillium (PAA
laboratories), 100 µg /ml streptomycin (PAA laboratories) and splitted 1:5 once
a week according to ATCC guidelines.
3T3 J2 cells were generated from the J2 clone of random-bred Swiss mouse
3T3 cells which was selected to provide optimal feeder support of keratinocytes
[Rheinwald and Green, 1975]. These cells were maintained in DMEM (Invit-
rogen) supplemented with 10% (v/v) bovine calf serum (BS) (Invitrogen), 100
IU/ml penicillin (PAA Laboratories), 100 µg/ml streptomycin (PAA Laborato-
ries). Cells were passaged nearly confluency and re-seeded at a density of approx-
imately 3,000/cm2. Cells were maintained for up to 12 passages after thawing,
after which a new stock of low passage number feeder cells was thawed to re-
place the old stock. Feeder cells were mitotically inactivated by incubation with
4 µg/ml mitomycin C (Sigma-Aldrich) for 2 hours at 37 ◦C to inhibit mitosis.
These were washed twice with PBS to remove the mitomycin C and incubated in
fresh FAD medium before used as feeders for keratinocytes. Cells were splitted
1:5 once a week.
3T3 J2-puro cells were stably transfected with pBabePuro retroviral vector to
render them resistant to puromycin [Levy et al., 1998]. These were handled in
the same way as J2-3T3 cells, in addition to the fact that the culture media was
supplemented with 2 µg/ml of puromycin (Sigma-Aldrich). Cells were splitted
1:5 once a week.
Phoenix E ecotropic packaging cells were obtained from ATCC with ap-
proval of G. Nolan (Standford University, USA) [Swift et al., 2001]. Cell mainte-
nance included cultivation in DMEM (Invitrogen) supplemented with 10% FCS
(Sigma-Aldrich), 100 U/ml penicillium (PAA laboratories), 100 µg /ml strepto-
mycin (PAA laboratories). Prior thawing, the culture dishes needed coating with
a 1:100 solution of collagen (BD Biosciences) in PBS at 37 ◦C for a minimum of 30
minutes, as these cells are very sensitive and tend to detach from the plasticware.
Cells were splitted 1:5 every 3 days.
70
AM12 amphotropic packaging cells first described by [Markowitz et al., 1988]
were cultured in DMEM (Invitrogen) supplemented with 10% FCS serum (Sigma-
Aldrich), 100 U/ml penicillium (PAA laboratories), 100 µg /ml streptomycin
(PAA laboratories). Cells were splitted 1:5 every 3 days.
Primary human keratinocytes
Simon Broad 1 and Salvador Aznar Benitah 2 kindly provided vials of human
keratinocytes (at passage 0) which had been isolated from neonatal foreskin and
were maintained on J2-3T3 mouse feeder cells. These cells were maintained in
complete FAD medium (FAD + FCS + HICE) which included one part Ham’s
F12 medium and three parts Dulbecco’s modified Eagle’s medium (DMEM), sup-
plemented with 1.8 x 10−4 M adenine (FAD); 10% (v/v) FCS (Sigma-Aldrich); 0.5
µg/ml hydrocortisone (Fisher Scientific), 5 µg/ml insulin (Sigma-Aldrich), 10−10
M cholera toxin (Sigma-Aldrich), 10 ng/ml EGF (Peprotech) (HICE). Before
passaging the keratinocytes, the J2-3T3 feeder cells were removed by incubation
in versene (Gibco) for 5 minutes. Keratinocytes were dissociated by incuba-
tion in a 1:4 dilution of 0.25%v/v) trypsin solution with no EDTA (Invitrogen)
in PBS (PAA Laboratories) for 5 minutes. Complete FAD medium was added
and the cells were recovered by centrifugation at 1000 x g for 5 minutes. Ker-
atinocytes were resuspended in complete FAD medium and replated at a density
of 4,000/cm2 on inactivated J2-3T3 feeder cells.
2.11 Transient transfection of HEK-293 cells for
luciferase reporter assay
HEK-293 cells were grown in 6-well plates and plated in 24-well plates for trans-
fection at a confluence of 50-60% using the Attractene Transfection Reagent (Qi-
agen) following manufacture’s instructions. Cells were transfected with a total
1Fiona Watt Lab, Cancer Research UK - Cambridge Research Institute
2Head of Epithelial Homeostasis and Cancer, Center of Genomic Regulation(CRG),
Barcelona
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of 450 ng of plasmid DNA from the Cignal c-Myc Reporter luciferase assay from
Qiagen (cignal reporter, cignal negative control and cignal positive control plas-
mids) as well as a wild-type Myc and a mutant Myc construct, K323/417R which
cannot be methylated at lysines 323 and 417 by GCN5. The two Myc constructs
were kind gifts of S. McMahon [Patel et al., 2004]. During transfection the cells
were kept in OptiMEM media (Invitrogen) containing 5% (v/v) FCS (Sigma-
Aldrich). Following transfection, the cells were recovered in complete growth
media containing DMEM (Invitrogen), 10%(v/v) FCS (Sigma-Aldrich), 0.1 mM
non essential amino-acids (NEAA) (PAA laboratories), 1 mM sodium pyruvate
(PAA laboratories), 100 U/ml penicillium (PAA laboratories), 100 µg /ml strep-
tomycin (PAA laboratories).
2.12 Transient transfection of Cos-7 cells for acety-
lation analysis
For MYC co-immunoprecipitation and acetylation assays the following constructs
were cloned into eukaryotic expression vectors: estrogen receptor domain fused
to a Flag-tag (ER-Flag), human MYC fused to ER and Flag-tag (MycER-Flag),
and full length cDNA for SIN3A. The cytomegalovirus-driven expression vector
containing TIP60 was a kind gift from S. Khochbin [Legube et al., 2002], GCN5
was kindly provided by S. Dent. Constructs were transfected using Cos-7 cells
which were grown in 150 mm2 dishes and transfected at 50% confluence with the
empty vector, or MYC, TIP60, GCN5 and SIN3A constructs with Lipofectamine
LTX and Plus Reagent (Invitrogen) and harvested after 24 hours.
2.13 Retroviral infection of human keratinocytes
Twenty micrograms of the retroviral constructs pBabe-puro [Morgenstern and
Land, 1991] and pBabeMYCER [Littlewood et al., 1995] were used transfect
Phoenix E cells by calcium-phosphate precipitation as described previously [Mor-
genstern and Land, 1991]. Two days after transfection 2 µg/ml of puromycin
(Sigma-Aldrich) were added to the normal culture media to select retrovirus pro-
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ducing cells. Once stable Phoenix E transfected cells had been obtained, these
were rinsed and incubated in puromycin-free medium overnight. The medium
conditioned in this way was then harvested, filtered with a 40 µm filter to remove
cell debris, and supplemented with 8 µg/ml of Polybrene. AM12 packaging at 60%
confluency, were grown in the filtered conditioned media overnight. The follow-
ing day, fresh conditioned media from Phoenix E cells was added to the infected
AM12 cells and two days later 2 µg/ml of puromycin (Sigma-Aldrich) were added
to normal AM12 media for selection of retrovirus-producing cell lines. Selection
was perform for at least five days until AM12 puromycin resistent could be used
to infect human keratinocytes. AM12 were then treated with 4 µg/ml mitomycin
C (Sigma-Aldrich) for 2 hours at 37 ◦C to inhibit mitosis, washed twice with
PBS (PAA Laboratories) and once with FAD++ culture medium (FAD + FCS +
HICE) culture medium, and used as feeders for infection of human keratinocytes,
which were seeded at normal passaging and density (4,000 cells/cm2). After three
to four days, when keratinocytes colonies were formed, puromycin selection was
performed by adding 2 µg/ml of puromycin (Sigma-Aldrich) to keratinocyte’s
normal growth medium. Cells were then expanded in T175cm2 flasks containing
3T3-J2-Puro feeder cells (previously mitomycin C treated), which were then re-
moved by treatment with versene (Invitrogen) prior trypsinization and collection
for ChIP-Seq experiments.
2.14 Biochemistry
2.14.1 Protein extraction from mouse skin tissue
Samples of frozen tissue were added to 1.5 ml of lysis buffer , RIPA [0.05% (w/v)
SDS (Sigma-Aldrich), 0.1% (w/v) Na-deoxycholate (Sigma-Aldrich), 0.5% NP-40
(v/v) (Sigma-Aldrich) in PBS] containing tablets of complete Mini EDTA-free
Protease Inhibitor Cocktail (Roche) and mixed using a homogeneizer. The cell
lysate was transfered to 1.5 ml microcentrifuge tubes and incubated on ice for
30 minutes. Samples were centrifuged at 4600 rpm (Eppendorf 5424R) for 10
minutes at 4◦C.The supernatant was kept, but when still cloudy, due to skin fat,
it was centrifuged several times until it became completely clear. Protein sample
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from the cell lysates was diluted in SDS sample buffer [40% (v/v) of glycerol,
0.8% (v/v) of SDS and 40 mM of DTT] after protein concentration was quan-
tified using the Pierce bicinchoninic (BCA) Protein Assay Kit (Thermo Fisher
Scientific), according to the manufacturer’s instructions. Protein concentration
was measured using a Spectrophotometer and the Softmax program for protein
quantification. Samples were aliquoted and kept at -80◦C with no more than two
cycles of freezing and thawing.
2.14.2 Protein extraction from cell lines
Transfected cells lines or cells treated with cycloheximide (50µg/µl) (Sigma-
Aldrich) were lysed in RIPA buffer, previously described, and the protein con-
tent was quantified using Pierce bicinchoninic (BCA) Protein Assay Kit (Thermo
Fisher Scientific), according to the manufacturer’s instructions. Samples were
aliquoted and kept at -80◦C with no more than two cycles of freezing and thaw-
ing.
2.14.3 Western-blotting
Cell protein lysates were homogeneized in SDS sample buffer [40% (v/v) of glyc-
erol, 0.8% (v/v) of SDS and 40 mM of DTT], containing bromophenol blue and
heated between 60-90 ◦C for 5 minutes before loading onto 10% BioRad pre-cast
polyacrylamide gels. Gels were run in SDS Running buffer [14g Glycine, 3g Tris
base, 1g SDS diluted to 100 ml of ultrapure water] at 200 V for 40 minutes,
after which the proteins were transferred onto a nitrocellulose membrane (GE
Healthcare) in Transfer buffer [14g glycine, 3 g of Tris-base diluted in 100 ml
of ultrapure water containing 10% (v/v) methanol] for 2 hours at 4 ◦C. Mem-
branes were blocked in 5% (w/v) non-fat milk in TBS-T (0.05% (v/v) Tween-20
in Tris-Buffered Saline, TBS) for 1 hour at 21-25 ◦C and incubated with primary
antibody in blocking solution overnight at 4 ◦C. Primary antibodies used detected
either MYC (sc-764, N-262, Santa Cruz) (1:500 dilution), TIP60 (sc-5725, N-17,
Santa Cruz) (1:500 dilution), GCN5 (sc-6303, N-18, Santa Cruz) (1:500 dilution),
SIN3A (sc-994, K-20, Santa Cruz) (1:500 dilution), mouse monoclonal anti-acetyl-
lysine (Cell Signalling Technology) (1:1000) or rabbit polyclonal tubulin (T3526,
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Sigma-Aldrich) (1:2000). Prior, incubation with Horseradish peroxidase (HRP)-
labeled secondary antibodies (GE Healthcare) (diluted 1:5000), the membranes
were washed three times with TBS. The HRP was detected using the Amersham
ECL detection system (GE Healthcare).
2.14.4 Co-immunoprecipitation assays
Cells were lysed in lysis buffer consisting of PBS without Ca2+ and Mg2+ (PAA
Laboratories), 0.5% (v/v) NP-40, 0.1% (w/v) sodium deoxycholate, 0.05% (w/v)
SDS, and protease inhibitor tablets (Roche). Lysates were centrifuged at 13,000
rpm (Eppendorf 5424R) for 10 minutes at 4 ◦C and the supernatant was then
added to Protein G Dynabeads (Invitrogen) which had been pre-incubated with
50 µg of rabbit polyclonal anti-c-Myc antibody (sc-764, N-262,; Santa Cruz) for
1 hour at 4 ◦C. Following 2 hours incubation at 4 ◦C, the beads were washed five
times with lysis buffer and the immunoprecipitated protein was then eluted with
SDS sample buffer at 70 ◦C. The protein supernatant was collected and ran in a
polycrylamide gel as previously described.
2.15 Luciferase Reporter assay
Cells, grown in 24-well plates, were previously transfected with plasmid DNA for
the protein of interest (wild-type Myc and a Myc mutant construct K323/417R)
and from the Cignal c-Myc Reporter kit (cignal reporter, cignal negative control
and cignal positive control plasmids), were gently washed with PBS (PAA Labo-
ratories) to prevent detachment of the cells from the plate. The plate was frozen
at -80 ◦C. The following day, cells lysates were obtained using a Lysis buffer solu-
tion from the Dual Luciferase Reporter Assay (Promega). Cells were treated with
Renilla and Firefly containing solutions according to the manufacturer’s suggested
protocol. Luciferase and Renilla were measured using a microplate luminometer
(Veritas).
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Chapter 3
Identification of transcriptional
target genes of MYC in
epidermis
Published observations have established that MYC induces a variety of biological
responses within a cell. When activated specifically in epidermal stem cells, MYC
has been shown to promote exit of stem cells from the niche and division of pro-
genitors following differentiation into the IFE and SG lineages [Frye et al., 2003].
The effect of MYC activation in basal undifferentiated epidermal keratinocytes is
shown by treatment of K14MycER mice with topical application of 4-OHT on the
shaved dorsal skin for four days (Figure 3.1, A-C). Histological analysis of H&E
stained skin sections from these mice, confirmed that MYC activation induces
thickening of the IFE as well as an enlargement of the SGs, as previously shown
[Frye et al., 2003]. RT-qPCR analysis confirmed that the phenotype observed
was due to an increase in Myc expression levels upon 4-OHT treatment (Figure
3.1, A-C).
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Figure 3.1: Effect of MYC activation in murine epidermis. (A) MYC was
induced in basal undifferentiated keratinocytes of K14MycER (TG) mice by topical
application of tamoxifen (4-OHT) for 4 days onto shaved dorsal skin resulting in hy-
perproliferation of the interfollicular epidermis, IFE (B,C - arrows) and enlargment of
the sebaceous glands, SG (B,C - arrow heads) compared to wild-type (WT). The effects
observed resulted from increased in Myc expression (D). HF denotes hair follicle.
3.1 Experimental design for ChIP-on-chip
To assess how MYC mechanistically regulates the genes involved in regulat-
ing epidermal stem cell fate, I established an experimental design (Figure 3.2)
which included chromatin immunoprecipitation combined with promoter tiling
arrays (ChIP-on-Chip), to identify MYC occupancy in activated epidermal stem
cells. ChIP-on-chip experiments were combined with a time-course experiment,
in which MYC activation was induced from zero to six days by 4-OHT treatment.
Evaluation of the skin phenotype was performed by examination of histological
skin samples stained with H&E, prior mRNA hybridization.
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Figure 3.2: Genome-wide analysis of MYC transcriptional functions in
murine epidermis. Mouse epidermal keratinocytes were isolated from dorsal skin
of wild-type (WT) and K14MycER mice, following treatment with tamoxifen (4-OHT)
for 4 days (4d), as previously described [Jensen et al., 2009]. Epidermal cells were
fixed with 1% (v/v) formaldehyde to covalently link transcription regulators to DNA
sites of interaction. Cells were harvested and chromatin in cell lysates was sheared by
sonication. The regulator-DNA complexes were enriched by ChIP with specific anti-
bodies, crosslinks were reversed, and enriched or control DNA fragments were amplified
by ligation mediated polymerase chain reaction. The amplified DNA was labeled with
distinct fluorophores - cyanine 3 (cy3) or 5 (cy5), combined and hybridized onto pro-
moter microarrays (ChIP-on-Chip). In addition, mice were treated with tamoxifen in
a time-course from 0 to 6 days (0-6d), the phenotype was evaluated by hematoxilin
and eosin (H&E) staining and mRNA was extracted and hybridized onto bead arrays
(mRNA expression Array) for gene expression analysis. ChIP-on-chip was compared
to mRNA gene expression data for functional analysis.
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3.2 Optimisation of ChIP parameters for genome
wide studies
An important step of the ChIP-on-chip protocol is optimisation of the sonication
conditions needed to shear the chromatin. Effective hybridization on probes from
Agilent promoter arrays relies on genomic DNA fragments of 500 bp [Sandmann
et al., 2006]. For this reason, following keratinocyte’s isolation and fixation, I
performed a time-course experiment, in which isolated, crosslinked keratinocytes
were sonicated at different processed times to identify the optimal chromatin
shearing conditions for hybridization (Figure 3.3). The sheared chromatin sam-
ples were treated with RNAse A and proteinase K (PNK) for RNA and protein
degradation and the genomic DNA fragments were isolated, following reverse
crosslinking at 65 ◦C, using phenol-chloroform extraction. Samples were run in a
2% (v/v) agarose gel. The optimal sonication processed time was found to be 12
minutes, as it yielded a smear of DNA with a peak of fragments at aproximately
500 bp. Experiments were repeated at least five times with consistent results.
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Figure 3.3: Optimization of sonication conditions for shearing genomic
DNA in mouse epidermal keratinocytes. Keratinocytes were fixed with 1% (v/v)
formaldehyde and crosslinked chromatin was sheared by sonication for 5, 10, 12 and 15
minutes using cycles of 30 seconds followed by 1 minute intervals. To verify the average
sequence length, within different batches of sheared chromatin, 50 µl of chromatin were
treated with RNAse A and proteinase K and the covalent crosslinks partially reversed
at 65 ◦C. DNA was purified by phenol-chlorophorm extraction and ethanol precipita-
tion and ran on this 2% (w/v) agarose gel by eletrophoresis. The size of genomic DNA
fragments decreased during the time-course. The optimal fragment size was observed
at 12 min where there is a peak around 500 base pairs (bp). MW stands for the 1 Kb
(Kilobase) molecular DNA marker.
81
3.Identification of transcriptional target genes of MYC in epidermis
Enrichment of genomic DNA fragments bound by MYC was evaluated by
PCR amplification of the murine Ncl promoter. Comparison of the intensity of
the 344 bp band obtained for the immunoprecipitate (IP) and whole cell extract
(wce) samples revealed an increase of at least two fold in genomic DNA fragments
bound by MYC in K14MycER mice, when compared to wild-type littermates.
Enrichment for trimethylation of histone H3 at lysine 4 (H3K4me3) was observed
in both mouse strains (Figure 3.4).
Figure 3.4: Chromatin immunoprecipitation (ChIP) experiments show in-
teraction of MYC and H3K4me3 at the Ncl promoter. PCR analysis of genomic
DNA from ChIP performed with MYC (IP c-Myc) and H3K4met3 (IP - H3K4me3) spe-
cific antibodies and lysates of crosslinked keratinocytes (wce), isolated from wild-type
and K14MycER mice. A primer set specific to the Ncl promoter was used. Samples of
20 ng of immunoprecipitated DNA (IP) or whole cell extracts (wce)s /input DNA in
a dilution series from 250, 80 to 20 ng were used. The higher intensity for the 344 bp
amplified band was observed in the IP samples (compared to wce control) and demon-
strate enrichment in DNA fragments containing MYC and H3K4me3 solely observed
for K14MycER samples. Wild-type samples only show enrichment for H3K4me3 at
the. MM stands for molecular DNA marker.
Subsequent experiments for enrichment of genomic DNA for validation of
MYC target genes were performed by ChIP-qPCR as presented later in this
chapter.
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3.3 Genome-wide location of MYC in epidermis
Once MYC enrichment was confirmed by gene specific PCR, ChIP-on-chip exper-
iments were performed against MYC and H3K4me3 on mouse proximal promoter
arrays. The histone mark H3K4me3 was used as a positive control, as it is known
to bind to enriched in regions close to the TSS of genes [Hampsey and Reinberg,
2003]. I used Agilent mouse proximal promoter arrays, that cover 17000 known
transcripts, with promoter sequences located 5.5 Kb upstream or 2.5 Kb down-
stream the TSS (NCBI35/mm7). Preliminary analysis of the ChIP-on-chip data
using the feature extraction software from Agilent identified thousands of MYC
binding sites in K14MycER isolated keratinocytes (Figure 3.5, B) when compared
to wild-type (Figure 3.5, A). Scatterplots represent the signal intensity between
IP (rBGSubsignal) and wce (gBGSubsignal) and show greater enrichment for
MYC in K14MycER mice, with more than 50% of the probes being bound.
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Figure 3.5: ChIP-on-chip analysis shows enrichment for MYC in
K14MycER mice. ChIP data from wild-type, wt (A) and K14MycER, tg (B) mouse
keratinocytes was obtained using Agilent promoter arrays and analyzed with the Agi-
lent Feature extraction software (v10.5). Scatterplots represent background normalized
signal level intensities for the immunoprecipitate (IP) sample (rBGSubsignal) relative
to whole cell lysate (wce) control (gBGSubsignal) for all genes 17000 transcripts (fea-
tures) spotted on the arrays. Each feature on the array is represented by a purple
dot in the scatter plot. Scatterplots show greater enrichment for MYC in K14MycER
mice, compared to wild-type. Signal intensities are shown in a log10 scale; rBG = red
background (cyanine 3), gRG = gBGSubsignal (cyanine 5).
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Following data analysis, 47 genes were identified as bound by MYC in wild-
type epidermal keratinocytes (Figure 3.6, A) compared to 7174 genes in K14MycER
mice (Figure 3.6, B). This result demonstrated that the endogenous expression
levels of Myc in the wild-type cells were noticeably low to enable identification
of its target genes (Figure 3.1, D). Both mouse strains were strongly enriched for
H3K4me3, overlapping in more than 8000 sites, (i.e. more than 80% of enriched
sites) (Figure 3.6, C), demonstrating that H3K4me3 enrichment was unchanged
upon Myc overexpression. MYC binding strongly correlated with H3K4me3 in
more than 90% of the sites, confirming previous reports [Guccione et al., 2006].
Figure 3.6: H3K4me3 correlates with MYC-binding and is unchanged in
response Myc overexpression. Venn diagrams for occurrence of H3K4me3 and
MYC in wild-type (A) and K14MycER transgenic mice (B). Occurrence of H3K4me3
highly overlaps in wild-type and K14MycER mice (89-98%, C). Data was obtained from
proximal promoter ChIP-on-chip assays using keratinocytes isolated from wild-type and
K14MycER treated for 4 days with tamoxifen (4-OHT).
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3.3.1 Genomic distribution of MYC binding events
MYC binding in close proximity to the TSS was observed for 40-60% of the
sites (Figure 3.7). However, MYC occupancy was widespread and also associ-
ated with a significant number of regions 0.8 Kb upstream the TSS in wild-type
keratinocytes. In addition, at least 10% of the genes located 0.2 Kb downstream
the TSS were also shown to be bound by MYC and enriched for H3K4me3 in
the wild-type. In K14MycER mouse keratinocytes, the distribution of H3K4me3
enriched sites correlated with MYC binding almost at 100%. Furthermore, since
proximal promoter arrays were used, it was not possible to assess whether MYC
was also located at introns or intergenic regions; potential non-coding RNA tar-
gets [Chang et al., 2008]. The discrepancy in the distribution of binding events
in wild-type compared to K14MycER mice is likely to be due to the low number
of binding events detected in wild-type epidermal cells using this method.
Figure 3.7: MYC preferentially binds to the transcription start site (TSS).
The distribution of MYC and H3K4me3 location across the mouse genome, in par-
ticular in K14MycER mice, shows that 60% of the bound regions are located at the
transcription start site (TSS), with the remaining 40% of genes bound being located
either 0.2 kilobases (Kb) upstream or 0.8 Kb dowstream. In wild-type mice, 50% of the
genes bound by MYC were also located upstream the TSS. In general, there is a high
correlation fo MYC binding with H3K4me3 in K14MycER mice, that is not observed
in wild-type mice.
Examples of MYC and H3K4me3 enriched regions in epidermal cells from
wild-type and K14MycER mice are provided in Figure 3.8. As previously men-
tioned, H3K4me3 is highly enriched in both mouse strains but stronger MYC
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binding is only observed in K14MycER mice. I found MYC was bound to the
promoter region of Ncl and Polycomb genes Ezh2 and Suz12, as previously re-
ported [Goodliffe et al., 2005; Greasley et al., 2000]. In addition, MYC was
identified in the promoter region of genes encoding cornified structural proteins,
such as S100A1 and S100A11. The interaction of MYC with epidermal differen-
tiation related genes has not been reported and it is particularly interesting as
it might indicate a role for MYC controlling epidermal differentiation. Finally,
MYC was also shown to bind to the promoter of Hdac2, a gene encoding for a pro-
tein involved in transcriptional repression through deacetylation of the histones
[Nagy et al., 1997].
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Figure 3.8: Examples of genes bound by MYC. All genes (Ncl, Suz12, S100a11,
Ezh2, Hdac2 and S100a1 ) show higher MYC (green peaks) binding in K14MycER mice
compared to endogenous Myc levels in wild-type. However, promoter regions in both
strains show the same levels of H3K4me3 (blue peaks). Enrichment was calculated by
the Log2 fold ratios (Log FC) of the signal intensities obtained for immunoprecipitated
fractions (IP) relative to whole cell lysate (wce) controls.
Confirmation of the interaction of MYC with the promoter regions of some of
the genes shown was confirmed by ChIP semi-quantitative PCR (ChIP-qPCR)
(Figure 3.9). As expected, enrichment for MYC binding was mainly observed
in K14MycER mice (grey bars), with more than 25 fold increase of MYC levels
at the promoter of Ncl and Suz12, when compared to wild-type (white bars).
In addition, binding of MYC to the promoter of Ezh2, Id2, Sprr1a, S100a1 and
Hdac2 was also confirmed.
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Figure 3.9: MYC binds to a diverse set of promoters in K14MycER mice.
Chromatin immunoprecipitation semi-quantitative PCR (ChIP-qPCR) was performed
to confirm the interaction of MYC with the promoter regions of the genes shown in wild-
type (white bars) and K14MycER (grey bars) mice. c-Myc enrichment was confirmed
in K14MycER mice for all genes shown. Data represents the mean values for two
biological replicates (n = 2) and bars the standard deviation of the mean.
3.3.2 Identification of functional MYC target genes
To assess whether MYC binding induced changes at the transcriptional level, I
performed RT-qPCR in a selected number of genes previously shown to be bound
by MYC (Ncl, Suz12, Sprr1a, Ezh2, Id2, S100a11 and Hdac2 ). In K14MycER
mice, MYC binding correlated with a two to three fold increase in the expression
levels of its target genes at day 4 of 4-OHT treatment (MYC activation). More
importantly, MYC mediated upregulation was already observed after 1 day of
MYC activation (Figure 3.10) for more than half of the genes.
MYC is known to bind to 15% of all active genes in the genome of a cell
[Rahl et al., 2010]. For this reason, it became essential to identify which binding
events, from the approximately 7000 genes targeted by MYC in the K14MycER
mice, produced effects at the transcriptional level. To identify functional MYC
binding sites, I performed a time-course experiment where I treated wild-type and
K14MycER mice from zero to six days with 4-OHT. The phenotype of the mice
was evaluated by H&E stainings of skin samples and mRNA samples were also
collected for gene expression analysis. As expected, MYC activation resulted in
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Figure 3.10: mRNA expression data for putative MYC target genes. mRNA
expression profiles of selected MYC bound genes shows increased expression (aprox-
imately 2-3 fold) upon c-Myc activation after 4 day (4d) tamoxifen treatment in
K14MycER mice (grey bars) when compared to wild-type (white bars). mRNA ex-
pression values were measured relative to Gapdh. Data represents the mean values for
three biological replicates (n = 3) and bars the standard deviation of the mean.
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thickening of the IFE, a phenotype that progressively increased with the number
of days of 4-OHT treatment (Figure 3.11).
Figure 3.11: Morphological changes in the epidermis upon MYC activation.
Tamoxifen (4-OHT) treated epidermis of wild-type and K14MycER mice over 6 days.
K14MycER mice show progressive thickening of the epidermis, an effect that was not
observed in wild-type littermates. Mouse dorsal skin was treated for 0, 1, 4 and 6 days
(d) with 4-OHT (A-D).
To identify which set of genes were responsible for the epidermal phenotype ob-
served upon MYC activation, I performed gene expression microarrays using skin
samples treated with 4-OHT at the different time-points. Hierarchical clustering
of the gene expression data shows that the most variable changes in expression
occurred between treated K14MycER mice and wild-type/untreated K14MycER
mice (Figure 3.12).
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Figure 3.12: MYC activation in epidermal keratinocytes triggers a spe-
cific gene expression profile. Hierarchical clustering of gene expression data shows
wild-type (WT) and K14MycER tamoxifen treated skin samples as two independent
groups. Within each group, additional clusters based on the duration of tamoxifen (4-
OHT) treatment were also generated (0d,1d,2d,4d,6d corresponds to days of treatment).
Untreated K14MycER, with no MYC activation, clustered with wild-type littermates.
Clustering was not affected by gender, age or array platform, but it was dependent on
genotype and duration of treatment.
In addition, the clustering analysis grouped samples which had been treated
with 4-OHT for the same amount of time. Exceptions were observed for three
wild-type skin samples treated with 4-OHT for zero and four days, as these sam-
ples clustered with K14MycER 4-OHT treated mice. In addition, a sample of
K14MycER treated for four days clustered with six days 4-OHT treated samples
of the same strain, probably due to a severe phenotype. Factors such as age, ar-
ray platform (ChIP) and gender did not affect the clustering outcome, however,
the growth phase of the HF cycle appeared to determine patterns of expression
in the epidermis. Histological analysis of H&E sections of dorsal epidermis from
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the outliers, revealed that these wild-type samples were obtained from mice in
which the HFs had entered the early anagen growth phase (data not shown) and
were not in telogen (resting phase of the HF), as all the other samples used in
the experiment. Increased Myc expression during anagen, possibly due to pro-
liferation of the HF matrix cells, might have contributed to a gene expression
pattern closely resembling the one observed for K14MycER mice. These results
strengthen the idea that all samples analyzed, in order to be comparable, must be
collected at the same phase of the HF cycle. All the subsequent data generation
and analysis performed was based on skin samples collected at the telogen phase
of the HF cycle. Gene expression data from skin samples of K14MycER mice
treated for four days with 4-OHT was compared with previous generated ChIP-
on-chip data for MYC binding in the mouse genome. I identified 2187 putative
MYC target genes in epidermis which corresponded to 30% of the differentially
expressed genes observed upon MYC activation (Figure 3.13).
Figure 3.13: MYC binds and trancriptionally regulates thousands of genes
in keratinocytes. The Venn diagram depicts an overlap between MYC bound genes
in K14MycER mice treated for four days with tamoxifen (4-OHT) and the resulting
gene expression changes. Upon MYC induction, 2187 genes (30% binding events) were
shown to be bound and regulated by MYC.
3.3.3 KEGG and Gene Ontology (GO) analysis
Functional analysis using bioinformatic tools on MYC target genes in epidermis
shows that MYC is involved in a diverse set of biological pathways such as:
MAPK, WNT, TGFβ, TP53, SHH and NOTCH signaling, as well as apoptosis,
cell cycle, ribosome biogenesis and DNA replication (Figure 3.14).
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Figure 3.14: KEGG pathway analysis of putative MYC target genes. The
number of genes for each KEGG category is depicted in the y-axis and a P-value <0.05
was used. Data was obtained using the David Functional Annotation Bioinformatic Mi-
croarray Analysis tool available online (http://david.abcc.ncifcrf.gov/). Only selected
KEGG pathways are shown.
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These results confirm the notion that MYC regulates genes involved in a
plethora of biological functions as it has been suggested by several groups [Dang
et al., 2006; Eilers and Eisenman, 2008; Zeller et al., 2003].
Gene ontology (GO) analysis on putative MYC target genes revealed as over-
represented gene categories metabolism, protein translation, morphogenesis, cell
cycle, chromatin modification and DNA damage, amongst others (Figure 3.15, A
red bars). The categories for biological functions were diverse and have all been
documented [Dang et al., 2006; Eilers and Eisenman, 2008; Zeller et al., 2003].
It is worth mentioning some of the genes that appear in the over-represented
categories, such as Polr2a. Recently, MYC has been involved in the release of the
pause of DNA polymerase II [Rahl et al., 2010], facilitating transcriptional elonga-
tion, therefore it is not surprising that MYC might modulate Polr2a expression.
Also worth mentioning is the fact that MYC regulates several genes involved in
chromatin remodeling such as Ruvbl1, Cbx3, Hdac2, Eed, Dnmt3b, Suz12, Mbd3
and Ezh2, confirming the role of MYC in regulation of global chromatin struc-
ture [Knoepfler et al., 2006]. MYC also targets genes encoding for important
regulators of the epidermal differentiation program such as OVOL1 and KLF4
[Segre et al., 1999; Teng et al., 2007]. This data also confirms MYC regulation
of the gene encoding for RNA methyltransferase NSun2, Nsun2, which has been
shown to mediate MYC-induced proliferation [Frye and Watt, 2006]. Finally, I
also analyzed genes located in under-represented GO categories (Figure 3.15, B
green bars) and found that most of these were related with signal transduction
through G-coupled receptors as well as ECM. Several of these genes have been
described as potential targets for MYC repression [Frye et al., 2003]. This group
also represented the stem cell marker, Lrig1, which was shown to be regulated by
MYC [Jensen et al., 2009].
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Figure 3.15: Functional categories of putative MYC target genes. Gene
ontology (GO) categories were obtained using the bioinformatic tool GeneTrail
(http://genetrail.bioinf.uni-sb.de/). Over-represented groups are listed on the top panel
(A, red bars) and under-represented categories at the bottom panel (B, green bars).
Examples of genes in each of the categories can be found on the right side of each graph.
Only selected GO categories are shown.
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3.3.4 Motif analysis
In order to understand if the phenotypic changes observed in the epidermis upon
MYC activation relied solely on MYC induction or were achieved in cooperation
with other TFs, I performed motif analysis on the list of 2187 MYC target genes
shown in (Figure 3.13). I used the bioinformatic tool Pscan to scans through
the set of sequences where MYC was bound to assess which TF motifs were sig-
nificantly over- or under-represented [Zambelli et al., 2009]. MYC-bound and
regulated genes revealed enrichment in consensus binding motifs for KLF4, TC-
FAP2, E2F1, SP1 and MYC. All these TFs’s promoters were bound (Figure 3.16)
and regulated by MYC, which is known to negatively regulate its own expression
[Penn et al., 1990].
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Figure 3.16: MYC putative cooperation with other transcription factors.
Motif analysis using the bioinformatic tool Pscan (http://159.149.109.9/pscan/) shows
that MYC binding regions are enriched in consensus motifs for KLF4, TCFAP2, MYC,
E2F1 and SP1 (A-E). In addition, MYC binds to the promoter region of the genes
encoding for these transcription factors, in K14MycER mice, as seen on the right hand
side of the panel. Enchiment values depicted from 0 to 4 represent the log2 FC of the
MYC enriched DNA fractions relative to background.
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3.4 Summary
Genome-wide location of MYC by ChIP-on-chip was successfully performed in
epidermal keratinocytes isolated from K14MycER mice following activation of
MYC by tamoxifen treatment. MYC was shown to bind and regulate an unusually
large and diverse set of biological functions, such as cell cycle (e.g E2f4 and
Pcna), metabolism (e.g Nmp3 and Rsp16 ), mRNA processing (e.g Nanos, Lsm6
and Rdbp) and chromatin remodelers (e.g Eed, Suz12 and Mbd3 ). It has been
postulated that activation of MYC in the epidermal basal layer, induces exit
of the stem cells from the niche through downregulation of genes involved in
adhesion, amplification of the progenitor’s pool and subsequent lineage specific
differentiation [Frye et al., 2003]. My data supports this hypothesis and shows
that MYC directly binds to the promoter region of these genes (e.g Itga2, Itga5,
Itgb1 and Lamc1 ) and affects their expression. Proliferation of the epidermal
progenitors can be explained by the fact that MYC regulates cell cycle related
genes, while increased differentiation might be attributed to the fact that MYC
also binds and induces upregulation of epidermal differentiation genes such as
S100a1, Sprr1a and S100a11 and regulators (e.g Ovol2, Klf4 and Ezh2 ), as seen
in (Figures 3.9, 3.10 and 3.15). MYC was also found to preferentially bind to
promoter regions carrying the histone mark H3K4me3, usually associated with
transcriptionally active genes. In addition, MYC induction does not affect the
distribution of H3K4me3 at the genome, as roughly the same number and location
of sites enriched in this histone mark are found in wild-type and K14MycER mice.
This observation, combined with the fact that MYC target genes are also enriched
for consensus motifs for binding of known epidermal differentiation regulators,
TCFAP2, KLF4 and E2F1(Figure 3.16), led to the assumption that MYC might
contribute to the activation not only of genes involved in growth, proliferation
and metabolism, but also genes determining lineage fate. Due to the fact that
very low peak resolution for MYC binding was observed in wild-type epidermal
cells, the majority of the analysis presented, as well as subsequent experiments,
were focused on the data obtained using the K14MycER mice.
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MYC determines tissue-specific
transcriptional networks
4.1 MYC transcriptional regulation at the EDC
As outlined in chapter 3, I found that MYC was bound to promoters of genes in-
volved in differentiation (S100a1, S100a11 and Sprr1a) and thought MYC might
be directly involved in the regulation of epidermal differentiation genes. The epi-
dermis is an excelent model to study the effect of MYC in lineage determination,
firstly because MYC activation induces a terminal differentiation program in the
IFE, and secondly because several of the genes encoding for proteins involved in
the differentiation process (cornification), are clustered in a region of the mouse
genome designated as epidermal differentiation complex (EDC) (Figure 4.1, A).
As previously mentioned, this region constitutes a 2.2 Mb (mega base) locus lo-
cated on mouse chromosome 3 and encodes 61 genes known to be important for
epidermal maturation.
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4.1.1 MYC associates with promoters of EDC genes
To assess whether MYC might be involved in the direct regulation of keratinocyte’s
differentiation I performed ChIP-on-chip where again, I used basal undifferenti-
ated keratinocytes isolated from the dorsal skin of K14MycER mice treated for
four days with 4-OHT and focused the ChIP-on-chip analysis on the EDC region.
MYC binding profile at the EDC revealed occupancy over more than 80% of
the gene promoters (Figure 4.1, B blue peaks). The majority of binding sites over-
lapped with H3K4me3, similarly to what had been observed when using mouse
genome-wide proximal promoter arrays (Figure 4.1, purple peaks). MYC binding
generaly excluded H3K27me3, a histone mark usually associated with silencing
(exceptions included Lor and Tchh promoters) (Figure 4.1, B green peaks).
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To evaluate if MYC binding at the EDC resulted in a direct regulation of
these genes at the transcriptional level, I compared MYC binding to the previous
obtained mRNA gene expression data for wild-type and K14MycER treated for
four days with 4-OHT. In wild-type epidermis, more than 80% of the genes at
the EDC were expressed above background level (Figure 4.1, C upper panel grey
bars). Activation of MYC resulted in a two to four fold increase in mRNA
gene expression for 17 out of the 55 EDC genes (Figure 4.1, C lower panel blue
bars). Importantly, 12 EDC genes were downregulated, with a significant mRNA
decrease for only for S100a1. To further confirm MYC induced upregulation of
EDC genes, I performed RT-qPCR using mRNA samples isolated from 4-OHT
treated dorsal skin of wild-type and K14MycER mice (Figure 4.2). For this
purpose, I selected a group of genes representing the EDC protein families S100A
(purple bars) and LCE (pink bars): S100 (S100a1, S100a16 and S100a11 ) and
Lce (Lce1e, Lce1g, Lce3f ). The Sprr family had already been represented by
confirmation of upregulation of Sprr1a upon MYC induction (Figure 3.10).
Activation of MYC induced upregulation of all genes analyzed compared to
wild-type, except for S100a1 which was downregulated, confirming the mRNA
global gene expression data obtained.
4.1.2 MYC directly regulates epidermal and keratin re-
lated genes
I performed mRNA gene expression arrays for K14Myc∆/∆ mice and compared
the results obtained for MYC ChIP-on-Chip at the EDC. I found that conditional
deletion of Myc in the epidermis resulted in repression of at least 11 EDC genes
(e.g S100a13, S100a14, S100a16, S100a6, S100a7, Prr9, Sprr1a, Sprr1b, Sprr4,
Ivl, and Tchhl1 ) (Figure 4.1, C lower panel blue bars). This effect on the ex-
pression level of EDC genes, suggests a direct role for MYC regulating epidermal
differentiation. Functional analysis on global mRNA expression data obtained
from Myc depleted epidermal samples shows that 48% of all genes repressed
upon Myc deletion were either epidermal or keratin associated (see Appendix)
(Figure 4.3, A-C).
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Figure 4.2: MYC regulates S100 and Lce genes. Gene expression for S100a (pur-
ple bars) and Lce (pink bars) family genes shows that MYC induction in K14MycER
mice results in upregulation of these genes when compared to wild-type, WT (except
for S100a1 ). mRNA levels were calculated relative to Gapdh and represent mean val-
ues for three biological replicates (n = 3). Bars represent the standard deviation of the
mean.
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Figure 4.3: Transcriptional changes upon Myc deletion in epider-
mis. (A) Percentages of genes associated with each gene ontology category (GO;
http://david.abcc.ncifcrf.gov/) repressed for more than 2 fold upon Myc deletion. (B)
Functional categories and examples of genes corresponding to each functional category.
(C) Several of the genes which are repressed upon Myc deletion are either epidermal
or keratino-associated.
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4.2 Dynamic expression of EDC genes in re-
sponse to MYC activation
To understand how MYC dynamically regulated EDC genes, I performed hier-
archical clustering on global mRNA expression levels obtained for isolated from
K14MycER keratinocytes, where MYC had been induced zero to six days. A dis-
tinct group of EDC genes was upregulated only after four to six days; whereas few
genes were downregulated (Figure 4.4, A). Because MYC binds to a large num-
ber of genes in the genome, corresponding to up to 15% of all expressed genes,
I confirmed MYC specifically regulated EDC genes by comparing the changes in
mRNA expression levels over the time-course with genes randomly chosen outside
the EDC region (non-EDC genes) (Figure 4.4, B). In general, MYC activation
resulted in an increase in the mRNA levels of EDC genes when compared to
randomly selected genes outside the EDC. This behaviour in gene expression dy-
namics was statistically significant for EDC genes only, specifically on days four
and six of 4-OHT treament; a result that was not observed for non-EDC genes.
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Figure 4.4: Distinct expression profile of epidermal differentiation complex
genes (EDC) genes upon MYC activation.(A) Cluster analysis of mRNA expres-
sion levels of EDC genes in K14MycER mice relative to wild-type littermates following
tamoxifen (4-OHT) treatment for the indicated time points in days, d. (B) Compari-
son of EDC gene expression from (A) versus randomly selected non-EDC genes across
mouse chromosome 3. Heatmaps show upregulated mRNA expression levels in red,
unchanged in white and downregulated in blue, with the corresponding fold change
values depicted in the color key legend on the left of the heatmap.
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In addition I also analyzed the mRNA expression profiles of the 5000 genes
with most significant variation in mRNA levels following MYC induction (Figure
4.5). The expression level of Rasd2 is shown as an example for the 46% genes
that were immediately upregulated after 1 day of 4-OHT treatment (mRNA levels
kept increasing until 6 days of treatment). Similarly, Alox12 represents 46% of the
genes with immediate reduction in mRNA levels after 1 day treatment, whereas
Lcn2 represents the group of 1.7% of genes which were upregulated only after 4
days of MYC induction. This group of genes comprised several EDC genes (e.g
S100a9, Sprr2g, Sprr2e, Sprr2d, Sprr2h and Lce3c).
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Figure 4.5: Representation of the expression profiles of 5000 genes in
MYC induced epidermis. These profiles represent the most common transcrip-
tional responses in a MYC induced time-course where triplicates samples of K14MycER
(MycER 1-3, red) and wild-type (1-3, blue) murine skin mRNA samples were used.
Rasd2, represents one example for the 46% of genes upregulated after 1 day of tamox-
ifen (4-OHT) treatment (left hand panel). Lcn2 represents the small group of genes
(1.7%) upregulated after 4 days 4-OHT treatment (middle panel). Alox12 is as an ex-
ample for 46% of genes downregulated after 1 day treatment with 4-OHT (right hand
panel).
As activation of MYC after 1 day 4-OHT treatment induced changes in the
mRNA levels of 92% of 5000 genes, I decided to perform a ChIP-on-Chip exper-
iment at this time point to confirm that the oncoprotein was in fact bound to
the promoter of EDC genes and directly regulating their mRNA expression levels
(Figure 4.6). Binding location of MYC after 1 day 4-OHT treatment confirmed
that the protein was already bound to the promoter of at least 80% of the tran-
scriptional active EDC genes observed at day 4. Analysis of MYC binding after
a longer induction period increased the resolution of the peaks and the number
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of binding events, demonstrating that the consequences of MYC activation in
epidermal cells are very dynamic and change in a low and high MYC microenvi-
ronment. Histological sections of dorsal skin of wild-type and K14MycER mice
treated for 1 day with 4-OHT were stained with H&E and the phenotype was
analyzed under the microscope (Figure 4.6). Low levels of MYC activation did
not phenotypically affected epidermal differentiation or proliferation, suggesting
that activation of MYC in the epidermis might exert a unique regulatory network
at the EDC cluster, possibly through cooperation with additional tissue-specific
TFs.
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4.2.1 MYC regulates EDC transcription by modulating a
tissue-specific regulatory network
To try to understand if the late transcriptional response of EDC genes upon MYC
activation, required additional tissue specific TFs, I performed clustering analysis
of ChIP-on-Chip data obtained for MYC, H3K4me3, H3K27me3, RBP2 and 8
transcription factors previously shown to be important for epidermal differentia-
tion (TCFAP2γ, SIN3A, MXI1, CEBPα, CEBPβ, KLF4, OVOL1 and OVOL2).
The goal was to identify genes co-regulated by MYC and 1 or more tissue-specific
TFs. This analysis was performed over part of mouse chromosome 3 and demon-
strated that MYC activation dramatically affected the overall transcription factor
binding profiles (Figure 4.7 A,B).
Figure 4.7: MYC determines specific regulatory networks. (A) Cluster anal-
ysis of binding events of the indicated tissue-specific transcription factors (TFs) to
chromosome 3 (Chr3) before - wild-type - and after - K14MycER - MYC induction
(B). Activation of MYC in epidermal keratinocytes completely remodels the binding
of tissue-specific TFs. Heatmaps show the number of shared binding events between
two TFs (light orange: low similarity and dark orange: high similarity). Highlighted
dashed boxes represent the TFs that most likely share a vast proportion of binding
sites.
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A more detailed analysis at the EDC region upon MYC induction revealed two
distinct clusters of TFs: one containing KLF4, OVOL1 and MYC and the other
containing SIN3A, MXI1 and CEBPα (Figure 4.8 A,B). The level of occupancy of
these TFs at the EDC was strongly dependent on the levels of MYC, contrarily to
what was observed for histone marks H3K4me3 and H3K27me3, which remained
unchanged and comparable in keratinocytes from wild-type and K14MycER mice
(Figure 4.8 C). In wild-type animals, with low levels of endogenous MYC, binding
of KLF4 and OVOL1 to the EDC S100a family of genes was low when compared
with the high occupancy of CEBPα, MXI1 and SIN3A (Figure 4.8 C, left hand
panel). Conversely, MYC induction favoured KLF4 and OVOL1 binding and
depleted SIN3A, CEBPα and MXI1 occupancy at the EDC (Figure 4.8 C, right
hand panel).
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Figure 4.8: MYC favours occupancy of KLF4 and OVOL1 at EDC. (A,B)
Cluster analysis of binding events of the indicated transcription factors to the EDC.
Heatmaps show the number of shared binding events between two TFs (light orange:
low similarity and dark orange: high similarity). (C) Occurrency of H3K4me3 (grey),
H3K27me3 (grey) and occupancy of the transcription factors (TF) indicated, to the
S100a family of genes from the EDC in wild-type (C, left hand panel) and K14MycER
(C, right hand panel) keratinocytes. Activation of MYC in K14MycER keratinocytes
enhances binding of KLF4 and OVOL1 (blue) and loss of SIN3A, MXI1 and CEBPα
(red).
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4.2.2 MYC tissue-specific regulator’s remodeling at EDC
does not occur via transcriptional regulation
To understand if binding or exclusion of CEBPα, SIN3A, KLF4 and OVOL1 to
the EDC was directly dependent on MYC transcriptional regulation, I performed
RT-qPCR analysis on tissue isolated from wild-type and K14MycER mice. Bind-
ing of KLF4 and OVOL1 in the transgenic mice was not directly dependent on
MYC activation as correspondent mRNA levels decreased upon MYC activation
(Figure 4.9 B,C). Moreover, Cebpα mRNA levels remained unchanged in wild-
type or transgenic animals, but interestingly Sin3a mRNA levels were higher in
homeostasis, probably due to an indirect effect as MYC does not bind to the
Sin3a promoter by genome-wide ChIP-on-chip analysis (data not shown) (Figure
4.9 D,E).
I also confirmed that the different TFs were expressed in the same cellu-
lar populations during epidermal differentiation. I used flow cytometry combined
with staining for the surface marker ITGα6 to isolate basal undifferentiated (High
ITGα6), differentiated (Low ITGα6) and progenitor (Mid ITGα6) epidermal cell
populations in wild-type and K14MycER transgenic mice (Figure 4.10 A,B). RNA
samples were obtained from each population and RT-qPCR analysis was per-
formed for assessing the expression levels of Itgα6 and Ivl, here used as controls
for undifferentiated and differentiated cells, respectively. I also measured the
mRNA levels in each cellular compartment for Myc, Klf4, Sin3a and Cebpα with
the purpose of assessing if both lineage specific TFs were expressed in the expected
cell compartments (Figure 4.10 C-H). In wild-type epidermis there was a clear
distinction between high, medium and low Itgα6 populations which disappeared
upon MYC activation (Figure 4.10 C). Ivl expression was higher in the progeni-
tor’s and differentiated epidermal cells (Mid and Low Itgα6) for both wild-type
and K14MycER transgenic mice (Figure 4.10 D). While Myc expression levels did
not change in basal, suprabasal or progenitor populations in wild-type epidermis,
MYC activation in the basal cells induced, as expected, higher levels of the Myc
oncogene in these cells when compared to progenitor or differentiated cells (Fig-
ure 4.10 F). Sin3a mRNA levels were high in basal wild-type keratinocytes but
upon MYC activation the expression increased in the progenitor population by
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Figure 4.9: Effect of activated MYC on mRNA levels of epidermal specific
transcription factors. mRNA levels for the genes indicated, in skin of wild-type
(WT) and K14MycER (TG) mice in response to tamoxifen (4-OHT) treatment for 4
days. The colours represent the increased binding of the correspondent proteins in
a high (blue) or low (purple) MYC microenvironment (i.e wild-type or K14MycER).
mRNA levels were calculated relative to Gapdh. Data represents the mean values for
three biological replicates (n = 3) and bars the standard deviation of the mean.
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two fold, when compared to basal undifferentiated K14MycER epidermal cells
(Figure 4.10 F). Cebpα was mainly expressed in the differentiated suprabasal
wild-type keratinocytes, whereas after MYC activation it was shown to be more
expressed in the population of progenitors (Figure 4.10 G). Klf4 expression in the
wild-type was observed mainly in the basal and progenitor’s population, whereas
upon MYC activation it changed to the suprabasal cells, as seen in (Figure 4.10
H and 4.11).
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Figure 4.10: mRNA gene expression levels of MYC and skin specific reg-
ulators at distinct cellular compartments. mRNA levels of the genes indicated
in the flow sorted epidermal populations in wild-type (A) and K14MycER (B) mouse
skin, with high, middle (mid) and low surface levels of ITGα6. Purple indicates co-
expression of the respective factors in differentiated epidermal populations (C-H). Mice
were treated for 4 days with tamoxifen (4-OHT). mRNA levels were calculated relative
to Gapdh. Data represents mean values for two independent biological replicates (n =
2). Bars represent the standard deviation of the mean.
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Wild-typeA B K14MycER
K
lf4
Figure 4.11: KLF4 expression in suprabasal epidermal layers upon MYC
activation. Skin sections from wild-type (A) and K14MycER (B) mice labelled with
KLF4 antibody. Arrow heads indicate cells expressing KLF4. Scale bar: 25µm.
4.2.3 MYC enriched regions at the EDC present consen-
sus motifs for additional tissue-specific regulators
Motif discovery analysis for regions enriched in MYC at the EDC revealed that
the sequences bound by MYC also present consensus motifs for CEBPα, KLF4
and TCFAP2α (Figure 4.12).
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Figure 4.12: Motif analysis for MYC enriched promoter regions. Analysis
was performed using the bioinformatic tool Pscan (http://159.149.109.9/pscan/)
. Motifs shown were calculated by an algoritm that retrieved a P-value<0.05
and performed on a list of genes shown to be bound and regulated by MYC in
K14MycER mice treated with 4-OHT. The CEBPA motif was detected in MYC
bound regions in wild-type mice, whereas KLF4 and TCFAP2α were enriched in
MYC bound genes in K14MycER mice treated with tamoxifen for 4 days.
4.3 Summary
In summary, I have shown that MYC binds to the promoter of EDC genes and
regulates their mRNA expression. The binding of this oncoprotein is gener-
ally associated with active transcription and indeed MYC preferentially binds
to H3K4me3 enriched promoters positively affecting the expression of 17 of 55
EDC genes by inducing an increase in mRNA levels from two to four fold. On
the other hand, MYC activation also results in a slight repression of 12 EDC
genes, but mRNA levels do not decrease more than two fold (with exception of
S100a1 ). There is also no changes in H3K4me3 or in H3K27me3 histone marks
at the promoter of EDC genes upon MYC activation (Figure 4.1 B,C). Confirma-
tion of these results (which have been obtained through global gene expression
analysis) was shown by RT-qPCR where eight out of the nine genes analyzed
were upregulated in K14MycER mice compared to wild-type (Figure 3.10).
MYC was bound to promoters of genes important for epidermal specific lin-
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eage/differentiation/homeostasis and data obtained for mRNA gene expression
levels in epidermis depleted of Myc has shown that several of the genes repressed
are genes essential for establishment of the cornified envelope (Figure 4.3, A-C).
In addition, MYC induced genome-wide changes at the mRNA level after 1 day of
4-OHT treatment, however expression of EDC genes was only affected after four
to six days of induction, even though MYC was already bound at their promoters
after one day (Figure 4.4, 4.5 and 4.6).
Moreover, ChIP-on-chip analysis focused on the EDC region for a set of specific
differentiation regulators has shown that MYC activation completely remodels
the occupancy of each of the TF regulators analyzed, favoring binding of KLF4
and OVOL1 and excluding occupancy of CEBPα, SIN3A and MXI1 (Figure 4.8
C). Gene expression analysis in wild-type and K14MycER mice for Klf4, Ovol1,
Sin3a, Cebpα and Myc was performed to understand if MYC induced TF re-
modelling at the EDC was due to regulation of these genes at the transcriptional
level. This analysis has shown that this was not the case, even though Sin3a
expression was repressed upon MYC activation (Figure 4.9). This effect however
must occur post-transcriptionally as MYC was not bound to the Sin3a promoter
in the ChIP-on-chip whole genome promoter analysis performed.
It is also important to mention the fact that MYC binding to the EDC might
be evolutionary conserved as ChIP-seq experiments in human epidermal ker-
atinocytes grown in vitro and retrovirally infected with the contruct MYCER
that induces expression of the MYCER protein upon 4-OHT treatment, have
shown that MYC also binds to the promoter of genes from the S100A, LCE and
FLG-like families (Figure 4.13).
In order to assess if TF binding correlated with expression at the same cellu-
lar compartments in the epidermis, gene expression analysis was performed on
sorted cells from the basal, progenitor’s and suprabasal epidermal populations
(Figure 4.10). In normal wild-type epidermis, Cebpα was shown to be more ex-
pressed in the suprabasal layers of epidermis; Sin3a was more expressed in the
basal layer, but generally expressed in all cell compartments, as well as Myc.
Subsequent MYC activation and amplification of the progenitor’s cell population
has shown that Myc remained highly expressed in undifferentiated keratinocytes
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whereas Cebpα and Sin3a were co-expressed in the progenitor’s cell populations.
Klf4 expression was only assessed in populations sorted for high and low ITGα6,
and therefore it was difficult to address from the gene expression data if MYC
and KLF4 were co-expressed in the same cellular compartments. However, im-
munohistochemistry images of KLF4 labelled epidermal cells on skin sections of
wild-type and K14MycER mice, clearly demonstrated that expression of KLF4
occurred in the suprabasal layers of the epidermis upon MYC induction, correlat-
ing with the mRNA gene expression data obtained. It is possible a scenario where
MYC induction would favor KLF4 binding to the EDC, and the later would then
induce the expression of EDC genes, such as the Sprr family. This would explain
the lag in activation of these genes upon MYC induction (Figure 4.11).
In conclusion, the consequences of MYC induction in the epidermis were very
dynamic and changes in the MYC protein levels exposed certain TF sequence mo-
tifs, as oppose to others at the EDC. Endogenous levels of MYC favored regions
where, for example CEBPα was co-bound, whereas in a high MYC microenvi-
ronment, binding motifs for KLF4 and TCFAP2α where more enriched (Figure
4.12). Interestingly, this MYC tissue-specific function might be evolutionary con-
served as, ChIP-seq experiments for enrichment of MYC in human keratinocytes
overexpressing a pBabeMycER retroviral construct, where MYC activation was
induced by 4-OHT treatment, also revealed binding of MYC at the human EDC
cluster in chromosome 1.
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Chapter 5
Transcriptional repression at the
epidermal differentiation complex
(EDC)
5.1 SIN3A as a repressor of MYC target genes
The drastic changes in occupancy of epidermal specific regulators (KLF4, CEBPα,
MXI1, SIN3A) upon MYC induction, suggested that one or more of these TFs
might regulate MYC transcriptional activity. A likely candidate would be SIN3A,
a multiprotein complex with deacetylase activity that is known to interact with
MYC antagonists (MXD/MNT family of proteins). A hypothetical scenario
would predict that SIN3A might induce MYC displacement at the EDC in order
to antagonize its function (i.e to repress MYC target genes). In line with this
hypothesis the binding sites occupied by both TFs at the S100a cluster target
the same promoters (Figure 4.8 C).
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5.1.1 MYC-SIN3A interaction targets MYC for degrada-
tion
Work in collaboration with Shobbir Hussain 1 involving co-immunoprecipitation
experiments using flag-tagged MycER (MycER-Flag) constructs, measurement
of MYC acetylation levels, as well as, cycloheximide experiments to determine
MYC’s half-life in the presence of SIN3A, have shown that SIN3A interacts with
MYC at the protein level targeting it for degradation (Figure 5.1 A-C). Degra-
dation of MYC happens most likely via de-acetylation. Overexpression of the
acetyltransferases GCN5 and TIP60 led to an increase in MYC acetylation lev-
els compared to controls (Figure 5.1 B, Ac-Lys), whereas MYC acetylation was
decreased when SIN3A was also overexpressed (Figure 5.1 B, Ac-Lys).
Moreover, when protein translation was inhibited via treatment with cyclo-
heximide, the half-life of the MYC protein was reduced when SIN3A was over-
expressed in combination with GCN5 (Figure 5.1 C). Interestingly, when the
Myc-mutant construct, Mycmt, that cannot be acetylated by GCN5 at lysines
positioned at locations 323 and 417 (K323 and K417) was used, no substantial
changes in the half-life of the protein were observed compared to cells overex-
pressing GCN5 alone, or in presence of GCN5 and Sin3a (Figure 5.1 D).
1Wellcome Trust Centre for Stem Cell Research, University of Cambridge
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Figure 5.1: MYC de-aceylation and degradation is mediated by SIN3A. (A)
SIN3A co-immunoprecipitates with Flag-tagged MycER (MycER-Flag) but not with
Flag-tagged ER (pCMV-ER-Flag); western-blots were labelled using antibodies for
SIN3A, MYC and Flag. (B) Overexpression of SIN3A inhibits acetylation of MYC by
GCN5 and TIP60. Cos-7 cells transfected with the indicated constructs were immuno-
precipitated for MYC (IP: Myc). Protein levels of MYC, GCN5, TIP60 and SIN3A
were detected in whole cells lysates by western-blot and were found to be comparable.
(C) Western-blot for MYC in Cos-7 cells overexpressing endogenous MYC and empty
vector control (Ev), wild-type MYC (Mycwt) and GCN5 or MYC, GCN5 and SIN3A,
following cycloheximide treatment for the indicated hours. (D) Western-blot of MYC
of Cos-7 cells overexpressing a MYC-mutant construct (Mycmt) and GCN5 or Mycmt,
GCN5 and SIN3A. The empty vector (Ev) was used as a negative control and Mycmt
cannot be acetylated by GCN5 at lysines 323 and 417 (Courtesy of Shobbir Hussain).
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Acetylation of the MYC protein by GCN5 is known to increase MYC stability
[Patel et al., 2004], therefore I performed a luciferase reporter assay for MYC and
the Myc-mutant construct, Mycmut to confirm that the mutant form of MYC ex-
hibited reduced transactivation activity when compared to the wild-type protein.
Indeed, decreased acetylation of the MYC protein affected its transactivation ac-
tivity more than two fold when compared to the wild-type protein.
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Figure 5.2: Decreased acetylation of MYC affects its transactivation ac-
tivity. A MYC reporter assay in HEK-293 cells expressing the empty vector control
(Ev), a wild-type Myc (Myc wt) or a mutant Myc contruct (Mycmut) which cannot
be acetylated by GCN5 at lysine 323 positions and 417. (+) indicates that cells were
transfected with the indicated constructs; (-) indicates non-transfected cells and (+/+)
indicates that the double concentration of the construct was used for transfection. The
transactivation activity of Mycmut is lower compared with the wild-type protein (Myc
wt).
According to these results I speculated that deletion of Sin3a in the epidermis
would lead to a stabilization of the MYC protein.
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5.1.2 Loss of Sin3a in the epidermis results in hyperpro-
liferation of the IFE
In wild-type skin, SIN3A is expressed in the IFE, HF and SGs (Figure 5.3, A).
Deletion of Sin3a in the epidermis, by crossing mice carrying a floxed Sin3a al-
lele with mice expressing Cre-recombinase (K14Sin3a∆/∆), resulted in increased
thickening of the IFE compared to wild-type (Figure 5.3 B-D), a phenotype sim-
ilar to the one observed for Myc overexpressing skin (Figure 3.1).
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Figure 5.3: Deletion of Sin3a in skin causes increased thickening of the epi-
dermis. (A,B) Skin sections from wild-type and K14Sin3A∆/∆ mice where Sin3a was
deleted in KRT14 positive cells from the epidermis, labelled with a SIN3A specific anti-
body. (C,D) Hematoxilin and eosin stained skin sections of wild-type and K14Sin3A∆/∆
mice. Sin3a is expressed in the interfollicular epidermis (IFE), sebaceous glands (SG)
and hair follicle (HF) and its deletion causes thicknening of the IFE, shown by vertical
bar. Dotted lines in B and D mark the basement membrane of the epidermis. Scale
bar: 100µm.
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The increase in thickness of the IFE, following Sin3a, deletion resulted from
an increase in proliferation, as seen by the higher number of KI67 positive cells
in K14Sin3A∆/∆ epidermis compared to wild-type skin (Figure 5.4 A,B).
K
i6
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WT K14Sin3A∆/∆
Figure 5.4: Sin3a deletion in the epidermis increases proliferation. Skin
sections of wild-type (A) and K14Sin3A∆/∆ (B) where Sin3a was deleted in basal
KRT14 positive epidermal cells labelled with a KI67 antibody. Scale bar: Scale bar:
25µm.
This increase in proliferation upon Sin3a deletion also resulted in an in-
crease in MYC expression, due to increase acetylation of MYC in epidermis from
K14Sin3A∆/∆ (data not shown), a phenotype similar to the one observed for
K14MycER upon MYC activation (Figure 5.5 B,D). These results were confirmed
at the protein and mRNA levels (Figure 5.5 E-G). At the mRNA level, the Sin3a
and Myc deletions were observed by comparison with wild-type littermates skin
samples containing epidermis and dermis. As Sin3a or Myc deletion was tar-
geted only to the epidermis, significant mRNA expression values for both genes
were still observed in dermal cells. However, protein obtained from epidermal
sample preparations, as well as immunohistochemistry using back skin samples
of mice where one or both proteins were deleted, revealed complete loss of MYC
or SIN3A.
So far, the data presented confirmed that conditional deletion of Sin3a or
overexpression of MYCER in KRT14 positive epidermal cells resulted in a similar
phenotype.
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Figure 5.5: MYC expression increases upon loss of Sin3a in the epidermis.
Skin sections of wild-type (A) and indicated transgenic mice (B-D) labelled for MYC
(upper panels) and SIN3A (lower panels). Dotted lines in D mark the basement mem-
brane. Scale bars: 100µm. (E) Western-blots show protein expression levels of MYC
and SIN3A in the skin of wild-type and indicated transgenic mice. Tubulin (Tub) was
used as a loading control. (F,G) mRNA levels of Myc and Sin3a in skin samples from
wild-type and the indicated transgenic mice, relative to Gapdh. Data represents the
mean values for three biological replicates (n = 3) and bars the standard deviation of
the mean.
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5.2 Loss of Sin3a in the epidermis increases MYC
occupancy at the EDC
As deletion of Sin3a in the epidermis led to an increase in MYC expression, this
suggested that upregulation of MYC target genes was a likely outcome.
5.2.1 Effects of MYC overexpression or Sin3a deletion in
TF occupancy
To test wether loss of Sin3a would increase MYC occupancy at its target genes,
I performed ChIP-on-chip experiments on chromossome 3 for MYC in Sin3a de-
pleted epidermis of K14Sin3A∆/∆ mice. I found that the number of MYC bound
genes, as well as the peak signal (maximum and averaged), increased when com-
pared to wild-type epidermis (Figure 5.6 A-C blue bars). Conversely, SIN3A
binding was also assessed in epidermis from Myc depleted (K14Myc∆/∆) or over-
expressed (K14MycER) skin, as well as wild-type (Figure 5.6 A-C red bars). As
expected, the number and signal intensity obtained for SIN3A binding events in
wild-type epidermis was higher than in Myc depleted or overexpressed epidermis.
In addition, the number of MYC bound genes commonly found in K14Sin3A∆/∆
and K14MycER epidermis was two fold higher when compared to the same num-
ber in wild-type versus K14MycER mice (Figure 5.6 D, red numbers). These
results suggest that K14MycER and K14Sin3A∆/∆ mice share a significant num-
ber of identical genes regulated by MYC.
The number of SIN3A binding sites in wild-type epidermis was higher than
in either Myc overexpressing or depleted epidermis, suggesting a that large pro-
portion of MYC target genes requires the presence of MYC Examples of SIN3A
and MYC binding in wild-type and each of the transgenic mouse lines analysed
are shown in (Figure 5.7).
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Figure 5.6: Enhanced SIN3A binding in the absence of Myc. ChIP-on-chip
analysis on chromossome 3 using SIN3A and MYC antibodies. The total number of
binding events (A) as well as maximum (B) and average (C) peak signals of the com-
bined replicates in epidermis of K14MycER, K14Myc∆/∆, wild-type and K14Sin3A∆/∆
mice is shown.
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Figure 5.7: Enrichment of SIN3A (red) and MYC (blue) on genes located
on chromosome 3. Location of SIN3A and MYC on the promoter region of genes on
chromosome 3, located outside the epidermal differentiation complex (EDC) in wild-
type, K14Sin3A∆/∆, K14Myc∆/∆ and K14MycER mice.
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So far, I have shown that SIN3A interacts with MYC, targets MYC for degra-
dation and occupies the promoter regions of MYC’s target genes, possibly re-
pressing them. Because SIN3A mediated repression relies on the recruitment
of MXD/MNT proteins, I performed ChIP-on-chip for MXI1 (known to interact
with SIN3A), in order to identify if MXI1 location was dependent on MYC levels,
as it had been observed for SIN3A. I found that the number and signal of MXI1
binding events was not affected by Sin3a loss, remaining unchanged in wild-type
and K14Sin3A∆/∆ epidermis (Figure 5.8 A-C).
Figure 5.8: Binding of MXI1 is independent of SIN3A. ChIP-on-chip analysis
on chromossome 3 using a antibody specific for MXI1. The total number of binding
events (A) and maximum (B) and average (C) peak signals of the combined replicates
in epidermis of K14MycER, K14Myc∆/∆, wild-type and K14Sin3A∆/∆ mice is shown.
The number of MXI1 binding events is largely dependent on MYC levels.
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Analysis of the binding of MXI1 at the EDC revealed that, as it had been
observed for SIN3A, MXI1 was preferentially enriched in wild-type epidermis
(Figure 5.9 C) when compared to Myc depleted or overexpressing skin (Figure
5.9 A,B). In addition, binding of MXI1 remained unchanged upon Sin3a deletion,
where the endogenous levels of MYC increased (Figure 5.9 D).
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Because Sin3a deletion in the epidermis resulted in an increase of the endoge-
nous levels of MYC, it seemed plausible to assume that the increased number of
differentiated suprabasal layers observed in the epidermis of K14Sin3A∆/∆ mice
resulted from increased differentiation, due to de-repression of MYC target genes
at the EDC (Figure 5.3, D). For this reason I analysed the mRNA gene expres-
sion levels of EDC genes in samples of epidermis depleted from Sin3a. The fold
change observed was similar to the expression profile of K14MycER mice (Figure
5.10).
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Further evidence that MYC and SIN3A targeted the same group of genes was
observed following the overlap of SIN3A binding events in wild-type skin, com-
pared to MYC in K14Sin3A∆/∆ at chromosome 3. I found that in this situation
there was a 71% overlap of binding events for both transcription factors, whereas
only a small percentage (18%) of all MYC bound genes was never targeted by
SIN3A in wild-type and MYC transgenic skin (Figure 5.11 A,B).
Figure 5.11: SIN3A targets MYC bound genes. (A) The top Venn di-
agram shows that 71% of MYC bound genes in K14Sin3A∆/∆ epidermis was
also bound by SIN3A in wild-type mice. (B) The bottom 4-way Venn diagram
(http://bioinfogp.cnb.csic.es/tools/venny/index.html) was used for identification of a
small percentage of MYC target genes in K14MycER mice which were never bound by
SIN3A in the conditions analysed: SIN3A ChIP-on-chip on chromossome 3 in wild-type,
K14MycER and K14Myc∆/∆ murine epidermis.
This data indicates that in the absence of the multiprotein repressor complex
SIN3A in the epidermis, MYC genomic occupancy at the EDC genes is facilitated.
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5.2.2 SIN3A cooperates in regulating genes involved in
proliferation
In addition to an increase in differentiation, loss of SIN3A also induced prolif-
eration in the epidermis (Figure 5.4, B). To understand if SIN3A also repressed
MYC target genes involved in cell growth and proliferation, I compared the dif-
ferentially expressed genes in skin of K14Sin3A∆/∆ mice with the MYC 2187
functional target genes which had been identified in K14MycER mice by genome-
wide ChIP-on-chip (Figure 3.13). From this comparison, 512 genes were found
to be targets of MYC as well as differentially expressed in K14Sin3A∆/∆ skin
(Figure 5.12). Functional analysis revealed that MYC-SIN3A regulated genes
over-representated GO categories were related with metabolism, cell cycle, cell
growth and RNA processing, as previously shown for MYC-only target genes
(Figure 3.15 and 5.12). Furthermore, motif discovery analysis on the common
512 genes, revealed enrichment for the Myc-Max binding consensus motif, E-box,
with high statistical significance.
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Figure 5.12: SIN3A target genes involved in cell growth and prolifera-
tion. Comparison of MYC functional target genes with differentially expressed genes
in K14Sin3A∆/∆ epidermis, followed by gene ontology (GO) analysis of MYC and
SIN3A regulated genes. Expression data for K14Sin3A∆/∆ was calculated relative to
wild-type after treatment with tamoxifen (4-OHT) for 14 days. The P-value for the
over-representation of Myc-Max binding sites in the 512 MYC and SIN3A-regulated
genes is shown.
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5.3 Summary
In this chapter I have shown that SIN3A is one of the epidermal differentiation
regulators that affects MYC transcriptional activity. MYC and SIN3A binding
to the EDC, at least in the conditions analysed, is mutually exclusive. Work in
collaboration with Shobbir Hussain has shown that SIN3A and MYC interact
at the protein level, and that when SIN3A is overexpressed, MYC acetylation
and therefore stability are decreased. As a consequence, MYC is targeted for
degradation and displaced from its target genes, which are then occupied by
SIN3A, as well as MXI1. In fact, I have shown that SIN3A and MXI1 occupancy
at the EDC genes is dependent on MYC levels. Because SIN3A is a known
transcriptional repressor that recruits MXD/MNT proteins, it seems likely that
it’s function in the epidermis is to repress MYC target genes. Indeed, when Sin3a
was deleted from the basal undifferentiated layers of the epidermis, it induced
an increase in the thickness of the IFE as well as the number of differentiation
suprabasal layers. I have shown that this was due to de-repression of EDC, as well
as proliferation genes. Genome-wide motif analysis of MYC target and SIN3A
regulated genes in the epidermis, has shown that the MYC-MAX consensus motif
was highly enriched. Lastly, functional analysis revealed that both MYC and
SIN3A control genes involved in cell growth, proliferation, metabolism and mRNA
processing, in addition to epidermal differentiation. In conclusion, I have shown
that SIN3A and MYC cooperate in the maintenance of epidermal homeostasis by
regulating genes involved in differentiation and proliferation.
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Chapter 6
Epidermal homeostasis is
controlled by SIN3A and MYC
6.1 Deletion of MYC rescues the phenotype of
K14Sin3A∆/∆ mice
To understand if the hyperproliferation and increased differentiation observed
in K14Sin3A∆/∆ epidermis was solely dependent on MYC, deletion of Myc in
this context was paramount. Analysis of skin sections of mice where Sin3a and
Myc were deleted in undifferentiated epidermal cells (K14Myc∆/∆K14Sin3a∆/∆)
demonstrated that upon Myc deletion, the epidermal morphology was largely
rescued (Figure 6.1 A-C).
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K14Sin3A∆/∆Wild-typeA B C K14Myc∆/∆Sin3A∆/∆
Figure 6.1: Deletion of Myc reverts K14Sin3a∆/∆ phenotype. Hematoxilin
and eosin staining of sections of wild-type (A), Sin3a deleted (K14Sin3a∆/∆, B), and
Myc and Sin3a deleted (K14Myc∆/∆Sin3a∆/∆, C) epidermis. Deletion of Myc in
K14Sin3a∆/∆ reverted the thickness of the interfollicular epidermis to levels compa-
rable to wild-type skin. Scale bar:150µm.
Confirmation of Myc mRNA gene expression levels in epidermis from K14Myc∆/∆Sin3a∆/∆
mice was performed by RT-qPCR and shows that the mRNA levels of Myc de-
creased to half when compared to wild-type control or Sin3a depleted epidermis.
(K14Sin3a∆/∆) (Figure 6.2).
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Figure 6.2: Myc levels decrease in K14Myc∆/∆Sin3a∆/∆ skin. mRNA expres-
sion levels of Myc measured by reversetranscriptase semi-quantitative PCR for wild-
type and the indicated transgenic mice. Results were calculated relative to Gapdh.
Data represents the mean values for three biological replicates (n = 3) and bars the
standard deviation of the mean.
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6.2 Loss of Myc in K14Sin3A∆/∆ restores pro-
liferation
Functional analysis performed on genes differentially expressed in K14Sin3a∆/∆
and K14Myc∆/∆Sin3a∆/∆ murine skin samples, confirmed that genes related to
proliferation and cell cycle that initially were two fold upregulated in Sin3a
depleted epidermis, where either restored to wild-type levels or repressed in
K14Sin3a∆/∆ epidermis (Figure 6.3).
-1 
0 
1 
2 
3 
4 
5 
6 
Ep
gn
Pr
l2
c3
G
jb
6
H
be
gf
Sl
fn
1
O
dc
1
Sf
n
Fc
gr
2b
Pr
l2
c2
Pt
ge
s
Ls
t1
C
xc
l1
0
C
yb
7b
1
Sa
t1
Sl
fn
2
Et
v4
Pp
ar
d
M
ar
ck
sl
1
Il4 Ap
ob
ec
1
Fo
xp
3
Tg
fb
1
Sa
sh
3
Ei
f2
ak
2
M
yd
88
In
pp
5d
Ad
a
H
cl
s1
E2
f3
Ifi
tm
3
An
xa
1
G
rn
Vs
ig
4
A
0 
1 
2 
A
vp
i1
 
M
ap
k6
 
B
irc
5 
C
dc
20
 
C
ha
f1
b 
P
lk
1 
C
dc
a8
 
D
bf
4 
C
cn
b1
 
G
sg
2 
C
dc
a3
 
C
ht
f1
8 
N
as
p 
U
hr
f1
 
A
ur
kb
 
N
ca
ph
 
C
dt
1 
K
if2
c 
C
cn
e1
 
P
pm
1g
 
E
2f
3 
Ti
m
el
es
s 
M
cm
2 
A
nl
n 
M
ad
2l
1 
E
rh
 
In
ce
np
 
lo
g2
 F
C
 T
ra
ns
ge
ni
c 
/ W
T
lo
g2
 F
C
Tr
an
sg
en
ic
 / 
W
T K14Sin3A∆/∆ K14Myc/Sin3A∆/∆
B
GO: Proliferation
GO: Cell cycle
Figure 6.3: Myc deletion in K14Sin3a∆/∆ restored normal proliferation.
Log2 fold change of genes categorized as cell proliferation (A) and cell cycle (B)
in Sin3a depleted skin (K14Sin3a∆/∆, red bars) or Myc and Sin3a depleted skin
(K14Myc∆/∆Sin3a∆/∆, blue bars). mRNA levels were normalized to wild-type (WT)
controls. Data was obtained from gene expression arrays where at least 4 biological
replicates were used.
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6.3 Loss of Myc in K14Sin3A∆/∆ restores differ-
entiation
Similarly, the expression pattern of epidermal differentiation regulators CEBPα
and KLF4 in K14Myc∆/∆Sin3a∆/∆ murine epidermis was restored to levels ob-
served in the wild-type (Figure 6.4 A-G). Analysis of the mRNA expression lev-
els of EDC genes was also found to be more comparable to wild-type than to
K14Sin3a∆/∆ epidermis (Figure 6.4 H).
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6. Epidermal homeostasis is controlled by SIN3A and MYC
Confirmation of the restored mRNA levels of selected EDC genes S100a1,
S100a10 and Lce1a2 was performed by RT-qPCR analysis (Figure 6.5). Com-
parison of mRNA levels of the indicated genes in acetone treated (negative con-
trol correspondent to wild-type) and K14Myc∆/∆Sin3a∆/∆ murine epidermis does
not show significant differences in expression when compared to K14MycER,
K14Myc∆/∆, or K14Sin3a∆/∆ (Figure 6.5, D).
Figure 6.5: mRNA expression levels of EDC genes restored in
K14Myc∆/∆Sin3a∆/∆ epidermis. Reverse transcriptase semi-quantitative PCR
(RT-qPCR) for the indicated transgenic mice treated with tamoxifen (4-OHT) for
either 4 days (K14MycER) , 14 days (K14Sin3a∆/∆ and K14Myc∆/∆Sin3a∆/∆ ) or
21 days (K14Myc∆/∆) compared to acetone treated mice (negative controls). Results
were calculated relative to Gapdh. Data represents the mean values for three biological
replicates (n = 3) and bars the standard deviation of the mean.
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6. Epidermal homeostasis is controlled by SIN3A and MYC
6.4 Summary
My data revealed that the effect of increased proliferation and differentiation
observed upon Sin3a deletion in epidermis, is a consequence of an increase in
Myc levels. This was confirmed when deletion of Myc in the epidermis of a
K14Sin3a∆/∆ background mouse line, resulted in restoration of the abnormal
proliferation and differentiation phenotype, previously observed at the IFE. This
effect was also confirmed at the genetic level when EDC genes, as well as genes
involved in growth and differentiation, were either restored to wild-type level
or repressed in K14Myc∆/∆Sin3a∆/∆ mice. In summary, a dramatic reduction
of both undifferentiated proliferating and differentiated epidermal cells in skin
of K14Myc∆/∆Sin3a∆/∆ mice was observe. These results suggest that MYC and
SIN3A target the same group of genes required for normal epidermal homeostasis,
but their roles in this process are antagonistic. MYC acts primarily as an activator
of proliferation and differentiation related genes, while SIN3A act as a repressor.
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Chapter 7
Conclusions and Future
Perspectives
MYC functions have been extensively studied in cancer, but few reports have
addressed the biological function of MYC in normal cells and tissues. Studies in
cell lines dramatically changed the view of MYC as a gene-specific transcription
factor, when genome-wide binding studies revealed widespread binding of MYC
to tens of thousands of sites in the genome (reviewed in Knoepfler [2007]). Con-
sistent with this I have shown that in epidermal stem and progenitor cells, MYC
modulates the transcriptional response of 2187 genes involved in processes as di-
verse as cell growth and proliferation, metabolism, apoptosis, mRNA processing,
non-coding RNA processing, differentiation and chromatin remodeling. In addi-
tion, MYC has been shown to modulate adhesion and opposing processes such
as proliferation and differentiation. While MYC induced proliferation has been
shown to be directly regulated at the promoter of cell cycle regulators such as
CDK4, the underlying mechanisms for MYC induced differentiation were thought
to be indirect. My work indicates that indeed MYC binds and transcriptionally
regulates the promoters of at least 15% of the genes in the genome of mouse epi-
dermal cells, including genes involved in epidermal differentiation, as shown by
the widespread binding of MYC to the epidermal differentiation complex (EDC)
in mouse chromosome 3. In particular, as it has been shown by others [Guccione
et al., 2006], MYC binding was widespread accross the genome and at the EDC,
in particular, overlapping with a chromatin mark generally found at active genes,
H3K4me3. My work shows, that enrichment for this chromatin mark in the epi-
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dermis, does not change following MYC activation, supporting a model where
the deposition of H3K4me3 is independent of MYC.
Overall, MYC induces rapid transcriptional changes to a large proportion of genes
in undifferentiated proliferating keratinocytes. This was observed following anal-
ysis of the gene expression profiles of K14MycER mice, where MYC was induced
either one to six days, revealing that most target genes were up- or downregu-
lated immediately after 1 day induction. Interestingly, EDC genes comprised the
only group of genes with a substantial delay in activation upon MYC induction
(only after 4 days). This observation led to the hypothesis that the EDC clus-
ter might require remodeling before initiating a transcriptional response. I have
shown that upon MYC activation, a selected set of epidermal differentiation-
specific regulators is removed, while another set is placed at the promoters of
EDC genes. These observations suggest that MYC controls the trancription of
these genes by direct binding to the promoter regions following recruitment of a
differentiation specific regulatory TF network. I observed that KLF4 and OVOL1
were some of the regulators involved in this network. Both TFs were recruited
to the EDC upon MYC induction, suggesting that these might replace MYC at
the promoter of the EDC genes. In particular, KLF4 has been shown to possibly
regulate the Sprr family of genes. In addition, previous work demonstrated that
KLF4 [Segre et al., 1999] and OVOL1 [Teng et al., 2007] are essential for estab-
lishment of the barrier function of the skin, negatively regulating Myc expression.
In my work I have also shown that there is a group of regulators that is dis-
placed from the EDC upon MYC activation, which comprises CEBPα, MXI1
and SIN3A. My data revealed that SIN3A and MYC target a large proportion
of common genes, known to be involved in proliferation and differentiation in
the skin. Previously, SIN3A has been defined as an important regulator of testis
[Payne et al., 2010] and adult muscle homeostasis [VanOevelen et al., 2010] as
well as a regulator of the myotube differentiation process, therefore it does not
seem surprising that SIN3A might as well have a role on epidermal homeostasis.
Although the biological role of SIN3A in the epidermal differentiation specific
network has not been fully elucidated, one possible mechanism of action might
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be through detection of DNA-bound MYC at the EDC and removal via deacety-
lation, since MYC acetylation decreases upon SIN3A overexpression, as well as
its half-life. Removal of MYC from the promoter regions of EDC genes facilitates
recruitment of MYC antagonists by SIN3A. One of MYC antagonists, MXI1,
correlated with SIN3A in terms of location across the EDC and was enriched
in wild-type and absent in K14MycER epidermis. Binding of MXI1 appears to
strongly depend on the availability of its binding motif, the E-box (for which it
competes with MYC), rather than on the levels of SIN3A, as MXI1 enrichment
in Sin3a depleted cells was comparable to wild-type.
The fact that overexpression of Myc in the epidermis prevents SIN3A binding,
indicates that in these conditions SIN3A is unable to form a stable complex with
MYC in order to induce it’s degradation, or stoichiometrically the number of
molecules for SIN3A and MYC is largely unbalanced, in a way that not enough
MYC molecules are targeted for degradation. It is possible that the interaction
between MYC and SIN3A is indirect, via other core-proteins mediating the de-
acetylase enzymatic activity, and not directly via the PAH2 domain of SIN3A,
as it has been described for MXD proteins. One possible candidate mediating
MYC deacetylation via SIN3A would be YY1, which has been shown to directly
interact with both proteins and to also cause degradation of MYC, although this
is still under debate [Gordon et al., 2006; Parija and Das, 2003; Yang et al., 1996].
SIN3A constitutes one of the few chromatin remodelers for which a direct link
with a TF has been described during epidermal stratification. Indeed, the pro-
cess of how chromatin remodelers (e.g DNA methyltransferase 1 DNMT1, histone
demethylase JMJD3, histone acetylases 1 and 2, chromatin modifying enzymes
Brg1 and Mi-2β and the polycomb group Ezh2) and TFs are coordinately regu-
lated to establish a skin specific regulatory network has been poorly understood.
Recently, in an effort to elucidate these interactions, Botchkarev and colleagues
have shown that deletion of the higher order genome organizer Satb1 in epider-
mal progenitors, prevents activation of genes in the EDC locus [Truong et al.,
2006]. In the absence of SATB1, decompression of the EDC locus is observed,
specifically in the central domain, resulting in a marked downregulation of termi-
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nal differentiation-associated genes. As a consequence of Satb1 deletion, specific
morphogical changes in the epidermis are observed, such as: thinning of the
granular layer and decrease of the epidermal thickness. Interestingly, Botchkarev
work also identified Satb1 as a direct downstream target of the TF p63, a known
master regulator of epidermal development and homeostasis. At the same time,
Driskell and colleagues identified another chromatin remodeler and known target
of MYC, SETD8 (monomethyltransferase of H4K20), which is also required for
normal p63 expression in skin [Driskell et al., 2011]. The role of SATB1 is to
induce remodeling of the chromatin architecture of the EDC by compression of
the central domain of the locus containing differentiation associated genes, but
this information is still lacking for SETD8. Neverthless, it is possible a scenario
where SETD8, in combination with SATB1 cooperatively bind to a region of
the EDC designated as the ’gene desert’. This region might contain evolution-
ary conserved regulatory sequences important for the formation of 3 dimensional
(3D) loop structures. The 3D loops allow the interaction of distal- and promoter-
regions and are important for gene transcriptional regulation. In skin, informa-
tion regarding the role of the ’gene desert’ present in the EDC is limited, but
studies in the Hoxd cluster during limb development have shown that gene desert
regions, also designated as ’regulatory archipelagos’ , contain several enhancer
like-sequences that contribute to gene expression [Montavon et al., 2011]. Pre-
sumably, such enhancer-like sequences might be present in the EDC ’gene desert’
and therefore it would be interesting to identify enhancer regions (for example
using H3K4me1 or H3K27Ac as markers) as well apply the use of the chromo-
some conformation capture technique (3C) with ChIP (ChIP-3C) [Fullwood and
Ruan, 2009] to identify potential interaction spots between distal- and promoter-
regions at the EDC during epidermal maturation.
Overall this study identified that MYC transcriptional functions in the epider-
mis are controlled by SIN3A. The activity of both proteins appears crucial for
maintenance of epidermal homeostais, as perturbation of these proteins expres-
sion affects epidermal morphology. The right balance between MYC and SIN3A
prevents hyperproliferation or differentiation, therefore rescuing the skin from
diseases such as cancer or psoriasis. In the future, it would be interesting to
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study if the specific process of degradation of MYC via deacetylation, possibly
exploring the ubiquitin proteosome pathway. Also, it would be exciting to ex-
plore if overexpression of SIN3A in vivo in basal undifferentiated keratinocytes is
able to prevent differentiation and/or proliferation and wether mutations in the
Sin3a locus might predispose to the formation of epidermal tumours. Lastly, the
possibility that other TFs, such as KLF4 and OVOL1, might also interact with
the MYC protein is very likely, and therefore it would be valuable to perform TF
location at various time-points to understand the tissue specific regulatory net-
works, during the differentiation process in skin, as well as sequential chromatin
immunoprecipitation experiments to identify other MYC interactors important
in the process.
In summary my work has shown that:
1. MYC directly regulates genes involved in cell adhesion and proliferation in
mouse epidermal stem and progenitor cells.
2. MYC regulates genes involved in epidermal specific differentiation.
3. MYC binding induces remodeling of the occupancy of tissue-specific tran-
scriptional regulators, an effect that is enhanced at the promoter of epider-
mal lineage specific genes.
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Appendix
Gene log2 fold-change
Krtap16-4 -4.406094451
Krtap16-9 -4.369305888
Krt33b -4.319155808
Krt33a -4.274609987
Krt81 -4.247673801
Krt86 -4.167640493
S100a3 -4.160445546
Krtap9-1 -4.160125002
Krtap16-9 -4.136371955
Krtap5-1 -4.092171413
Krtap4-1 -4.086366855
Krtap11-1 -4.044824358
Krtap6-2 -4.04300514
Krt34 -4.008367231
Krtap3-1 -3.981801044
Krt86 -3.977885451
Krt73 -3.962887702
Krtap6-1 -3.955978334
Krtap4-16 -3.922609954
Krtap6-2 -3.896878614
Krtap17-1 -3.895732922
AK173067 -3.892441163
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Gene log2 fold-change
Krtap2-4 -3.873521483
Krtap7-1 -3.871735756
Krtap16-7 -3.871420502
Vsig8 -3.832521374
Krt86 -3.773462007
AK020703 -3.721535688
Krt71 -3.713099818
Krtap16-8 -3.698839829
Krtap1-5 -3.684733773
Krtap16-10 -3.667033255
Krt31 -3.661278777
Krtap5-2 -3.63879009
Krtap31-2 -3.628625449
Krtap4-7 -3.610565271
Krtap31-2 -3.582216079
AY026312 -3.576947317
Krt35 -3.567152982
Krtap4-13 -3.553960528
Cryba4 -3.547299745
2310033E01Rik -3.441872202
RP23-212C14.7 -3.439127269
Krtap10-10 -3.433411048
Ly6g6d -3.425286804
Krtap1-4 -3.395323943
AK020694 -3.393646475
Cyp2g1 -3.390027167
LOC100040214 -3.386898776
Psors1c2 -3.367115852
Krt28 -3.366392537
Krt72 -3.320526507
Krt27 -3.308350788
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Gene log2 fold-change
Krt83 -3.265051131
Krt26 -3.232622758
Krt86 -3.146452147
LOC100040201 -3.143534867
AK017438 -3.119866462
Krtap26-1 -3.09026475
Adh6b -3.035552698
Lrrc15 -3.03306489
Crym -2.981082108
Krtap26-1 -2.978715784
AK020696 -2.966013187
Cpm -2.957236435
Krtap13-1 -2.945094031
Gjb2 -2.923630369
Krt73 -2.921231518
Krtap9-3 -2.898023266
Gjb2 -2.876692122
Krtap6-3 -2.856134382
Prr9 -2.834858389
Sct -2.817960419
AK220314 -2.748579524
Ctse -2.738962071
Si -2.712885358
Tchhl1 -2.690342596
A030003K21Rik -2.662221347
S100a7a -2.661157797
BC048518 -2.65727806
Padi1 -2.648052855
D730001G18Rik -2.631668835
Cpm -2.610117529
Gjb2 -2.589816667
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Gene log2 fold-change
Cyp2g1 -2.571638167
AK009595 -2.536481843
NR001463 -2.487222583
Krt84 -2.442914182
Gnmt -2.415183936
Fam26d -2.402116649
Krtap14 -2.371758828
Gjb6 -2.337016334
Krtap16-7 -2.311637567
Krtap16-5 -2.307255311
Si -2.304274608
Krt36 -2.289411262
Dlx3 -2.276098249
Mlana -2.245948402
BC039632 -2.240736683
Chac1 -2.184681333
Krt82 -2.14577175
Ctps -2.125399737
2310007B03Rik -2.113100904
Ctps -2.072317051
AK009595 -2.023613005
Dclk3 -2.008677417
Krtap16-10 -1.996617509
Ctps -1.990219768
Slc7a8 -1.970057002
Dct -1.957346269
Krt82 -1.9340153
Fbp1 -1.923199106
Eef2 -1.899222393
NR001463 -1.881815084
AK037168 -1.875285882
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Gene log2 fold-change
Tmem90a -1.868944521
BC042411 -1.859516166
Krtap16-1 -1.835449142
Hspa8 -1.82749694
Slc40a1 -1.822658096
Dusp2 -1.792051514
Akr1c18 -1.783154767
AK173067 -1.782584613
Upp1 -1.769756477
Otop2 -1.760150203
Tyrp1 -1.756218973
Erdr1 -1.735490805
Krtap15 -1.733706352
Sytl2 -1.727567885
2310033E01Rik -1.723180785
Vsig8 -1.707512732
Ppp1ca -1.704595687
Bhlha9 -1.70459358
Dusp14 -1.701908657
Fxyd4 -1.684756511
Mt4 -1.681362374
Dct -1.669290134
Eif5a -1.66108632
Atp13a4 -1.657298575
Gp9 -1.627712717
Eef2 -1.627619225
EG433923 -1.601780498
Casp14 -1.586549749
Fam46b -1.582392579
4930438A08Rik -1.57116359
Foxe1 -1.567077225
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Gene log2 fold-change
Alox8 -1.557238761
Slc39a8 -1.556398185
Lyg2 -1.549592805
Krtap31-1 -1.539568232
Tro -1.53909724
Pitrm1 -1.537337291
Sprr1b -1.522700856
Sfn -1.518027649
Slc4a1 -1.517745223
Ass1 -1.506479479
Dnase1l2 -1.505609081
Msx2 -1.500298966
Eraf -1.493270608
Sp6 -1.492466906
Eef2 -1.488002939
Dnajc6 -1.483089091
Msx1 -1.479856359
Mlf2 -1.472757887
Gpnmb -1.472542841
Fzd5 -1.434833335
D12Ertd553e -1.419990904
Sp6 -1.419120718
Tyrp1 -1.414240573
Gabrp -1.399854425
6330442E10Rik -1.399150495
Rtkn2 -1.392510144
Krt36 -1.392055711
Hnrnpa2b1 -1.387855001
Fam26d -1.387030389
Fdps -1.383267304
Dnase1l2 -1.382429465
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Gene log2 fold-change
Mycl1 -1.376456394
Rab15 -1.376335597
Hnrnpa1 -1.375451707
Cct3 -1.366837538
Ovol1 -1.359112001
Slc5a5 -1.358949143
Tagln3 -1.358313477
Cnfn -1.355636961
Eif5a -1.354616748
Otub2 -1.354539253
Krtap12-1 -1.348906882
Wnt5a -1.347344574
Zdhhc13 -1.346015865
Mfsd2 -1.339305332
Nkd2 -1.338315702
Slc7a5 -1.335802548
AI646023 -1.331901864
Rnf222 -1.330337048
Spint1 -1.325041113
Zdhhc13 -1.319867671
Fgf22 -1.317585038
AK003073 -1.315967683
Rnaset2b -1.315064878
Cnfn -1.31190376
Slc6a13 -1.311683375
Gcat -1.306003204
Krtap8-2 -1.292335361
Shh -1.292299123
Mup2 -1.28756728
Gng13 -1.287497159
Ptbp1 -1.286699036
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Gene log2 fold-change
Slc39a6 -1.283150789
Bmp8a -1.281430259
Serinc2 -1.281380419
Edn2 -1.277450255
Krtap5-4 -1.272545192
Tubb6 -1.269879462
Serinc2 -1.267810497
Nop58 -1.267409942
Eif4a1 -1.264260105
Lmnb1 -1.259126341
AK137397 -1.256515702
Erdr1 -1.253432504
Rars -1.25144353
Dnase1l2 -1.246488416
Mki67 -1.243872968
AK082735 -1.241038183
Rps27a -1.234746142
Actb -1.230763404
Calr -1.23047366
1110012J17Rik -1.229225933
Cdc2a -1.228338285
S100a14 -1.227315443
Krt75 -1.227136572
Cited4 -1.224296137
NR001463 -1.222655277
Tyrp1 -1.217248529
Otub2 -1.208183753
4732456N10Rik -1.208175132
Cyp2d22 -1.205668831
Ivl -1.202504913
ASK2 -1.195744553
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Gene log2 fold-change
Ranbp1 -1.186329269
Cyp17a1 -1.184797116
Tpm1 -1.184514584
Dnajc6 -1.182243267
Lsr -1.179539666
Hnrnpk -1.179520469
AK031134 -1.173947995
Hmgb2 -1.172664605
Nfil3 -1.172202172
Tnc -1.16890659
Hist1h2ak -1.167115782
Sqle -1.165340017
Hist1h2ah -1.164319131
Ccbl1 -1.164097665
Cux1 -1.162710542
Pik3r3 -1.162070704
Gnmt -1.161504626
Gprc5a -1.160743864
Krtap5-5 -1.158313245
AK008417 -1.157498305
Fzd10 -1.148479177
BC003885 -1.142955319
D4Bwg0951e -1.14118881
Pla2g2e -1.140170907
Mfap3l -1.138526417
Npm3 -1.136696225
Rnd3 -1.135318406
Ccbl1 -1.132050033
Atp6v0d1 -1.130820049
AK079261 -1.130716432
Sprr1a -1.129493205
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Gene log2 fold-change
Krt36 -1.129159387
Mrpl3 -1.126900297
Acot7 -1.126866243
St14 -1.126088013
Fads3 -1.124300718
Nup210 -1.122380191
Acsm3 -1.122242658
AK052609 -1.122051536
Uck2 -1.12064945
2610029G23Rik -1.117250918
Gpc3 -1.116597488
Fzd10 -1.115804231
Hspd1 -1.114763083
Eif2s3x -1.110135182
AK034531 -1.108778614
Slc25a37 -1.106269191
Atp12a -1.105233172
Tgm3 -1.10516005
Ephb1 -1.100751373
Acaa2 -1.100690687
Upp1 -1.099319558
Lyg2 -1.096166404
Birc5 -1.094057833
Vangl2 -1.093921633
Top2a -1.090717172
Ivl -1.08939805
Ptbp1 -1.087294325
Fabp5 -1.085636736
Hist1h2ad -1.085328792
Nme1 -1.085219693
Ard1a -1.081185638
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Gene log2 fold-change
C330005M16Rik -1.080866798
Upp1 -1.079064966
Eif3i -1.078798482
Cxcl14 -1.076886316
Rnaset2b -1.076343244
Cdk4 -1.075316741
Hoxc13 -1.075153438
Krtap5-4 -1.073134498
Ctse -1.067900515
Hopx -1.066619091
Slc25a37 -1.063207038
Hist1h2af -1.060739035
ENV -1.060045996
Acot1 -1.058592562
Krt82 -1.053108776
Mup2 -1.052838957
Cytsb -1.051989696
Hnrnpa1 -1.049051306
Hist1h2ah -1.048233524
Rpl13a -1.047588935
Cenpa -1.045776855
Lypla2 -1.043644171
H2afx -1.038912234
Abhd2 -1.038585344
Oca2 -1.037314046
Tspan6 -1.035560718
Psmd7 -1.034437506
Acpl2 -1.034313482
Cxcl14 -1.033682484
Npm3 -1.033374583
Unc5b -1.032435227
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Gene log2 fold-change
E2f2 -1.030809693
Ptbp1 -1.029961801
Frag1 -1.028222774
Rpgrip1 -1.025489508
Fzr1 -1.025463977
Tpm1 -1.025328855
Rbbp7 -1.024228811
Acaa2 -1.021185653
Pbk -1.018999491
Rab1b -1.018907391
Otub2 -1.018037178
Eif2b4 -1.017827053
Dnase1l2 -1.017664334
Clu -1.015135375
Actn4 -1.014558124
Slc1a4 -1.013841419
1700019N12Rik -1.013280876
Acot7 -1.013177076
Cldn10 -1.01167167
Nhp2 -1.011492892
Foxq1 -1.009518251
Birc5 -1.008187431
Rab25 -1.005347967
5730437N04Rik -1.004548525
Ptgds -1.004437679
Tspan3 -1.004435242
Cdh6 -1.003234531
Uck2 -1.002638023
165
Gene log2 fold-change
Table 1: List of genes repressed in K14Myc∆/∆ mice. Majority of the genes are either
related to keratins or to regulators of the differentiation process in the epidermis. Data
represents normalized Log2 fold changes of a minimum of four biological replicates
(n=4) and P-values below 0.05.
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